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Abstract
In causal inference for longitudinal data, standard methods usually assume that the underlying processes are
discrete time processes, and that the observational time points are the time points when the processes change
values. The identification of these standard models often relies on the sequential randomization assumption,
which assumes that the treatment assignment at each time point only depends on current covariates and the
covariates and treatment that are observed in the past. However, in many real world data sets, it is more
reasonable to assume that the underlying processes are continuous time processes, and that they are only
observed at discrete time points. When this happens, the sequential randomization assumption may not be
true even if it is still a reasonable abstraction of the treatment decision mechanism at the continuous time
level. For example, in a multi-round survey study, the decision of treatment can be made by the subject and
the subject's physician in continuous time, while the treatment level and covariates are only collected in
discrete times by a third party survey organization. The mismatch in the treatment decision time and the
observational time makes the sequential randomization assumption false in the observed data. In this
dissertation, we show that the standard methods could produce severely biased estimates, and we would
explore what further assumptions need to be made to warrant the use of standard methods. If these
assumptions are false, we advocate the use of controlling-the-future method of Joffe and Robins (2009) when
we are able to reconstruct the potential outcomes from the discretely observed data. We propose a full
modeling approach and demonstrate it by an example of estimating the effect of vitamin A deficiency on
children's respiratory infection, when we are not able to do so. We also provide a semi-parametric analysis of
the controlling-the-future method, giving the semi-parametric efficient estimator.
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ABSTRACT
CAUSAL INFERENCE FOR DISCRETELY OBSERVED CONTINUOUS TIME
PROCESSES
Mingyuan Zhang
Supervisers: Dylan Small and Marshall Joﬀe
In causal inference for longitudinal data, standard methods usually assume that the
underlying processes are discrete time processes, and that the observational time
points are the time points when the processes change values. The identiﬁcation of
these standard models often relies on the sequential randomization assumption, which
assumes that the treatment assignment at each time point only depends on current
covariates and the covariates and treatment that are observed in the past. However,
in many real world data sets, it is more reasonable to assume that the underlying
processes are continuous time processes, and that they are only observed at discrete
time points. When this happens, the sequential randomization assumption may not
be true even if it is still a reasonable abstraction of the treatment decision mechanism
at the continuous time level. For example, in a multi-round survey study, the decision
of treatment can be made by the subject and the subject’s physician in continuous
time, while the treatment level and covariates are only collected in discrete times by
v
a third party survey organization. The mismatch in the treatment decision time and
the observational time makes the sequential randomization assumption false in the
observed data. In this dissertation, we show that the standard methods could produce
severely biased estimates, and we would explore what further assumptions need to
be made to warrant the use of standard methods. If these assumptions are false, we
advocate the use of controlling-the-future method of Joﬀe and Robins (2009) when
we are able to reconstruct the potential outcomes from the discretely observed data.
We propose a full modeling approach and demonstrate it by an example of estimating
the eﬀect of vitamin A deﬁciency on children’s respiratory infection, when we are not
able to do so. We also provide a semi-parametric analysis of the controlling-the-future
method, giving the semi-parametric eﬃcient estimator.
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Chapter 1
Introduction
1.1 Standard Causal Inference in Longitudinal Data
In a cross-sectional observational study of the eﬀect of a treatment on an outcome,
a usual assumption for making causal inferences is that there are no unmeasured
confounders, i.e., that conditional on the measured confounders, the data is gener-
ated as if the treatment was assigned randomly. Under this assumption, a consistent
estimate of the average causal eﬀect of the treatment can be obtained from a cor-
rect model of the association between the treatment and the outcome conditional on
the measured confounders (Cochran, 1965). In a longitudinal study, the analogue
of the no unmeasured confounders assumption is that at the time of each treatment
assignment, there are no unmeasured confounders; this is called the sequential ran-
domization or sequential ignorability assumption:
(A1) The longitudinal data of interest are generated as if the treatment is random-
ized in each period, conditional on the current values of measured covariates and the
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history of the measured covariates and the treatment.
The sequential randomization assumption implies that decision on treatment assign-
ment is based on observable history and contemporaneous covariates and that people
have no ability to peek into the future. Robins (1986) has shown that for a longitu-
dinal study, unlike for a cross-sectional study, even if the sequential randomization
assumption holds, the standard method of estimating the causal eﬀect of the treat-
ment by the association between the outcome and the treatment history conditional
on the confounders can provide a biased and inconsistent estimate. This bias can
occur when we are interested in estimating the joint eﬀects of all treatment assign-
ments and when the following conditions hold:
(c1) conditional on past treatment history, a time-dependent variable is a predictor
of the subsequent mean of the outcome and also a predictor of subsequent treatment;
(c2) past treatment history is an independent predictor of the time-dependent vari-
able.
An example in which the standard methods are biased is the estimation of the causal
eﬀect of the drug AZT (zidovudine) on CD4 counts in AIDS patients. Past CD4
count is a time-dependent confounder for the eﬀect of AZT on future CD4 count,
since it not only predicts future CD4 count but also subsequent initiation of AZT
therapy. Also, past AZT history is an independent predictor of subsequent CD4
count (Herna´n, Brumback and Robins, 2002).
To eliminate the bias of standard methods for estimating the causal eﬀect of
2
treatment in longitudinal studies where sequential randomization holds but there
are time-dependent confounders satisfying conditions (c1) and (c2) (e.g., past CD4
counts), Robins (1992, 1994, 1998, 1999) developed a number of innovative meth-
ods, including g-computation algorithm, structural nested models (SNMs) with g-
estimation, and marginal structural models (MSMs) with IPTW (inverse probability
of treatment weighted) estimation.
A signiﬁcant portion of this thesis focuses on structural nested models (SNMs)
and their associated methods of g-testing and g-estimation. The basic idea of the g-
test is the following. Given a hypothesized treatment eﬀect and a deterministic model
of the treatment eﬀect, we can calculate the potential outcome that a subject would
have received if she never received the treatment; if the hypothesized treatment eﬀect
is the true treatment eﬀect, then this potential outcome will be independent of the
actual treatment the subject received conditional on the confounder and treatment
history, under the sequential randomization assumption (A1). G-estimation involves
ﬁnding the treatment eﬀect that makes the g-test statistic have its expected null
value. A formal description of g-estimation is given in Section 2.2.1 of Chapter 2.
G-estimation is very attractive because researchers are usually only required to
model the propensity score for the treatment. The estimate is consistent when the
model of the treatment assignment is correct. It is also possible to construct a g-
estimator that is locally eﬃcient doubly robust. As long as we can correctly model
either the propensity score for the treatment or the conditional distribution for the
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potential outcomes conditional on the covariates, the estimator will be consistent,
asymptotically normal and regular. The researchers get “two shots” rather than
one to get a consistent estimate. Moreover, if we can correctly model the both the
propensity score and the conditional distribution of the potential outcomes simulta-
neously, the estimator achieves the semi-parametric eﬃciency bound under the sole
restriction that the assumption (A1) is true. In another word, there exists no other
estimator that is more eﬃcient than the locally eﬃcient doubly robust g-estimator.
1.2 When the Longitudinal Data are Discrete Time Obser-
vations from Continuous Time Processes
Intriguing as the standard methods are, they are mostly designed for discrete time
models. The discrete time models assume that the treatment, covariates and outcome
processes can only change values at discrete time points, and that these discrete time
points are fully observed. If at these observational time points we are able to measure
all the covariates that is needed for the input of the decision making mechanism, we
could reasonably assume assumption (A1) in the data, and in principle we might
be able to model the decision making mechanism correctly given enough data. The
standard methods would apply. Lok (2007) has extended the theory to continuous
time processes, under the condition that the full continuous time paths of treatment
and covariates are observed.
In this thesis, we consider causal inference in longitudinal data, but we assume
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that the longitudinal data are discrete time observations of continuous time processes.
In many real world problems, this is a more realistic assumption. For example, in
the example of the eﬀect of Zidovudine (AZT) on CD4 count, a data set from the
Multi-center AIDS Cohort Study (Kaslow et al., 1987) can be used. In the study, the
patients might visit the doctors any time during the years, and the doctors would
decide the use of AZT at the time of the visits. However, the organization who
collected the data only regularly collected them once every six months. It is more
reasonable to assume that the treatment, covariates and outcomes processes are in
continuous time, but only observed at discrete time points. More details on this
study and other real world examples are in Chapter 2 and Chapter 3.
When this setting is true, standard methods that ignore the continuous time
structure could produce severely biased estimates. In particular, we identify two
important sources of the bias:
∙ Unmeasured Confounders:
The identiﬁcation of the standard methods rely crucially on sequential random-
ization assumption in the data. In the setting that is of interest in this disser-
tation, the sequential randomization assumption could be a reasonable abstrac-
tion at the treatment decision level, i.e., the continuous time level. However,
It is unlikely to be true in the observed data in discrete times. The covariates
in between two consecutive time points are not measured and they could be
important unmeasured confounders that associated with both the treatment
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and the outcomes. As a result, the standard discrete time methods could be
biased.
∙ Treatment Measurement Error:
When the treatment process is only observed at discrete time points, the
amount of treatment that the subject receives may not be known precisely.
For example, when the treatment aﬀects the outcome cumulatively, discretely
observed treatment process will not give us exact amount of cumulative treat-
ment; when the treatment has direct or indirect eﬀect on future outcomes, the
past treatment aﬀecting the outcomes at the discrete observational time points
may not be observed. The treatment measurement error problem also includes
the case when we do observe the whole continuous time treatment process, but
the treatment eﬀect varies with covariate processes, which might be unobserved
in between two consecutive observational time points. In all these cases, even
given the true parameters in the causal model, we will not be able to accurately
reconstruct the counterfactual outcomes, or the mimicking counterfactual out-
comes in case of non-rank preserving models (see Lok 2004), or the mean of
counterfactual outcomes in case of mean models (see Herna´n, Brumack and
Robins, 2002). Any comparison among the counterfactuals might be biased.
This dissertation discusses conditions and methods that could eliminate or reduce
these two sources of bias in several scenarios. In particular, it is organized as follows.
Chapter 2 focuses on the problem of unmeasured confounder. We assume that the
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covariate and outcome processes are observed in discrete time points while the full
continuous time treatment process is observed. This is practical when the treatment
is a binary process and at the observational time points we are able to ask subjects
about their treatment history (e.g., time of initiation and time of cessation). Under
certain rank preserving models, we are free of the treatment measurement error prob-
lem. We discuss the use of standard methods in this scenario, and focus especially
on SNMs and their associated g-test and g-estimation. Conditions on the continuous
time processes are given in the chapter to warrant the use of a modiﬁed g-estimation.
When these conditions fails, we propose the controlling-the-future method of Joﬀe
and Robins (2009), which are based on a relaxed discrete time sequential randomiza-
tion assumption that allows the treatment to depend on future potential outcomes
given the past treatment and covariates. We show that the method can be used
to correct or reduce bias from the unmeasured confounders in our continuous time
setting. The content of this chapter is based on a working paper by Zhang et al.
(2009).
Chapter 3 considers a case when we do not have the full continuous time treat-
ment process and both the unmeasured confounder and the treatment error problems
arise. We propose a full modeling approach for causal inference, demonstrated by an
example of analyzing causal eﬀect of vitamin A deﬁciency on children’s respiratory
infection from a longitudinal data collected in Indonesia in 1983 (see Sommer et al.,
1983). The level of vitamin A deﬁciency could change any time in the years, while
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the data were only collected once every season. Important covariates that predict the
change in the levels of vitamin A deﬁciency and are related to the outcomes may be
unobserved causing the unmeasured confounder problem. The treatment in between
two observational time points are unobserved, causing the treatment error problem.
The treatment error problem is worsened by the fact that we only observe a coarsened
vitamin A deﬁciency level. In this chapter, we model the data generating process
as a continuous time Markov process observed at discrete time points. We design
an MCMC algorithm to estimate the Markov model. The content of this chapter is
based on a working paper by Zhang and Small (2009).
Chapter 4 revisits the controlling-the-future method we used in Chapter 2. We
view the relaxed sequential randomization assumption and the controlling-the-future
method as a powerful extension of the standard g-estimation for dealing with unmea-
sured confounders. In this chapter, we provide a theoretical analysis of this method
using the semi-parametric theory. In parallel to the standard theory for g-estimation,
we derive the nuisance tangent space under the sole restriction of the relaxed sequen-
tial randomization assumption, and we calculate the eﬃcient score under a single
period semi-parametric model. We also propose a locally eﬃcient doubly robust es-
timator for the controlling-the-future method. The calculation of nuisance tangent
space and the eﬃcient score are then extended to multi-period model with repeated
outcomes. Chapter 4 can be viewed as a theoretical supplement for Joﬀe and Robins
(2009).
8
Chapter 5 is the appendices, which include related the technical proofs in previous
chapters.
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Chapter 2
Causal Inference for Continuous Time Processes
when Covariates Are Observed Only at Discrete
Times
In this chapter, we study assumptions and methods for making causal inferences
about the eﬀect of a treatment that varies in continuous time when its full history of
continuous time treatment process is observed but its time-dependent confounders
are observed only at discrete times. In the framework of Section 1.2, we have un-
measured confounders, and under the causal models we will assume for this chapter
(see Section 2.7), we are free of the measurement error problems. In such settings,
standard discrete time g-estimation usually do not work, except when certain condi-
tions are assumed for the continuous time process. In this chapter, we formulate such
conditions. When these conditions do not hold, we propose a controlling-the-future
method that can produce consistent estimates when g-estimation is consistent, and
10
is still consistent in some cases when g-estimation is severely inconsistent.
2.1 Motivations and the Basic Setup
First, we describe two motivating examples when treatment changes values in con-
tinuous time while covariates are only observed at discrete times.
2.1.1 Examples of Treatments Varying in Continuous Time where Co-
variates are Observed Only at Discrete Times
Example 1: The eﬀect of AZT (Zidovudine) on CD4 counts. The Multicenter AIDS
Cohort Study (Kaslow et al., 1987) has been used to study the eﬀect of AZT on CD4
counts (Herna´n, Brumback and Robins, 2002; Brumback et al. 2004). Participants
in the study are asked to come semi-annually for visits at which they are asked
to complete a detailed interview including a complete history of AZT use, as well
as take a physical examination and provide blood samples from which CD4 counts
are obtained. Decisions on AZT use are made by subjects and their physicians, and
switches of treatment might happen any time between two visits. These decisions are
based on the values of diagnostic variables, possibly including CD4 and CD8 counts,
presence of certain symptoms, and other related time-dependent covariates. However,
these covariates are only measured by MACS at the time of visits; the values of these
covariates at the exact times that treatment decisions are made between visits are
not available.
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Example 2: The eﬀect of diarrhea on children’s height. Diarrheal disease is one
of the leading causes of childhood illness in developing regions of the world (Kosek,
Bern and Guerrant, 2003). Consequently, there is considerable concern about the
eﬀects of diarrhea on a child’s physical and cognitive development (Moore et al.,
2001; Guerrant et al., 2002). A data set which provides the opportunity to study the
impact of diarrhea on a child’s height is a longitudinal household survey conducted
in Bangladesh in 1998-1999 after Bangladesh was struck by its worst ﬂood in over
a century in the summer of 1998 (del Ninno et al., 2001; del Ninno and Lundberg,
2005). The survey was ﬁelded in three waves from a sample of 757 households: round
1 in November, 1998; round 2 in March-April, 1999; and round 3 in November, 1999.
The survey recorded all episodes of diarrhea for each child in the household in the
past six months or since the last interview by asking the families at the time of each
interview. In addition, the survey recorded at each of the three interview times several
important time-dependent covariates for the eﬀect of diarrhea on a child’s future
height: the child’s current height and weight, the amount of ﬂooding in the child’s
home and village; and the household’s economic and sanitation status. The child’s
current height and weight in particular are time-dependent confounders that satisfy
conditions (c1) and (c2) in Section 1.1, making standard longitudinal data analysis
methods biased (see Martorell and Ho, 1984 and Moore et al., 2001 for discussion of
evidence for and reasons why current height and weight satisfy conditions (c1) and
(c2)). The time-dependent confounders of current height and weight are available
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only at the time of the interview, and changes in their value that might aﬀect the
exposure of the child to the “treatment” of diarrhea, which varies in continuous time,
are not recorded in continuous time.
2.1.2 An Model Data Generating Process
In both the examples of AZT and diarrhea, the exposure or treatment process hap-
pens continuously in time and a complete record of the process is available, but the
time-dependent confounders are only observed at discrete times. There could be var-
ious interpretations of the relationship between the data at the treatment decision
level and the data at the observational time level. To clarify the problem of interest
in this chapter, we consider the following model data generating process:
(a1) A patient takes a certain medicine under the advice of a doctor.
(a2) A doctor continuously monitors and records a list of health indicators of her
patient, and decides the initiation and cessation of the medicine solely based
on current and historical records of these conditions, the historical use of the
medicine, as well as possibly random factors unrelated to the patient’s health.
(a3) A third party organization asks a collection of patients from various doctors
to visit the organization’s oﬃce semi-annually. The organization measures the
same list of health indicators for the patients at the time of the visits, and asks
the patients to report the detailed history of the use of the medicine between
two visits.
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(a4) We are only provided with the third party’s data.
Note that in (a2), we assume the sequential randomization assumption (A1) at the
treatment decision level.
The AZT example can be approximated by the above data generating process. In
the AZT example, (a1) and (a2) approximately describes the joint decision making
process by the patient and the doctor in the real world. (a3) can be justiﬁed by
reasonably assuming that the staﬀs at the MACS receive similar medical training
and use similar medical equipment as the patients’ doctors. In the diarrhea example,
the patient’s body, rather than a doctor determines whether the patient gets diar-
rhea. Assumption (a3) then is saying that the third party organization (the survey
organization) collects enough health data, and that if all the history of such health
data are available, the organization will be able to predict as well as is possible with
current medical knowledge whether a patient gets diarrhea at the time of the survey.
2.1.3 Diﬃculties Posed by Treatments Varying in Continuous Time when
Covariates Are Observed Only at Discrete Times
Suppose our data are generated as in the previous section, and we apply discrete
time g-estimation at the discrete times at which the time-dependent covariates are
observed; we will denote these observation times by 0, . . . , 퐾. In discrete time g-
estimation, we are testing whether the observed treatment at time 푡 (푡 = 0, . . . , 퐾)
is, conditional on the observed treatments at times 0, 1, . . . , 푡 − 1 and observed co-
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variates at times 0, . . . , 푡, independent of the putative potential outcomes at times
푡 + 1, . . . , 퐾 calculated under the hypothesized treatment eﬀect, where the putative
potential outcomes considered are what the subject’s outcome would be at times
푡 + 1, . . . , 퐾 if the subject never received treatment at any time point (see Sec-
tion 1.1). The diﬃculty with this procedure is that even if sequential randomization
holds when the measured confounders are measured in continuous time (as is as-
sumed in (a2)), it may not hold when the measured confounders are measured only
at discrete times. For the discrete time data, there can be unmeasured confounders.
In the MACS example, the diagnostic measures at the time of AZT initiation are
missing unless the start of AZT initiation occurred exactly at one of the discrete
times that the covariates are observed; the diagnostic measures at the initiation time
are clearly important confounders for the treatment status at the subsequent ob-
servational time. In the diarrhea example, the nutrition status of the child before
the start of a diarrhea episode is missing unless the start of the diarrhea episode
occurred exactly at one of the discrete times that covariates are observed; this nutri-
tion status is also an important confounder for the diarrhea status at the subsequent
observational time. Continuous time sequential randomization does not in general
justify sequential randomization holding for the discrete time data, meaning that
discrete time g-estimation can produce inconsistent estimates even when continuous
time sequential randomization holds.
In this chapter, we approach this problem from two perspectives. First, we give
15
conditions on the underlying continuous time processes under which discrete time se-
quential randomization is implied, warranting the use of discrete time g-estimation.
Second, we propose a new estimation method called the controlling-the-future method
that can produce consistent estimates whenever discrete time g-estimation is consis-
tent and produce consistent estimates in some cases when discrete time g-estimation
is inconsistent.
Our discussion focuses on a binary treatment and repeated continuous outcomes.
We also assume that the cumulative amount of treatment between two visits is ob-
served. This is true for Examples 1 and 2, the AZT and diarrhea studies respectively.
If cumulative treatment is not observed, there will often be a measurement error prob-
lem in the amount of treatment, as is discussed in Section 1.2. Chapter 3 will present
an example dealing with measurement error problems.
The organization of the chapter is as follows: Section 2.2 reviews the standard
discrete time structural nested model and g-estimation, introduces settings for contin-
uous time studies, and shows what we mean by applying discrete time g-estimation on
discrete time observed data when the underlying process is in continuous time; Sec-
tion 2.3 proposes conditions on the continuous time processes such that discrete time
g-estimation works, and discusses their interpretability and usefulness; Section 2.4
describes our controlling-the-future method; Section 2.5 presents a simulation study;
Section 2.6 provides an application to the diarrhea study discussed in Example 2;
Section 2.7 concludes the chapter.
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2.2 Standard Discrete Time Structural Nested Model and
G-estimation and Their Versions with Underlying Con-
tinuous Time Processes
In this section, we review the discrete time SNM and g-estimation, introduce the
notation for a continuous time study, formally deﬁne continuous time sequential
randomization and explain the application of discrete g-estimation on the discrete
time observations from the continuous time process.
2.2.1 Discrete Time Structural Nested Model and G-estimation
We describe a deterministic structural nested model, assuming all variables can only
change at discrete, observable times. To save notation for the continuous time model,
we use a star superscript on every variable in this section.
We assume that the study starts at time 0 and ends at time 퐾. All variables can
only change values at time 0, 1, 2, ..., 퐾. We use 퐴∗푘 to denote the binary treatment
decision at time 푘. Under the discrete time setup, 퐴∗푘 is assumed to be the constant
level of treatment between time 푘 and time (푘+1). We use 푌 0∗푘 to denote the baseline
counterfactual outcome of the study at time 푘, if the subject does not receive any
treatment throughout the study, and use 푌 ∗푘 to denote the actual outcome at time
푘. In this chapter, we assume that all 푌 0∗푘 ’s and 푌
∗
푘 ’s are continuous variables. Let
퐿∗푘 be the vector of covariates collected at time 푘. As a convention, 푌
∗
푘 is included in
퐿∗푘.
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We consider a simple deterministic model for illustration purpose. Generalizations
of the results in this chapter for more complicated models are in Section 2.7. The
model we consider is
푌 ∗푘 = 푌
0∗
푘 + Ψ
푘−1∑
푖=0
퐴∗푖 (2.2.1)
where Ψ is the causal parameter of interest, and can be interpreted as the eﬀect of
one unit of the treatment on the outcome. In this model, the treatment aﬀects the
outcome cumulatively.
Model (2.2.1) is a rank-preserving model. It assumes that for subject 푖 and 푗,
with the same observed treatment history up to time 푘, if we observe 푌푘,푖 < 푌푘,푗, we
must have 푌 0∗푘,푖 < 푌
0∗
푘,푗 .
The general purpose of causal inference is to estimate Ψ from the observables,
the 퐴∗푘’s and 퐿
∗
푘’s (note that the 푌
∗
푘 ’s are included in 퐿
∗
푘’s). One way to achieve the
identiﬁcation of Ψ is to assume sequential randomization (A1).
Given this notation and model (2.2.1), a mathematical formulation of (A1) is
푝푟(퐴∗푘∣퐿¯∗푘, 퐴¯∗푘−1, 푌 0∗푘+) = 푝푟(퐴∗푘∣퐿¯∗푘, 퐴¯∗푘−1) (2.2.2)
where 퐿¯∗푘 = (퐿0, 퐿1, ..., 퐿푘), 퐴¯
∗
푘−1 = (퐴0, 퐴1, ..., 퐴푘−1), and 푌
0∗
푘+ = (푌
0∗
푘+1, 푌
0∗
푘+2, ...,
푌 0∗퐾 ).
For any hypothesized value of Ψ, we deﬁne a putative counterfactual
푌 0∗푘 (Ψ) = 푌
∗
푘 −Ψ
푘−1∑
푖=0
퐴푖
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Then under (2.2.1) and (2.2.2), the correct Ψ should solve
퐸[푈(Ψ)] ≡ 퐸{
∑
푘<푚≤퐾
1≤푖≤푁
[퐴∗푖,푘 − 푝푘(푋∗푖,푘)]푔(푌 0∗푖,푚(Ψ), 푋∗푖,푘)} = 0 (2.2.3)
where 푖 is the index for each subject and there are 푁 subjects, 푋∗푖,푘 = (퐿¯
∗
푖,푘, 퐴¯
∗
푖,푘−1),
푝푘(푋
∗
푖,푘) = 푃푟(퐴
∗
푖,푘 = 1∣푋∗푖,푘) is the propensity score for subject 푖 at time 푘, and 푔 is
any function. This estimating equation can be generalized with 푔 being a function
of any number of future 푌 0∗푖,푚(Ψ)’s and 푋
∗
푖,푘.
To estimate Ψ, we solve the empirical version of (2.2.3):
푈(Ψ) ≡
∑
푘<푚≤퐾
1≤푖≤푁
[퐴∗푖,푘 − 푝푘(푋∗푖,푘)]푔(푌 0∗푖,푚(Ψ), 푋∗푖,푘) = 0 (2.2.4)
The method is known as g-estimation. The eﬃciency of the estimate depends on
the functional form of 푔. The optimal 푔 function that produces the most eﬃcient
estimation can be derived (Robins, 1992).
In real applications, the treatment assignment scheme, or the true propensity
score 푝푘(푋
∗
푘) is usually unknown, and is parameterized as 푝푘(푋
∗
푘 , 훽). Then additional
estimating equations are needed to identify 훽. One may use various 푔 functions to
construct these estimating equations, as long as these equations are not linearly
correlated. For example, the following estimating equations could be used:
푈(Ψ, 훽) =
∑
푘<푚≤퐾
1≤푖≤푁
[퐴∗푖,푘 − 푝푘(푋∗푖,푘)][푌 0∗푖,푚(Ψ), 푋∗푖,푘]푇 = 0 (2.2.5)
The formulas for estimating the covariance matrix of (Ψˆ, 훽ˆ) are given in the
appendices in Section 5.1.
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2.2.2 A Continuous Time Deterministic Model and Continuous Time
Sequential Randomization
We now extend the model in Section 2.2.1 to a continuous time model, and deﬁne
a continuous time version of the sequential randomization assumption (A1) as a
counterpart of (2.2.2).
Same as before, we assume that the continuous time study starts at time 0 and
ends at an integer time 퐾, but now the variables can change their values at any real
time between 0 and 퐾. The model in Section 2.2.1 is then extended as follows:
∙ {푌푡; 0 ≤ 푡 ≤ 퐾} is the continuous time continuously valued outcome process.
∙ {퐿푡; 0 ≤ 푡 ≤ 퐾} is the continuous time covariate process. It can be multi-
dimensional, and 푌푡 is an element of 퐿푡.
∙ {퐴푡; 0 ≤ 푡 ≤ 퐾} is the continuous time binary treatment process.
∙ {푌 0푡 ; 0 ≤ 푡 ≤ 퐾} is the continuous time continuously valued potential out-
come process if the subject does not receive any treatment from time 0 to
time 퐾. It can be thought of as the natural process of the subject, free of
treatment/intervention.
A natural extension of model (2.2.1) is
푌푡 = 푌
0
푡 + Ψ
∫ 푡
0
퐴푠푑푠 (2.2.6)
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where Ψ is the causal parameter of interest. Ψ can be interpreted as the eﬀect rate
of the treatment on the outcome.
In this continuous time model, a continuous time version of the sequential ran-
domization assumption (A1) can be formalized, though it does not have the simple
form similar to Equation (2.2.2). It was noted by Lok (2007) that a direct extension
of the formula (2.2.2) involves “conditioning null events on null events”.
Lok (2007) formally deﬁned continuous time sequential randomization when there
is only one outcome at the end of the study. We propose a similar deﬁnition for studies
with repeated outcomes under the deterministic model (2.2.6).
Following Lok (2007), we assume that all the continuous time stochastic processes
are ca`dla`g processes (continue a` droite, limite´e a` gauche, i.e., continuous from the
right, having limit from the left), throughout this chapter. Let 푍푡 = (퐿푡, 퐴푡, 푌
0
푡 ).
Let 휎(푍푡) be the 휎-ﬁeld generated by 푍푡, i.e., the smallest 휎-ﬁeld that makes 푍푡
measurable. Let 휎(푍¯푡) be the 휎-ﬁeld generated by
∪
푢≤푡 휎(푍푢). Similarly, 휎(푍¯푡, 푌
0
푡+)
is the 휎-ﬁeld generated by 휎(푍¯푡)
∪
휎(푌 0푡+), where 휎(푌
0
푡+) is the 휎-ﬁeld generated by∪
푢>푡 휎(푌
0
푢 ). By deﬁnition, the sequence of 휎(푍¯푡), 0 ≤ 푡 ≤ 퐾, forms a ﬁltration.
The sequence of 휎(푍¯푡, 푌
0
푡+), 0 ≤ 푡 ≤ 퐾, also forms a ﬁltration, because 휎(푍¯푡, 푌 0푡+) ⊂
휎(푍¯푠, 푌
0
푠+), for 푡 < 푠 (note that this is true under the deterministic model (2.2.6) but
not in general).
Let 푁푡 be a counting process determined by 퐴푡. It counts the number of jumps
in the 퐴푡 process. Let 휆푡 be the intensity process of 푁푡 with respect to 휎(푍¯푡).
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(The explicit deﬁnition of 푁푡 and an explicit formula for 휆푡 is in the appendices in
Section 5.2.) 푀푡 = 푁푡 −
∫ 푡
0
휆푠푑푠 will be a martingale w.r.t. 휎(푍¯푡).
Deﬁnition 2.2.1. With 푁푡, 휆푡 and 푀푡 deﬁned as above, the ca`dla`g process 푍푡 ≡
(퐿푡, 퐴푡, 푌
0
푡 ), 0 ≤ 푡 ≤ 퐾 is said to satisfy the continuous time sequential ran-
domization assumption, or CTSR, if 푀푡 is also a martingale w.r.t. 휎(푍¯푡, 푌
0
푡+). Or,
equivalently, 휆푡 is also the intensity of 푁푡, w.r.t. the ﬁltration of 휎(푍¯푡, 푌
0
푡+).
In this deﬁnition, given 퐴0, the counting process {푁푡}푇0 oﬀers an alternative
description of the treatment process {퐴푡}푇0 . The intensity process 휆푡, which models
the jumping rate of 푁푡, plays the same role as the propensity scores in discrete
time model, which models the switching of the treatment process. Deﬁnition 2.2.1
formalizes the assumption (A1) in the continuous time model, by stating that 휆푡 does
not depend on future potential outcomes. It is worth noting that the deﬁnition here
is only for a rank preserving model. A generalization of this deﬁnition is given in
Section 5.6.
2.2.3 Modiﬁed G-estimation on Discrete Time Observed Data from the
Continuous Time Model
In this chapter, we assume that the continuous process deﬁned in Section 2.2.2 can
only be observed at integer times, namely, times 0, 1, 2, ..., and 퐾. We use the
same set of starred notation as in Section 2.2.1, but interpret them as discrete time
observations from the model in Section 2.2.2. Speciﬁcally,
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∙ {퐴∗푘, 푘 = 0, 1, 2, ..., 퐾} denotes the set of treatment assignments observable at
times 0, 1, 2, ..., 퐾. We use 퐴¯∗푘 to denote the observed history of observed dis-
crete time treatment up to time 푘, i.e., (퐴∗0, 퐴
∗
1, ..., 퐴
∗
푘). Additionally, we use
푐푢푚퐴∗푘 =
∫ 푘−
0
퐴푠푑푠 to denote the cumulative amount of treatment up to time
푘. Note that in the continuous time model, 푐푢푚퐴∗푘 ∕=
∑푘−1
푘′=0퐴
∗
푘′ , as it would
in discrete time models. We let 푐푢푚퐴
∗
푘 = (푐푢푚퐴
∗
1, 푐푢푚퐴
∗
2, ..., 푐푢푚퐴
∗
푘). We
note that in practice, people sometimes use 퐴˜∗푘 = 푐푢푚퐴
∗
푘+1 − 푐푢푚퐴∗푘 as the
treatment at time 푘, when applying discrete time g-estimation on discrete time
observational data. Such use of g-estimation usually requires stronger condi-
tions than the conditions discussed in this chapter. Throughout this chapter,
we deﬁne the treatment at time 푘 as 퐴∗푘.
∙ We deﬁne 퐿∗푘, the observed covariates at time 푘 to be 퐿푘−, the left limit of 퐿 at
time 푘, following the convention that in discrete model, people usually assume
that the covariates are measured before the treatment decision. 푌 ∗푘 and 푌
0∗
푘
are also deﬁned as 푌푘− and 푌 0푘− respectively, following the same convention.
퐿¯∗푘 denotes (퐿
∗
0, 퐿
∗
1, ..., 퐿
∗
푘), and 푌¯
∗
푘 and 푌¯
0∗
푘 are deﬁned accordingly. 푌
0∗
푘+ =
(푌 0∗푘+1, 푌
0∗
푘+2, ..., 푌
0∗
퐾 ).
With this notation, following the spirit of g-estimation, which controls all observed
history in the propensity score model for the treatment, we propose the following
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estimating equation:
푈(Ψ) ≡
∑
푘<푚≤퐾
1≤푖≤푁
[퐴∗푖,푘 − 푝푘(푋∗푖,푘)]푔(푌 0∗푖,푚(Ψ), 푋∗푖,푘) = 0 (2.2.7)
where 푋∗푖,푘 is the collection of 퐿¯
∗
푖,푘, 퐴¯
∗
푖,푘−1 and 푐푢푚퐴
∗
푖,푘, 푝푘(푋
∗
푖,푘) = 푃푟(퐴
∗
푖,푘 = 1∣푋∗푖,푘),
and 푌 0∗푖,푚(Ψ) = 푌
∗
푖,푚 −Ψ푐푢푚퐴∗푖,푘.
In practice, 푝푘(푋
∗
푖,푘) is unknown and has to be parametrized as 푝푘(푋
∗
푖,푘; 훽), and
we use diﬀerent functions 푔 to identify the all the parameters, as in Section 2.2.1.
The covariance matrix of estimated parameters can be estimated as in Appendix A.
The estimating equation has the same form as (2.2.4), except for two important
diﬀerences. First, the propensity score model in this section conditions on additional
푐푢푚퐴
∗
푖,푘. In the discrete time model of Section 2.2.1, 푐푢푚퐴
∗
푖,푘 would be a transformed
version of 퐴¯∗푖,푘−1, and was redundant information. However, with continuous time
underlying processes, 푐푢푚퐴
∗
푖,푘 is new information on the treatment history. Second,
the putative counterfactual 푌 0∗푖,푚(Ψ) is calculated by subtracting the 푐푢푚퐴
∗
푖,푘 from
푌 ∗푖,푚, instead of
∑푘−1
푙=0 퐴
∗
푖,푙. We will refer later to the g-estimation in this section
as the modiﬁed g-estimation (although it is the true spirit of g-estimation). The
justiﬁcation and limitation of using the modiﬁed g-estimation will be discussed in
Section 2.3.
We refer to the g-estimation in Section 2.2.1 as naive g-estimation, when it is
applied to data from continuous time model. When the data come from a continuous
time model, the naive g-estimation can be severely biased, as we will show in our
simulation study and the diarrhea application. One source of bias is a measurement
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error problem,
∑푘−1
푙=0 퐴
∗
푖,푙 is not the correct measure of the treatment; another source
of bias is that important information 푐푢푚퐴푖,푘 is not conditioned on in the propensity
score. Although we would not expect researchers to use the naive g-estimation when
the true cumulative treatments are available, we present the simulation and real
application results using this method as a reference to show how severely biased
the estimates would be had we not known the true cumulative treatments and the
measurement error problem had dominated.
2.3 Justiﬁcation of the Use of the Modiﬁed Discrete Time
G-estimation
Given discrete time observational data from continuous time underlying processes,
solving equation (2.2.7) provides an estimate for Ψ. For this Ψ estimate to be con-
sistent, an analogue to condition (2.2.2) is needed:
푝푟(퐴∗푘∣퐿¯∗푘, 퐴¯∗푘−1, 푐푢푚퐴∗푘, 푌 ∗0푘+) = 푝푟(퐴∗푘∣퐿¯∗푘, 퐴¯∗푘−1, 푐푢푚퐴∗푘) (2.3.1)
Condition (2.3.1) is a requirement on the observed variables at discrete times. It
is not a condition at the level of the data-generating process, and cannot be easily
used to determine the appropriateness of using the modiﬁed g-estimation by domain
knowledge. This contrasts with the case of discrete time ignorability for the discrete
time data. In this section, we will seek conditions at the data generating process
level that can justify the use of g-estimation.
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2.3.1 Sequential Randomization at Any Finite Subset of Time Points
Recall the data generating process described in Section 2.1.2. The third party or-
ganization periodically (e.g., semi-annually) collects the health data and treatment
records of the patients. Suppose a researcher thinks (2.3.1) holds for the time points
at which the third party organization collects these data. If the time points have
not been chosen in a special way to make (2.3.1) hold, then the researcher will often
be willing to make the stronger assumption that (2.3.1) would hold for any ﬁnite
subset of time points at which the third party organization chose to collect data. For
example, for the diarrhea study, the survey was actually conducted in November,
1998, March-April, 1999 and November, 1999. If a researcher thought (8) held for
these three time points, then she might be willing to assume that (2.3.1) should also
held if instead the survey was conducted in December, 1998, February, 1999, May,
1999 and October, 1999.
Before formalizing the researcher’s assumption on any ﬁnite subset of time points,
we observe that
Proposition 2.3.1. Under the deterministic model assumption (2.2.6), the true
model for the propensity score has the following property:
푝푟(퐴∗푘 = 1∣퐿¯∗푘, 퐴¯∗푘−1, 푐푢푚퐴∗푘) = 푝푟(퐴∗푘 = 1∣퐿¯∗푘, 퐴¯∗푘−1, 푌¯ 0∗푘 ) (2.3.2)
Proof. Under the deterministic assumption (2.2.6) and the correct Ψ, (퐿¯∗푘, 퐴¯
∗
푘−1,
푐푢푚퐴
∗
푘) is a one-to-one transformation of (퐿¯
∗
푘, 퐴¯
∗
푘−1, 푌¯
0∗
푘 ).
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Using Proposition 2.3.1, we state sequential randomization assumption at any
ﬁnite subset of time points as
Deﬁnition 2.3.2. A ca`dla`g process 푍푡 ≡ (퐿푡, 퐴푡, 푌 0푡 ), 0 ≤ 푡 ≤ 퐾 is said to satisfy
the ﬁnite time sequential randomization assumption, or FTSR, if for any ﬁnite
subset of time points, 0 ≤ 푡1 < 푡2 < ⋅ ⋅ ⋅ < 푡푛 < 푡푛+1 < ⋅ ⋅ ⋅ < 푡푛+푙 ≤ 퐾, we have
푝푟(퐴푡푛∣퐿¯푡푛−, 퐴¯푡푛−1 , 푌¯ 0푡푛−, 푌 0푡푛+) = 푝푟(퐴푡푛∣퐿¯푡푛−, 퐴¯푡푛−1 , 푌¯ 0푡푛−) (2.3.3)
where 퐿¯푡푛− = (퐿푡1−, 퐿푡2−, ⋅ ⋅ ⋅ , 퐿푡푛−), 퐴¯푡푛−1 = (퐴푡1 , 퐴푡2 , ⋅ ⋅ ⋅ , 퐴푡푛−1), 푌¯ 0푡푛− = (푌 0푡1−,
푌 0푡2−, ⋅ ⋅ ⋅ , 푌 0푡푛−), and 푌 0푡푛+ = (푌 0푡푛+1−, 푌 0푡푛+2−, ⋅ ⋅ ⋅ , 푌 0푡푛+푙−).
Finite time sequential randomization assumption obviously justiﬁes the use of g-
estimation in the settings described in Section 2.2.2. It does not refer to continuous
time sequential randomization directly. However, the following theorem shows that
it is a stronger assumption than the CTSR assumption.
Theorem 2.3.3. If a continuous time ca`dla`g process 푍푡 satisﬁes ﬁnite time sequen-
tial randomization, under some regularity conditions, it will also satisfy continuous
time sequential randomization.
Proof. See the appendices in Section 5.3. The regularity conditions are also stated
in Section 5.3.
The result of Theorem 2.3.3 is natural. As mentioned in Section 2.1.3, the contin-
uous time sequential randomization does not imply FTSR, because in discrete time
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observations, we do not have the full continuous time history to control. To compen-
sate for the incomplete data problem, some stronger assumption on the continuous
time processes has to be made if identiﬁcation is to be achieved.
2.3.2 A Markovian Condition
Given the ﬁnite time sequential randomization assumption described above, two im-
portant questions arise. First, Theorem 2.3.3 shows that the FTSR assumption is
stronger than the continuous time sequential randomization assumption. It is natu-
ral to ask how much stronger it is than the CTSR assumption. Secondly, the FTSR
assumption has a descriptive nature, and unlike the usual sequential randomization
assumption (A1), it is not an assumption on the data generating process and thus is
not useful for incorporating domain knowledge to justify itself. A condition at the
data generating process level will be more helpful for researchers in deciding whether
g-estimation is valid.
We answer both questions partially in the following theorem.
Theorem 2.3.4. Assuming that the process (푌 0푡 , 퐿푡, 퐴푡) follows the continuous time
sequential randomization assumption, and that the process (푌 0푡−, 퐿푡−, 퐴푡) is Marko-
vian, for any time 푡 and 푡+ 푠, 푠 > 0, we have
푝푟(퐴푡∣퐿푡−, 푌 0푡−, 푌 0푡+푠) = 푝푟(퐴푡∣퐿푡−, 푌 0푡−), (2.3.4)
which implies the ﬁnite time sequential randomization assumption.
Proof. The proof can be found in the Section 5.4.
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We make the following comments on the theorem.
∙ The theorem partially answers our ﬁrst question - the FTSR assumption is
stronger than the CTSR assumption, but the gap between the two assump-
tions is less than a Markovian assumption. The result is not surprising, as with
missing covariates between observational time points, we would hope that the
variables at the observational time points well summarize the missing informa-
tion. The Markovian assumption guarantees that variables at a observational
time point summarize all information prior to that time point.
∙ The theorem also partially answers our second question. The CTSR assump-
tion is usually justiﬁed by domain knowledge of how treatments are decided.
Theorem 2.3.4 suggests that the researchers could further look for biological
evidence that the process is Markovian to validate the use of g-estimation. The
Markovian assumption can also be tested. One could ﬁrst use the modiﬁed
g-estimation to estimate the causal parameter, construct the 푌 0 process at the
observational time points, and then test whether the full observational data of
퐴,퐿, 푌 0 come from a Markov process. A strict test of whether the discretely ob-
served panel data come from a continuous time (usually non-stationary) Markov
process could be diﬃcult and is beyond the scope of this chapter. As a starting
point, we suggest Singer’s trace inequalities (Singer, 1981) as a criterion to test
for the Markovian property. A weaker test of the Markovian property is to test
conditional independence of past observed values and future observed values
29
conditioning on current observed values.
∙ In the theorem, equation (2.3.4) looks like an even stronger version of continu-
ous time sequential randomization assumption - the treatment decision seems
to be based only on current covariates and current potential outcomes. One
could of course directly assume this stronger version of randomization and ap-
ply g-estimation. However, Theorem 2.3.4 is more useful as we are assuming
a weaker untestable CTSR assumption and a Markovian assumption that is
testable in principle.
∙ The theorem suggests that it is suﬃcient to control for current covariates and
current potential outcomes for g-estimation to be consistent. In practice, we
advise controlling for necessary past covariates and treatment history. The
estimate would still be consistent if the Markovian assumption is true, and it
might reduce bias when the Markovian assumption is not true. As a result,
we do control for previous covariates and treatments in our simulation and
application to the diarrhea data.
∙ It is worth noting that the labeling of time is arbitrary. In practice, researchers
can label whatever they have controlled for in their propensity score as the
“current” covariates, which could include covariates and treatments that are
measured or assigned previously in physical time. In this case the dimension
of the process that needs to be tested for the Markovian property should also
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be expanded to include older covariates and treatments in physical time.
∙ Finally, we note that a discrete time version of the theorem is implied by Corol-
lary 4.2 of Robins (1997), if we set, in his notation, 푈푎푘 to be the covariates
between two observational time points and 푈푏푘 to be the null set.
As a discretized example, we illustrate the idea of Theorem 2.3.4 by a directed
acyclic graph (DAG) in part (a) of Figure 2.1, which assumes that all variables
can only change values at time points 0, 1/2, 1, 3/2, 2, ...,푚. Note that we do not
distinguish the left limit of variables and themselves in all DAGs of this chapter,
for reasons discussed in Appendix C. We also assume that the process can only be
observed at time 0, 1, 2, ...,푚. It is easy to verify that the DAG satisﬁes sequential
randomization at the 0, 1/2, 1, 3/2, 2, ...,푚 time level. The DAG is also Markovian
in time. For example, if we control 퐴1, 퐿1, 푌
0
1 , any variable prior to time 1 will be
d-separated from any other variable after time 1.
Part (b) of Figure 2.1 veriﬁes that 퐴1 is d-separated from 푌
0
푚,푚 > 1 by the
shaded variables, namely, 퐿1 and 푌
0
1 , which justiﬁes equation (2.3.2). As implied
by Theorem 2.3.4, the modiﬁed g-estimation works for data observed at the integer
times if they are generated by the model deﬁned by this DAG.
It is true that the Markovian condition that justiﬁes the g-estimation equation
(2.2.7) is restrictive as will be discussed in the following section. However, our simula-
tion study shows that g-estimation has some level of robustness when the Markovian
assumption is not seriously violated.
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(a) DAG of a Markovian Process
(b) Veriﬁcation of Equation (2.3.2)
Figure 2.1: Directed Acyclic Graph
2.4 The Controlling-the-future Method
In this section, we consider situations in which the observational time sequential
randomization fails and seek methods that are more robust to this failure than the
modiﬁed g-estimation given in Section 2.2.3. The method we are going to introduce
is proposed by Joﬀe and Robins (2009), which deals with a more general case of the
existence of unmeasured confounders. It can be applied to deal with unmeasured
confounders coming from either a subset of contemporaneous covariates or a subset
of covariates that represent past time, the latter case being of interest for this chap-
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ter. The method, which we will refer to as the controlling-the-future method (the
reason for the name will be more clear later on), gives consistent estimates when
g-estimation is consistent, and it produces consistent estimates in some cases even
when g-estimation is severely inconsistent.
In what follows, we will ﬁrst describe an illustrative application of the controlling-
the-future method, and then discuss its relationship with our framework of g-estimation
in continuous time processes with covariates observed at discrete times.
2.4.1 Modiﬁed Assumption and Estimation of Parameters
We assume the same continuous time model as in Section 2.2.2. Following Joﬀe
and Robins (2009), we consider a revised sequential randomization assumption on
variables at the observational time points
푝푟(퐴∗푘∣퐿¯∗푘, 퐴¯∗푘−1, 푐푢푚퐴∗푘, 푌 0∗푘+) = 푝푟(퐴∗푘∣퐿¯∗푘, 퐴¯∗푘−1, 푐푢푚퐴∗푘, 푌 0∗푘+1) (2.4.1)
This assumption relaxes (2.3.1). At each time point, conditioning on previous
observed history, the treatment can depend on future potential outcomes, but only
on the next period’s potential outcome. In Joﬀe and Robins’ extended formulation,
this can be further relaxed to allow for dependence on more than one period of future
potential outcomes, as well as other forms of dependence on the potential outcomes..
If the revised assumption (2.4.1) is true, we obtain a similar estimating equation
as (2.2.7). For each putative Ψ, we map 푌 ∗푘 to
푌 0∗푘 (Ψ) = 푌
∗
푘 −Ψ푐푢푚퐴∗푘
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the potential outcome if the subject never received any treatment under the hypoth-
esized treatment eﬀect Ψ.
Deﬁne the putative propensity score as
푝푘(Ψ) ≡ 푝푟(퐴∗푘 = 1∣퐿¯∗푘, 퐴¯∗푘−1, 푐푢푚퐴∗푘, 푌 0∗푘+1(Ψ)) (2.4.2)
Under assumption (2.4.1), the correct Ψ should solve
푈(Ψ) = 퐸{
∑
1≤푖≤푛
푘+1<푚≤퐾
[퐴∗푖,푘 − 푝푖,푘(Ψ)]푔(푌 0∗푖,푚(Ψ), 푋∗푖,푘, ℎ푖,푘)} = 0 (2.4.3)
where 푋∗푖,푘 = (퐿¯
∗
푖,푘, 퐴¯
∗
푖,푘−1, 푐푢푚퐴
∗
푖,푘), ℎ푖,푘 = 푌
0∗
푖,푘+1(Ψ), and 푔 is any function and
can be generalized to functions of 푋∗푖,푘, ℎ푖,푘 and any number of future potential
outcomes that are later than time 푘 + 1, e.g. 푔(푌 0∗푖,푘+2(Ψ), 푌
0∗
푖,푘+3(Ψ), 푋
∗
푖,푘, ℎ푖,푘). In
most real applications, the model for 푝푘(Ψ) = 퐸[퐴
∗
푘∣푋∗푘 , ℎ푘] is unknown, and is usually
estimated by a parametric model
푝푖,푘(Ψ; 훽푋 , 훽ℎ) = 퐸[퐴푖,푘∣푋∗푖,푘, ℎ푖,푘; 훽푋 , 훽ℎ].
We can solve the following set of estimating equations to obtain the estimates of
Ψ, 훽푋 and 훽ℎ
푈(Ψ, 훽푋 , 훽ℎ) (2.4.4)
=
∑
1≤푖≤푛
푘+1<푚≤퐾
(퐴∗푖,푘 − 푝푖,푘(Ψ; 훽푋 , 훽ℎ))[푔(푌 0∗푖,푚(Ψ), 푋∗푖,푘, ℎ푖,푘), 푋∗푖,푘, ℎ푖,푘]푇 = 0
The estimation of the covariance matrix of Ψ, 훽푋 and 훽ℎ is similar to the usual
standard g-estimation, which is described in Appendix A.
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Two important features of estimating equation (2.4.4) distinguish it from es-
timating equation (2.2.7). First, in (2.4.4) there is a common parameter Ψ in
both 푝푘’s model and 푌
0∗
푚 (Ψ), caused by the fact that the treatment depends on
future potential outcome. Second, in (2.4.4), the sum over 푚 and 푘 is restricted to
푚 > 푘 + 1, while in (2.2.7) we only need 푚 > 푘. If we use 푚 = 푘 + 1 in (2.4.4),
퐸{[퐴∗푖,푘 − 푝푖,푘(Ψ)]푔(푌 0∗푖,푘+1(Ψ), 푋∗푖,푘, ℎ푖,푘)} = 0 usually does not lead to the identiﬁca-
tion of Ψ, unless certain functional forms of the propensity score model are assumed
to be true (see Joﬀe and Robins 2009).
2.4.2 The Controlling-the-future Method and the Markovian Condition
Joﬀe and Robins’ revised assumption (2.4.1) is an assumption on the discrete time
observational data. It relaxes the observational time sequential randomization (2.3.1)
because (2.3.1) always implies (2.4.1). At the continuous time data generating level,
(2.4.1) allows less stringent underlying stochastic processes than the Markovian pro-
cess in Theorem 2.3.4.
In particular, we identify two important scenarios where the relaxation happens.
One scenario is to allow for more direct temporal dependence for the 푌 0 process,
which we will refer to as the non-Markovian-푌 0 case. The other scenario is to allow
colliders in 퐿, which we will refer to as the leading-indicator-in-퐿 case. We illustrate
both cases by modifying the directed acyclic graph (DAG) example in Figure 2.1.
The Non-Markovian-푌 0 Case
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(a) Not control for future 푌 0푡
(b) Control for future 푌 0푡
Figure 2.2: Directed Acyclic Graph with Non-Markovian 푌 0푡
Assume for example, our data is generated from the DAG in Figure 2.2 where
we allow the dependence of 푌 02 on 푌
0
1 , even if 푌
0
3/2 is controlled. In part (a) of
Figure 2.2, we control for observed covariates (퐿0, 퐿1), treatment (퐴0, 퐴1/2) and
current and historical potential outcome (푌 00 , 푌
0
1 ) for treatment at time 1 (퐴1), i.e.,
we have controlled for all historically observed covariates, treatment and cumulative
treatment as suggested in the comments for Theorem 2.3.4. In this case, the modiﬁed
g-estimation fails, because the paths like 퐴1 ← 퐿1/2 ← 푌 01/2 → 푌 03/2 → 푌 02 → ...→ 푌 0푚
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are not blocked by the shaded variables. In part (b) of Figure 2.2, we control for the
additional 푌 02 . 퐴1 is not completely blocked from 푌
0
푚, but some paths that are not
blocked in part (a) are now blocked, for example, the path of 퐴1 ← 퐿1/2 ← 푌 01/2 →
푌 03/2 → 푌 02 → 푌 05/2 → ...→ 푌 0푚. Also, no additional paths are opened by conditioning
on 푌 02 . We would usually expect that the correlation between 퐴1 and 푌
0
푚 is weakened.
Under the framework of Joﬀe and Robins (2009), we can control for more than one
period of future potential outcomes, and expect to further weaken the correlation
between 퐴1 and 푌
0
푚. A modiﬁcation of assumption (2.4.1) that conditions on more
future potential outcomes may be approximately true.
The scenario relates to real world problems. For instance, in the diarrhea exam-
ple, 푌 0푡 is the natural height growth of a child without any occurrence of diarrhea.
Height in the next month not only depends on current month’s height, but also de-
pends on previous month’s height: the complete historical growth curve of the child
provides information on genetics and nutritional status, and provides information
about future natural height beyond that of just current natural height. Therefore,
the potential height process for the child is not Markovian. (For a formal argument
why children’s height growth is not Markovian, see Gasser, T. et al. 1984.) By the
reasoning we discussed above, g-estimation fails. However, if we assume that the
delayed dependence of natural height wanes out after a period of time (like in Figure
2.2), controlling for the next period potential height in the propensity score model
might weaken the relationship between current diarrhea exposure and future potential
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height later than the next period, and the assumptions of the controlling-the-future
method might hold approximately.
(a) Not control for future 푌 0푡
(b) Control for future 푌 0푡
Figure 2.3: Directed Acyclic Graph with Leading Indicator in 퐿푡
The Leading-indicator-in-퐿 Case
In Figure 2.1, we do not allow any arrows from future 푌 0 to previous 퐿, which
means that among all measures of the subject, there is no elements in 퐿 that contain
any leading information about future 푌 0. This means that 푌 0 is a measure that is
ahead of all other measures. This is not realistic in many real world problems. In
the example of the eﬀect of the diarrhea on height, weight is an important covariate.
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While both height and weight reﬂect the nutritional status of a child, malnutrition
usually aﬀects weight more quickly than height, i.e., the weight contains leading
information for the natural height of the child. Figure 2.1 is then not an appropriate
model for studying the eﬀect of the diarrhea on height.
In Figure 2.3, we allow arrows from 푌 01/2 to 퐿0, from 푌
0
1 to 퐿1/2 and so on, which
assumes that 퐿 contains leading indicators of 푌 0, but the leading indicators are
only ahead of 푌 0 for less than one unit of time. Part (a) of Figure 2.3 shows that
controlling for history of covariates, treatment and potential outcomes does not block
퐴1 from 푌
0
푚. On the path of 퐴1 ← 퐿1/2 → 퐿1 ← 푌 03/2 → 푌 02 → 푌 05/2 → ...→ 푌 0푚, 퐿1
is a controlled collider. However, in part (b), if we do control for 푌 02 additionally, the
same path will be blocked. In general, if we assume that there exist leading indicators
in covariates and that the leading indicators are not ahead of potential outcomes for
more than one time unit, g-estimation will fail, but the controlling-the-future method
will produce consistent estimates.
The fact that the controlling-the-future method can work in the leading infor-
mation scenario can also be related to the discussion of Section 3.6 of Rosenbaum
(1984). The main reason for g-estimation’s failure in the DAG example is that 퐿1/2
is not observable and cannot be controlled. If 퐿1/2 is observed, it is easy to verify
that the DAG in Figure 2.3 satisﬁes sequential randomization on the ﬁnest time grid.
The idea behind the controlling-the-future method is to condition on a “surrogate”
for 퐿1/2. The surrogate should satisfy the property that 푌
0
푚 is independent of the un-
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observed 퐿1/2 given the surrogate and other observed covariates, (similar to formula
3.17 in Rosenbaum (2007)). In the leading information case, when 푚 > 푘+ 1 and we
have covariates 퐿¯푘 that are only ahead of the potential outcome until time at most
푘+ 1, then the future potential outcome 푌 0푘+1 is a surrogate. It is easy to check that
in Figure 2.3, 퐿1/2 is independent of 푌
0
푚, given 푌
0
2 , 퐿1, 퐴0, and 푐푢푚퐴1 (equivalently
푌 01 ).
It is worth noting that we do not need to control for anything except 푌 02 in Fig-
ure 2.3 to get a consistent estimate. It is possible to construct more complicated
DAGs in which controlling for additional past and current covariates is necessary,
which involves more model speciﬁcations for the relationships among diﬀerent co-
variates and deviates from the main point of this chapter.
In Section 2.5, we will simulate data in cases of non-Markovian-푌 0푡 and leading-
indicator-in-퐿푡 respectively, and show that the controlling-the-future method does
produce better estimates than the g-estimation. However, it worth noting that when
the modiﬁed g-estimation in Section 2.2.3 is consistent, the controlling-the-future
estimation is considerably less eﬃcient, because it uses less data and estimates more
parameters.
2.5 Simulation Study
We set up a simple continuous time model that satisﬁes sequential ignorability in
continuous time, and simulate and record discrete time data from variations of the
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simple model. We estimate causal parameters from both the modiﬁed g-estimation
and the controlling-the-future estimation. We also present the estimates from naive
g-estimation in Section 2.2.1, where we ignore the continuous time information of the
treatment processes, as a reference to show the severity of the bias in presence of the
measurement error problem. The results support the discussions in Section 2.3 and
Section 2.4
In the simulation models below, M1 satisﬁes the Markovian condition in Theorem
2.3.4. It also serves as a proof that there exist processes satisfying the conditions in
Theorem 2.3.4.
2.5.1 The Simulation Models
We ﬁrst consider a continuous time Markov model, which satisﬁes the CTSR assump-
tion.
∙ 푌 0푡 is the potential outcome process if the patient is not receiving any treatment.
We assume that
푌 0푡 = 푔(푉, 푡) + 푒푡
where 푔(푉, 푡) is a function of baseline covariates 푉 and time 푡. Let 푔(푉, 푡) be
continuous in 푡, and 푒푡 follows an Ornstein-Uhlenbeck process, i.e.
푑푒푡 = −휃푒푡푑푡+ 휎푑푊푡
where 푊푡 is the standard Brownian motion.
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∙ 푌푡 is the actual outcome process and follows the deterministic model (2.2.6):
푌푡 = 푌
0
푡 + Ψ
∫ 푡
0
퐴푠푑푠
∙ 퐴푡 is the treatment process, taking binary values. The jump of the 퐴푡 process
follows the following formula:
푝푟(퐴푠 jumps once from (푡, 푡+ ℎ]∣퐴¯푡, 푌¯푡, 푌¯ 0) = 푠(퐴푡, 푌푡)ℎ+ 표(ℎ)
푝푟(퐴푠 jumps more than once from (푡, 푡+ ℎ]∣퐴¯푡, 푌¯푡, 푌¯ 0) = 표(ℎ)
where 퐴¯푡 and 푌¯푡 are the full continuous time history of treatment and outcome
up to time 푡, and 푌¯ 0 is the full continuous time path of potential outcome from
time 0 to time 퐾. By making 푠(.) independent of 푌¯ 0, we make our model
satisfy the continuous time sequential randomization assumption.
In this model, the only time-dependent confounder is the outcome process itself.
We also consider several variations of the above model (denoted as M1 in below):
∙ Model (M2) extends (M1) to the non-Markovian-푌 0푡 case. Speciﬁcally, we
consider 푒푡 in the model of 푌
0
푡 follows a non-Markovian process, namely an
Ornstein-Uhlenbeck process in random environments, which is deﬁned as the
following:
1. 퐽푡 is a continuous time Markov process taking values in a ﬁnite set {1, ...,푚},
which is the environment process.
2. we have 푚 > 1 sets of parameters 휃1, 휎1, ..., 휃푚, 휎푚.
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3. 푒푡 follows an Ornstein-Uhlenbeck process with parameters 휃푗, 휎푗, when
퐽푡 = 푗; the starting point of each diﬀusion is chosen to be simply the end
point of the previous one.
∙ Model (M3) extends (M1) to another setting of non-Markovian 푌 0푡 process,
where
푌 0푡 = 푔(푉, 푡) + 0.8푒푡−1 + 0.2푒푡
푒푡 follows the same Markovian Ornstein-Uhlenbeck process as in M1. Every
other variable is the same as in M1.
∙ Model (M4) considers the case with more than one covariate. In M4, we keep
the assumptions on 푌 0푡 as in (M1) and the deterministic model of 푌푡. We add
one more covariate, which is generated as follows
퐿−푡 = 0.2푌푡 + 0.8푌
0
푡+0.5 + 0.5휂푡
휂푡 follows an Ornstein-Uhlenbeck process independent of the 푌
0
푡 process. In this
speciﬁcation, the covariate 퐿−푡 contains some leading information about 푌
0, but
it is only ahead of 푌 0 for 0.5 length of a time unit. Here we use 퐿−푡 instead of
퐿푡 to denote that it is the covariate other than 푌푡 itself. The simulation model
for 퐴푡 process is given in Appendix E.
In all these models, to simulate data, we use 푔(푉, 푡) = 퐶 a constant, Ψ = 1, a time
span from 0 to 5, and a sample size of 5000. Details of other parameter speciﬁca-
tions can be found in Section 5.5. We generate 5000 continuous paths of 푌푡 and 퐴푡
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(and 퐿−푡 in M4), from time 0 to time 5, and record 푌
∗
0 , 퐴
∗
0, 푌
∗
1 , 퐴
∗
1, ..., 푌
∗
4 , 퐴
∗
4, 푌
∗
5 and
푐푢푚퐴∗1, ..., 푐푢푚퐴
∗
5 (and 퐿
−∗
0 , ...퐿
−∗
4 in M4) as the observed data.
2.5.2 Estimations and Results under M1
Figure 2.4 shows a typical continuous time path of 푌 0푡 , 푌푡 and 퐴푡. The treatment
switches around time 0.7 and time 2.8.
Figure 2.4: Example of Continuous Time Paths Under M1
We apply three estimating methods on data simulated from M1: the naive discrete
time g-estimation described in Section 2.2.1, which ignores the underlying continuous
time processes; the modiﬁed g-estimation described in Section 2.2.3, which controls
for the all the observed discrete time history; and the controlling-the-future method
in Section 2.4.1 of controlling for the next period’s potential outcome in addition to
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the discrete time history.
For estimation, even though we know the data generating process, it is too com-
plicated to use the correct model for the propensity score, i.e., the correct functional
form for 푝푘(Ψ) ≡ 푝푟(퐴∗푘∣퐿¯∗푘, 푌¯ ∗푘 , 퐴¯∗푘−1, 푐푢푚퐴
∗
푘, 푌
0∗
푘+(Ψ)). Therefore, we use the follow-
ing approximations (Note that we control for past treatment and covariates as well.
See comments for Theorem 2.3.4):
1. Standard g-estimation ignoring continuous time processes (naive g-estimation)
푙표푔푖푡(푝푘(Ψ)) = 훽0 + 훽1퐴
∗
푘−1 + 훽2푌
∗
푘−1 + 훽3푌
∗
푘
2. G-estimation controlling for all observed history (modiﬁed g-estimation)
푙표푔푖푡(푝푘(Ψ)) = 훽0 + 훽1퐴
∗
푘−1 + 훽2푌
∗
푘−1 + 훽3푌
∗
푘 + 훽4푐푢푚퐴
∗
푘
3. The controlling-the-future method, controlling for next period potential out-
comes (controlling-the-future estimation)
푙표푔푖푡(푝푘(Ψ)) = 훽0 + 훽1퐴
∗
푘−1 + 훽2푌
∗
푘−1 + 훽3푌
∗
푘 + 훽4푐푢푚퐴
∗
푘 + 훽5푌
0∗
푘+1(Ψ)
We plug these models for the propensity scores in estimation equations (2.2.5),
(2.2.7) and (2.4.4) respectively. (Note in equation (2.2.5), 푌 0∗푘 (Ψ) = 푌
∗
푘 −Ψ
∑푘−1
푙=0 퐴
∗
푙 ,
while in the other two, 푌 0∗푘 (Ψ) = 푌
∗
푘 −Ψ푐푢푚퐴∗푘.)
The ﬁrst panel of Table 2.1 shows a summary of the estimates of causal param-
eters for 1000 simulations from M1. The naive g-estimation gives severely biased
estimates. Controlling for all observed history and controlling for additional next
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period potential outcome both give us unbiased estimates. As we discussed at the
end of Section 2.4.2, the controlling-the-future method has lower eﬃciency.
The last row of the ﬁrst panel in Table 2.1 shows the coverage rate of 95% conﬁ-
dence interval estimated from the 1000 independent simulations. Naive g-estimation
has a zero coverage rate, while the other two methods have coverage rates around
95%.
2.5.3 Simulation Results under M2 and M3
In M2, we generate data from a non-Markovian 푌 0푡 , namely the Ornstein-Uhlenbeck
process in random environment. The results in the second panel of Table 2.1 are
typical for diﬀerent values of parameters under M2. The naive g-estimation performs
badly, while both the other methods still work ﬁne with the data generated from M2.
This shows that the modiﬁed g-estimation and the controlling-the-future method
have some level of robustness to mild violations of the Markovian assumption.
The third part of Table 2.1 shows the results of simulation from M3, where 푌 0
violates Markov property more substantially. In this case, we can see that the mean
of the modiﬁed g-estimates is biased, but the mean of the controlling-the-future
estimates is almost unbiased. In last row of the third panel, the coverage rate for the
modiﬁed g-estimation drops to 0.855, while the controlling-the-future method still
has a coverage rate of 0.956.
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Table 2.1: Estimated Causal Parameters from Data Generated by M1-4
Simulation Results from M1
True Parameter = 1
Naive g-est. mod. g-est. ctr-future est.
Mean Estimate† 0.7728 1.0005 0.9988
S.D. of Estimates‡ 0.0183 0.0191 0.0403
S.D. of the Mean Estimate∗ 0.0005 0.0006 0.0013
Absolute Bias ∗∗ 0.2272 0.0005 0.0012
Coverage⋄ 0 0.946 0.956
Simulation Results from M2
True Parameter = 1
Naive g-est. mod. g-est. ctr-future est.
Mean Estimate† 0.7651 1.0016 1.0000
S.D. of Estimates‡ 0.0132 0.0158 0.0371
S.D. of the Mean Estimate∗ 0.0004 0.0005 0.0012
Absolute Bias∗∗ 0.2349 0.0016 0.0000
Coverage⋄ 0 0.953 0.950
Simulation Results from M3
True Parameter = 1
Naive g-est. mod. g-est. ctr-future est.
Mean Estimate† 0.7580 0.9845 1.0026
S.D. of Estimates‡ 0.0149 0.0180 0.0487
S.D. of the Mean Estimate∗ 0.0005 0.0006 0.0015
Absolute Bias∗∗ 0.2420 0.0155 0.0026
Coverage⋄ 0 0.855 0.956
Simulation Results from M4
True Parameter = 1
Naive g-est. mod. g-est. ctr-future est.
Mean Estimate† 0.7816 1.0853 1.0085
S.D. of Estimates‡ 0.0201 0.0289 0.0806
S.D. of the Mean Estimate∗ 0.0006 0.0009 0.0025
Absolute Bias∗∗ 0.2184 0.0853 0.0085
Coverage⋄ 0 0.115 0.948
† Averaged Over Estimates from 1000 Independent Simulations of Sample Size 5000.
‡ Sample Standard Deviation of the 1000 Estimates.
∗ Sample S.D/
√
1000.
∗∗ Absolute Value of (1-Mean Estimates).
⋄ Coverage Rate of 95% Conﬁdence Intervals for 1000 Simulations.
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2.5.4 Estimations and Results under M4
In M4, we create a covariate 퐿−푡 that has leading information about 푌
0
푡 . In the data
simulated from M4, the observational time sequential randomization (2.3.1) no longer
holds, although the data are generated following continuous time sequential random-
ization. This simulation serves as a numerical proof to the claim that continuous time
sequential randomization does not imply discrete time sequential randomization.
To show this, we run the following two logistic regression model for 푘 = 2 and
푚 = 4
∙ Not controlling for the next period potential outcome (used in modiﬁed g-
estimation)
퐿표푔푖푡(푃 (퐴∗푘 = 1)) =훽0 + 훽1푐푢푚퐴
∗
푘 + 훽2퐿
−∗
푘−1 + 훽3퐿
−∗
푘 + 훽4퐴
∗
푘−1 (2.5.1)
+ 훽5푌
∗
푘 + 훽6푌
∗
푘−1 + 훽8푌
0∗
푚
∙ Controlling for the next period potential outcome (used in controlling-the-
future estimation)
퐿표푔푖푡(푃 (퐴∗푘 = 1)) =훽0 + 훽1푐푢푚퐴
∗
푘 + 훽2퐿
−∗
푘−1 + 훽3퐿
−∗
푘 + 훽4퐴
∗
푘−1 (2.5.2)
+ 훽5푌
∗
푘 + 훽6푌
∗
푘−1 + 훽7푌
0∗
푘+1 + 훽8푌
0∗
푚
We can use the true values of 푌 0∗푘+1 and 푌
0∗
푚 in the regression to test the discrete time
ignorability, since the data are simulated by us. Table 2.2 shows the estimates of 훽7
and 훽8 in both regression models. The result shows that the coeﬃcient of 푌
0∗
푚 , 훽8, is
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Table 2.2: Veriﬁcation of Observational Time Sequential Randomization Under M4
Reg. Model 2.5.1∗ Reg. Model 2.5.2∗
훽7 0.1868
p-value 5.56e-05
훽8 0.0936 0.0134
p-value 0.0006 0.691
∗ Simulation sample size = 10000
signiﬁcant if we do not control for the future potential outcome, and is not signiﬁcant
if we control for the future potential outcome. This shows that observational time
sequential randomization (2.3.1) does not hold, while the revised assumption (2.4.1)
holds.
The estimation results from M4 are in the fourth panel of Table 2.1. In applying
these methods we use the following propensity score models separately.
1. G-estimation ignoring the underlying continuous time processes (naive g-esti-
mation)
푙표푔푖푡(푝푘(Ψ)) = 훽0 + 훽1퐴
∗
푘−1 + 훽2푌
∗
푘−1 + 훽3푌
∗
푘 + 훽5퐿
−∗
푘−1 + 훽6퐿
−∗
푘
2. G-estimation controlling for all observed history (modiﬁed g-estimation)
푙표푔푖푡(푝푘(Ψ)) = 훽0 + 훽1퐴
∗
푘−1 + 훽2푌
∗
푘−1 + 훽3푌
∗
푘 + 훽4푐푢푚퐴
∗
푘 + 훽5퐿
−∗
푘−1 + 훽6퐿
−∗
푘
3. The controlling-the-future method controlling for next period potential out-
comes (controlling-the-future estimation)
푙표푔푖푡(푝푘(Ψ)) =훽0 + 훽1퐴
∗
푘−1 + 훽2푌
∗
푘−1 + 훽3푌
∗
푘 + 훽4푐푢푚퐴
∗
푘 + 훽5퐿
−∗
푘−1
+ 훽6퐿
−∗
푘 + 훽7푌
0∗
푘+1(Ψ)
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Both the naive g-estimation and the modiﬁed g-estimation give us estimates with
severe bias, and have coverage rate of 0 and 0.115 separately, for the 95% conﬁdence
interval constructed from them. It is worth noting that model 3 is misspeciﬁed
but, nevertheless, leads to much less biased estimates and the controlling-the-future
method has a coverage rate of 0.948.
2.6 Application To The Diarrhea Data
In this section, we apply the diﬀerent approaches to the diarrhea example mentioned
in Section 2.1 (Example 2). We use a set of 224 children with complete records
between age 3 and age 6 from 757 households in Bangaldesh around 1998. The
outcomes, 푌 ∗푘 , are the heights of the children in centimeters measured at round 푘
of the interviews, for 푘 = 1, 2, 3. The treatment 퐴∗푘 at the interview 푘 is deﬁned
as 퐴∗푘 = 1 if the child was sick with diarrhea during the past two weeks of the
interview, and 퐴∗푘 = 0 otherwise. The cumulative treatment 푐푢푚퐴
∗
푘 is the number
of days the child suﬀered from diarrhea from four months before the ﬁrst interview
(July 15푡ℎ, 1998) to the 푘푡ℎ interview. Baseline covariates 푉 include age in months,
mother’s height and whether the household was exposed to the ﬂood. Time dependent
covariates other than the outcome, i.e., 퐿−∗푘 , include mid-upper arm circumference,
weight for age z-score, type of toilet (open place, ﬁxed place, unsealed toilet, water
sealed toilet or other), garbage disposal method (throwing away in own ﬁxed place,
throwing away in own non-ﬁxed place, disposing anywhere or other method), water
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purifying process (ﬁlter, ﬁlter and broil, or other), and source of cooking water (from
pond or river/canal, or from tube well, ring well or supply water).
We apply naive g-estimation, modiﬁed g-estimation and the controlling-the-future
method to this data set. Since we only have three rounds, the actual propensity score
models and the estimating equations for the three methods are
∙ Naive g-estimation uses the following propensity score model
푙표푔푖푡{푝푟[퐴∗푘 = 1∣푉, 퐿−∗푘 , 푌 ∗푘 ]} = 훽0 + 훽푉 푉 + 훽퐿퐿−∗푘 + 훽푌 푌 ∗푘
where 푘 = 1, 2.
The estimating equations follow the form of (2.2.5) in Section 2.2.1:
∑
1≤푘<푚≤3
1≤푖≤푛
[퐴∗푘,푖 − 푝푟(퐴∗푘,푖 = 1∣푉푖, 퐿−∗푘,푖 , 푌 ∗푘,푖)]
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
푌 0∗푚,푖(Ψ)
푉푖
퐿−∗푘,푖
푌 ∗푘,푖
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
= 0
where 푌 0∗푚,푖(Ψ) = 푌
∗
푚,푖 −Ψ
∑푚−1
푙=1 퐴푙.
∙ Modiﬁed g-estimation uses this propensity score model
푙표푔푖푡{푝푟[퐴∗푘 = 1∣푉, 퐿−∗푘 , 푌 ∗푘 , 푐푢푚퐴∗푘]}
=훽0 + 훽푉 푉 + 훽퐿퐿
−∗
푘 + 훽푌 푌
∗
푘 + 훽푐푢푚퐴푐푢푚퐴
∗
푘
where 푘 = 1, 2.
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The estimating equations follow the form of (2.2.7) in Section 2.2.3.
∑
1≤푘<푚≤3
1≤푖≤푛
[퐴∗푘,푖 − 푝푟(퐴∗푘,푖 = 1∣푉푖, 퐿−∗푘,푖 , 푌 ∗푘,푖, 푐푢푚퐴∗푘,푖)]
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
푌 0∗푚,푖(Ψ)
푉푖
퐿−∗푘,푖
푌 ∗푘,푖
푐푢푚퐴∗푘,푖
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
= 0
where 푌 0∗푚,푖(Ψ) = 푌
∗
푚,푖 −Ψ푐푢푚퐴푚.
∙ Controlling-the-future estimation uses the following propensity score model
푙표푔푖푡{푝푟[퐴∗1 = 1∣푉, 퐿−∗1 , 푌 ∗1 , 푐푢푚퐴∗1, 푌 0∗2 (Ψ)]}
=훽0 + 훽푉 푉 + 훽퐿퐿
−∗
1 + 훽푌 푌
∗
1 + 훽푐푢푚퐴푐푢푚퐴
∗
1 + 훽푌 0푌
0∗
2 (Ψ)
The estimating equations follow (2.4.4) in Section 2.4
∑
1≤푖≤푛
[퐴∗1,푖 − 푝푟(퐴∗1,푖∣푉푖, 퐿−∗1,푖 , 푌 ∗1,푖, 푐푢푚퐴∗1,푖, 푌 0∗2,푖 (Ψ))]
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
푌 0∗3,푖 (Ψ)
푉푖
퐿−∗1,푖
푌 ∗1,푖
푐푢푚퐴∗1,푖
푌 0∗2,푖 (Ψ)
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
= 0
where 푌 0∗3,푖 (Ψ) = 푌
∗
3,푖 −Ψ푐푢푚퐴3.
The interpretation of Ψ in the last two models is that one day of suﬀering from
diarrhea reduces the height of the child by Ψ centimeters. For naive g-estimation,
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Table 2.3: Estimation of Ψ from the Diarrhea Data Set
Method Estimate Std Err
Naive g-est. -0.3991 0.2469
Modiﬁed g-est. -0.3481 0.2832
controlling-the-future est. -0.0840 0.1894
the underlying data generating model treats the exposure at the observational time
as the constant exposure level for the next six months, which does not make sense in
the context. Ψ in this model should be interpreted as the eﬀect of having diarrhea
at the time of visits, as oppose to having diarrhea at any time, on the height of the
child, which does not make too much sense either.
The estimated Ψ and its standard deviation are reported in Table 2.3. Modiﬁed
g-estimation estimates Ψˆ = −0.3481, which means that the height of the child is
reduced by 0.35cm if the child has one day of diarrhea. Our controlling-the-future
method produces an estimate of Ψˆ = −0.0840. Although all the estimates are not
signiﬁcant because of the small sample size, the sign and magnitude of the estimate
from the controlling-the-future method are consistent with other research on diar-
rhea’s eﬀect on height (e.g. Moore et al. 2001).
In addition, we notice that the standard deviation of the modiﬁed g-estimate is
higher than that of the controlling-the-future estimate. As discussed at the end of
Section 2.4.2, if the modiﬁed g-estimation is consistent, we would expect that the
controlling-the-future estimation will have larger standard deviation. The standard
deviations in Table 2.3 provide evidence that the modiﬁed g-estimation is not con-
sistent.
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2.7 Conclusion
In this chapter, we have studied causal inference from longitudinal data when the
underlying processes are in continuous time but the covariates are only observed at
discrete times. We have investigated two aspects of the problem. One is the validity
of the discrete time g-estimation. Speciﬁcally, we investigate a version of g-estimation
that follows the spirit of standard discrete time g-estimation but is modiﬁed to incor-
porate the information of the underlying continuous time treatment process, which
we referred to as modiﬁed g-estimation throughout the chapter. We have shown that
an important condition that justiﬁes this g-estimation is the ﬁnite time sequential
randomization assumption at any subset of time points, which is strictly stronger
than the continuous time sequential randomization. We have also shown that a
Markovian assumption and the continuous time sequential randomization would im-
ply the FTSR assumption. The Markovian condition is more useful than the FTSR
assumption, in the sense that it can potentially help researchers decide whether the
application of g-estimation is appropriate. The other aspect is the controlling-the-
future method that we propose to use when the condition to warrant g-estimation
does not hold. Controlling-the-future method can produce consistent estimates when
g-estimation is inconsistent and is less biased in other scenarios. In particular, we
identiﬁed two important cases in which controlling the future is less biased, namely,
when there is delayed dependence in the baseline counterfactual process and when
there are leading indicators of the counterfactual process in the covariate process.
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In our simulation study, we have shown the performance of the modiﬁed g-
estimation and the controlling-the-future estimation. The results conﬁrm our dis-
cussion in earlier sections. The simulation results have also warned about the danger
of applying naive g-estimation, which is usually severely biased and inconsistent when
its underlying assumptions are violated, as in the situations considered.
We have applied the g-estimations and the controlling-the-future method to es-
timating the eﬀect of diarrhea on a child’s height, and estimated that its eﬀect is
negative but not signiﬁcant. The real application also provides some evidence that
the modiﬁed g-estimation is not consistent.
All the discussion in this chapter are based on a particular form of causal model
- equation (2.2.6). However, all the arguments could apply to a class of more general
rank preserving models, with necessary adjustments in various equations. If we
assume a generic rank preserving model with 푌푡 = 푓(푌
0
푡 , ℎ(퐴¯푡−); Ψ), where 퐴¯푡− is
the continuous time path of 퐴 from time 0 to 푡−, ℎ is some functional (e.g., in
our chapter ℎ(퐴¯푡−) =
∫ 푡
0
퐴푠푑푠), and 푓 is some strictly monotonic function with
respect to the ﬁrst argument(e.g., in our chapter, 푓(푥, 푦; Ψ) = 푥 + Ψ푦), we map
푌 ∗푘 to 푌
0∗
푘 = 푓
−1(푌 ∗푘 , ℎ(퐴¯푘−); Ψ), where 푓
−1 is the inverse of 푓(푥, 푦; Ψ) with respect
to 푥 for any given 푦. We can then substitute all 푐푢푚퐴∗푘’s in this chapter by the
ℎ(퐴¯푘−)’s. All the discussions and formulas in the chapter would still work, under the
assumption that we observe all ℎ(퐴¯푘−)’s, which can be easily satisﬁed with detailed
continuous time records of the treatment. It should be noted that the argument does
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not work if a time-varying covariate modiﬁes the eﬀect of treatment. For example,
if 푌푡 = 푌
0
푡 + Ψ
∫ 푡
0
퐿2푠퐴푠푑푠, where 퐿푠 is a time varying covariate, observing the full
continuous time treatment process is not enough. Some imputation for the 퐿푠 process
is necessary.
The methods considered here have several limitations. These include rank preser-
vation, a strong assumption that the eﬀects of treatment are deterministic. This
assumption facilitates interpretation of models. In other work on structural nested
distribution and related models (e.g., Robins, 2008), rank preservation has been
shown to be unnecessary in settings in which one is not modeling the joint distri-
bution of potential outcomes under diﬀerent treatments. We expect that this is the
case here as well, and work justifying this more formally is in progress.
In this chapter, we also require that cumulative amount of treatment (or the full
continuous time treatment process, if using other causal models mentioned above)
between the discrete time points when the covariates are observed is known. In a
word, we are free of the treatment measurement error problem mentioned in Sec-
tion 1.2. The next chapter presents an example of getting causal inference when we
do have the treatment measurement error problem.
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Chapter 3
Causal Inference for a Discretely Observed
Continuous Time Non-stationary Markov Process
In this chapter, we consider an example when both the treatment process and the
covariate process are only observed at discrete time points. The problems of un-
measured confounders and the treatment measurement error both arise. In order to
identify causal eﬀect in this scenario, it is natural to expect that more modeling as-
sumptions are needed. In this chapter, we propose a continuous time non-stationary
Markov model to infer the eﬀect of vitamin A deﬁciency on respiratory infection
among young children. An MCMC algorithm is developed to estimate the model
from the discretely observed data. Our simulation and real application show that
the model and the estimation algorithm work reasonably well, and we are able to
infer a strong eﬀect of vitamin A deﬁciency on respiratory infection.
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3.1 Introduction
Vitamin A deﬁciency has been reported to have signiﬁcant consequences in developing
countries in terms of child’s mortality and morbidity (Vijayaraghavan et al., 1990;
West et al., 1991; Daulaire et al., 1992). Severe vitamin A deﬁciency is usually
identiﬁed by its ocular manifestation, xerophthalmia, the signs of which include night
blindness, conjunctival or corneal xerosis. Beginning in the early 1980s, it has been
revealed that even subclinical vitamin A deﬁciency has broad consequences in child’s
mortality and morbidity (Humphrey, 1992). In this chapter, we use a subset of the
cohort studied by Somer, Katz and Tarwotjo (see Sommer et al., 1983) to study the
causal eﬀect of vitamin A deﬁciency on the occurrence of respiratory disease for young
children. In this longitudinal data set, 250 preschool children were examined up to
six consecutive quarters for the occurrence of respiratory infection and the presence
of xerophthalmia. The covariates of interest include ages in months (centered at 36),
gender, cosine and sine terms for annual cycle, and presence of stunting (deﬁned as
being below the 85th percentile in height for age of the National Center for Health
Statistics (NCHS) standard), which indicates longer term nutritional status.
The same data set has been analyzed by Zeger and Karim (1991) using a logistic
model with random eﬀect (we have dropped the variable height for age to simplify
computation) and by Zeger and Liang (1991) with a feedback time series model, and
important discoveries have been found from this data set. In Zeger and Karim’s work,
they found signiﬁcant association between xerophthalmia and respiratory infection
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conditional on other covariates, by carefully incorporating within-subject correla-
tions with a random eﬀect term in their logistic regression model. In Zeger and
Liang’s work, they studied the feedback relationship among xerophthalmia, respira-
tory infection and diarrheal disease using a multivariate time series model, and found
signiﬁcant evidence for a feedback cycle between xerophthalmia and diarrheal disease
but not for a feedback cycle between xerophthalmia and respiratory infection. Both
analysis are associational (see Robins et al., 1999).
In this chapter, we would like to make causal inferences of vitamin A deﬁciency
on respiratory infection, while incorporating the dynamic nature of the subject evolv-
ing with the time. In particular, we hope to properly adjust for baseline covariates,
seasonality and possible feedback cycles among time dependent covariates simulta-
neously, and answer questions like, what is the probability of a child suﬀering from
respiratory disease a year later, if the child starts taking vitamin A supplement that
eﬀectively eliminates any vitamin A deﬁciency, as compared with the same probabil-
ity if the child does not take any vitamin A supplement and grows naturally.
To achieve this goal, we model the longitudinal data under Rubin’s counterfac-
tual framework (Rubin, 1974), and assume that the covariates, vitamin A deﬁciency
levels, actual outcomes and counterfactual outcomes for the occurrence of respiratory
infection follow a continuous time Markov process that is only partially observed at
the six discrete follow-up times. Two features of this model make our study novel
and of particular interest for its generalization to other problems. First, we try to
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infer the causal eﬀect of vitamin A deﬁciency level, which is latent, and the symptom
of xerophthalmia is only a surrogate for vitamin A deﬁciency, indicating whether vi-
tamin A deﬁciency level is above some threshold (see the discussion section of Zeger
and Liang (1991)). Secondly, we only observe this surrogate and other time depen-
dent covariates at discrete time points, even though everything changes in continuous
time.
These two features distinguish our model from the established semi-parametric
methods for longitudinal data developed by Robins and his collaborators (Robins,
1986, 1992, 1994, 1998; Robins et al., 1999). In most of Robins’ work, data are as-
sumed to be generated from a discrete time process, and at each time point, all the
confounders are observed such that the treatment looks as if it is randomly assigned
conditional on all the covariates and historical treatment levels (the ignorability as-
sumption, see assumption (A1) in Section 1.1). In our data set, the presence/absence
of respiratory disease, the presence/absence of stunting and the level of vitamin A
deﬁciency can all switch at any time between two consecutive time points, and it is
more reasonable to assume that the whole process is in continuous time and only
observed at discrete times. In Chapter 2, we have shown that even if the ignorability
assumption is true in continuous time, it may not hold at discrete observational times
and thus the standard g-estimation of Robins may be biased.
The model in this chapter also diﬀers from the ones discussed in Chapter 2. In
Chapter 2, the full continuous time history of the exact amount of treatment is
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assumed to be known, in which case a modiﬁed ignorability assumption and the
controlling-the-future method of Joﬀe and Robins (Joﬀe and Robins, 2009) can be
used to identify the causal eﬀect semi-parametrically in some scenarios. However,
the luxury of observing the exact amount of treatment is not available in our data
set, as the treatment level, the real vitamin A deﬁciency level, is unobserved. Only
when the deﬁciency reached a level high enough can xerophthalmia be observed and
recorded in the data, and xerophthalmia itself is not recorded in continuous time -
it is observable only at the time of the visits. In a word, we are suﬀering from the
measurement error problem discussed in Section 1.2. While standard semi-parametric
approach fails to adjust for the measurement error, more assumptions are needed for
identiﬁcation. In this chapter, we choose to use a full parametric model.
This chapter also contributes to the literature of estimating a discretely observed
continuous time Markov process. Vast amount of research work has been done on
various cases of the problem, including discretely observed continuous time diﬀu-
sions, e.g., (Johannes et al., 2009; Elerian et al., 2001; Blackwell, 2003; Aı¨t-Sahalia,
2002), discretely observed stationary continuous time Markov chain, e.g., (Bladt and
Sørensen, 2005), and discretely observed two-state non-stationary continuous time
Markov chain, e.g., (Singer, 1981). In our model, we are facing a discretely ob-
served 32-state non-stationary continuous time Markov chain. We are able to ﬁnd
an MCMC algorithm to estimate the parameters for our particular problem. It will
be of great interest to search for more general and more eﬃcient algorithms for esti-
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mating discretely observed non-stationary continuous time Markov process in future
research.
The organization of the chapter is as follows: Section 3.2 describes our continuous
time Markov model under the counterfactual framework; Section 3.3 describes our
MCMC algorithm for estimating the model; Section 3.4 is a simulation study of our
computational algorithm; Section 3.5 reports the results for applying our model to
the vitamin A deﬁciency data; Section 3.6 concludes the chapter.
3.2 A Markov Model
In this chapter, we denote the level of vitamin A deﬁciency at time 푡 by an ordinal
latent variable 퐴∗푡 with 푑 states (e.g., 푑 = 4 and the states are 0, 1, 2, 3). We deﬁne
퐴푡 to be a binary indicator of xerophthalmia, which will take value 1 if 퐴
∗
푡 ≥ 푐 and
0 if 퐴∗푡 < 푐 (e.g., 푐 = 2 if 푑 = 4). Let 퐿푡 be the binary indicator of whether the child
is stunted at time 푡, and 푌푡 be the binary variable that indicates whether the child is
suﬀering from respiratory infection at time 푡. Consider the counterfactual outcome
푌
퐴¯∗푠−,0
푡 , 푡 ≥ 푠, which is the potential outcome for respiratory infection status at time
푡, if the subject receives the realized treatment 퐴∗푙 from time 0 to just prior to time
푠 and keeps the treatment level at the lowest (i.e., 0) from time 푡 and on.
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3.2.1 The Causal Model
We assume the following model for the causal relationship between 퐴∗푡 and 푌푡.
푃 (푌푡 = 1∣푌 퐴¯
∗
푡−,0
푡 , 퐴
∗
푡 ) =
⎧⎨⎩
1 if 푌
퐴¯∗푡−,0
푡 = 1
0 if 푌
퐴¯∗푡−,0
푡 = 0, 퐴
∗
푡 = 0
훿푗 if 푌
퐴¯∗푡−,0
푡 = 0, 퐴
∗
푡 = 푗 (푗 > 0)
(3.2.1)
The model describes how the treatment levels aﬀect the realized outcome 푌푡, given
the baseline potential outcome at time 푡. The 훿’s are the causal eﬀect of 퐴푡 on 푌푡.
In (3.2.1), we assume that if 푌
퐴¯∗푡−,0
푡 = 1, 푌푡 = 1, i.e., if the child would suﬀer
from respiratory infection even without any vitamin A deﬁciency, any vitamin A
deﬁciency could only make the child worse. If 푌
퐴¯∗푡−,0
푡 = 0, diﬀerent levels of vitamin
A deﬁciency results in diﬀerent levels of risk for the child to get respiratory infection,
and we would expect that the higher the level of vitamin A deﬁciency is, the higher
risk of respiratory infection the child has. It is worth noting that in this model, 푌푡 = 0
if 푌
퐴¯∗푡−,0
푡 = 0 and 퐴
∗
푡 = 0, which is a consistency assumption that is often assumed
in most causal research work (e.g., Robins et al. (2000)). For example, with a single
outcome 푌 표푏푠푒푟푣푒, people usually assume that 푌 표푏푠푒푟푣푒 = 푌 푎 if 퐴 = 푎, where 푌 푎 is the
counterfactual outcome under treatment level 푎.
3.2.2 Continuous Time Markov Process
We assume that (퐴∗푡 , 푌
퐴¯∗푡−,0
푡 , 퐿푡, 푌푡) follows a continuous time Markov process, which
will be described below. Note that 퐴푡 is only a coarsened observation of 퐴
∗
푡 . We
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also assume that the observational times are 0, 1, ⋅ ⋅ ⋅ , 퐾. At each time point 푘, only
(퐴푘, 푌푘, 퐿푘) are observed. Any variables in between two consecutive time points and
any potential outcomes are not observable. Figure 3.1 shows a discretized example of
the data generating process from this model. In the example, (퐴∗푡 , 푌
퐴¯∗푡−,0
푡 , 퐿푡, 푌푡) can
change values at time 1, 1.5, 2, 2.5, 3 and 3.5, but only (퐴푘, 푌푘, 퐿푘) can be observed
at time 1, 2, and 3.
Figure 3.1: Discretized Example of Data Generating Process
The Transition Rate Matrix 푄
The continuous time Markov process (퐴∗푡 , 푌
퐴¯∗푡−,0
푡 , 퐿푡, 푌푡) has 32 states (4 by 2 by 2
by 2), each state being denoted by a vector 푠 = (푎∗, 푦0, 푙, 푦)푇 , where 푎∗ ∈ {0, 1, 2, 3},
푦0 ∈ {0, 1}, 푙 ∈ {0, 1} and 푦 ∈ {0, 1}. We model the Markov process by specifying
how we construct the transition rate matrix 푄(푡). 푄(푡) is a 32 by 32 matrix, which
may depend on covariates like time, age and gender. Note that unlike stunting, time,
age and gender are not time-dependent confounders. They are not modeled as the
state of the Markov process, but are conditioned on when calculating the transition
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rate matrix.
We denote 푋푡 = (퐴
∗
푡 , 푌
퐴¯∗푡−,0
푡 , 퐿푡, 푌푡) and consider the elements in 푄(푡):
푞푡(푠1, 푠2) = lim
ℎ↓0
푃푟(푋푡+ℎ = 푠2∣푋푡 = 푠1, 푎푔푒, 푠푒푥)
ℎ
for 푠1 ∕= 푠2, and
푞푡(푠, 푠) = −
∑
푠′ ∕=푠
푞푡(푠, 푠
′)
We factorize
푃 (푋푡+ℎ∣푋푡, 푎푔푒, 푠푒푥)
=푃 (퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ∣푋푡, 푎푔푒, 푠푒푥)푃 (퐿푡+ℎ∣푋푡, 푎푔푒, 푠푒푥,퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ )
× 푃 (푌푡+ℎ∣푋푡, 푎푔푒, 푠푒푥,퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ , 퐿푡+ℎ)
=푃 (퐴∗푡+ℎ∣푋푡, 푎푔푒, 푠푒푥)푃 (푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ∣푋푡, 퐴∗푡+ℎ, 푎푔푒, 푠푒푥)
× 푃 (퐿푡+ℎ∣푋푡, 푎푔푒, 푠푒푥,퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ )× 푃 (푌푡+ℎ∣퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ).
Note that with this factorization, we have assumed that 푌푡+ℎ is independent of
푋푡, 푠푒푥, 푎푔푒 and 퐿푡+ℎ conditional on 퐴
∗
푡+ℎ and 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ . This assumption means
that causal eﬀect of 퐴푡+ℎ on 푌푡+ℎ does not depend on any pre-treatment covariate.
Similar assumptions have been assumed in many causal researches (e.g. the model
of additive eﬀect discussed in the Section 2 of Rosenbaum (2002) is such a model).
We model each component in the factorization as
∙ Model for the jump of 퐴∗푡
푃 (퐴∗푡+ℎ = 푗∣푋푡, 푎푔푒, 푠푒푥) (3.2.2)
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=⎧⎨⎩
ℎ훼(퐴∗푡+ℎ;퐴
∗
푡 , 퐿푡, 푌푡, 푎푔푒, 푠푒푥, 푡) + 표(ℎ), ∣퐴∗푡 − 푗∣ = 1
표(ℎ), ∣퐴∗푡 − 푗∣ > 1
The model assumes that the level of vitamin A deﬁciency can only switch to
an adjacent level when it switches.
∙ Model for the jump of 푌 퐴¯
∗
(푡)−,0
푡
푃 (푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ = 푗∣푋푡, 퐴∗푡+ℎ, 푎푔푒, 푠푒푥) (3.2.3)
=ℎ훽(푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ;푋푡, 푎푔푒, 푠푒푥, 푡) + 표(ℎ), 푌
퐴¯∗푡−,0
푡 ∕= 푗;
∙ Model for the jump of 퐿푡
푃 (퐿푡+ℎ = 푗∣푋푡, 푎푔푒, 푠푒푥,퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ) (3.2.4)
=ℎ훾(퐿푡+ℎ;푋푡, 푎푔푒, 푠푒푥,퐴
∗
푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ , 푡) + 표(ℎ), 퐿푡 ∕= 푗.
∙ 푃 (푌푡+ℎ∣퐴∗푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ) is deﬁned in (3.2.1). We denote
푝푦(푦; 푎, 푦
0) = 푃 (푌푡+ℎ = 푦∣퐴∗푡+ℎ = 푎, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ = 푦
0).
Remark 3.2.1. By assuming that the 훼 function is not a function of 푌
퐴¯∗푡−,0
푡 and
is a function of 푌푡 and 퐿푡, and that the 훽 function is not a function of 퐴
∗
푡+ℎ, we
have assumed continuous time ignorability for our model, i.e., the treatment only
depends on realized past covariates and past treatments and does not depend on
future potential outcomes. For a formal deﬁnition of continuous time ignorability
assumption and the proof that the model conforms with the ignorability assumption,
see Section 5.6.
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Given (3.2.2), (3.2.3) and (3.2.4), the elements of the transition rate matrix 푄(푡)
are, for 푠1 ∕= 푠2
푞푡(푠1, 푠2) =
⎧⎨⎩
훼푡(푎2; 푎1, 푙1, 푦1)푝푦(푦2; 푎2, 푦
0
2) if ∣푎1 − 푎2∣ = 1, 푙1 = 푙2, 푦01 = 푦02
훽푡(푦
0
2; 푠1)푝푦(푦2; 푎2, 푦
0
2) if 푦
0
1 ∕= 푦02, 푎1 = 푎2, 푙1 = 푙2
훾푡(푙2; 푠1, 푎2, 푦
0
2)푝푦(푦2; 푎2, 푦
0
2) if 푙1 ∕= 푙2, 푎1 = 푎2, 푦01 = 푦02
0 otherwise
where
훼푡(푎2; 푎1, 푙1, 푦1) =훼(퐴
∗
푡+ℎ = 푎2;퐴
∗
푡 = 푎1, 퐿푡 = 푙1, 푌푡 = 푦1, 푎푔푒, 푠푒푥, 푡)
훽푡(푦
0
2; 푠1) =훽(푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ = 푦
0
2;푋푡 = 푠1, 푎푔푒, 푠푒푥, 푡)
훾푡(푙2; 푠1, 푎2, 푦
0
2) =훾(퐿푡+ℎ = 푙2;푋푡 = 푠1, 푎푔푒, 푠푒푥,퐴
∗
푡+ℎ = 푎2,
푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ = 푦
0
2, 푡).
Initial Conditions and the Conditional Likelihood Function
For a complete model, we also need to give the initial probability distribution for
(퐴∗0, 푌
퐴¯∗0−,0
0 , 퐿0, 푌0). The causal relationship and the feedback cycles are already en-
coded in (3.2.1) and the deﬁnition of 푄(푡). It would be reasonable to make inference
from a conditional likelihood that conditions on the initial states. However, 퐴∗0, 푌
퐴¯∗0−,0
0
are unobserved, and only (퐴0, 퐿0, 푌0) are observed. We hereby assume that
푃 (퐴∗0, 푌
퐴¯∗0−,0
0 ∣퐴0, 퐿0, 푎푔푒, 푠푒푥) =
1
2
× 1
2
× 퐼퐴0=(퐴∗0≥푐) (3.2.5)
This initial distribution claims that 퐴∗0 is uniform on {0, 1} if 퐴0 = 0, and uniform on
{2, 3} if 퐴0 = 1, and that 푌 퐴¯
∗
0−,0
0 is uniform on {0, 1}, conditional on the value of 퐴0
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and 퐿0. This assumption gives the levels of 퐴
∗ certain physical meaning. If we view
the true level of vitamin A deﬁciency as a continuous measure and xerophthalmia
as an indicator whether the true level is above a threshold, (3.2.5) assumes that the
cut-point between 퐴∗ = 1 and 퐴∗ = 0 is the median of the conditional distribution
of the true level, conditioning on 퐴 = 0, and that the cut-point between 퐴∗ = 2 and
퐴∗ = 3 is the median of the conditional distribution of the true level, conditioning
on 퐴 = 1.
With equation (3.2.5) and model (3.2.1), 푃 (퐴∗0, 푌
퐴¯∗0−,0
0 ∣퐴0, 퐿0, 푌0, 푎푔푒, 푠푒푥) can be
calculated. Given 푃 (퐴∗0, 푌
퐴¯∗0−,0
0 ∣퐴0, 퐿0, 푌0, 푎푔푒, 푠푒푥), a conditional likelihood function
of the observed data can be calculated as
푓(퐴1, ..., 퐴퐾 , 퐿1, ..., 퐿퐾 , 푌1, ..., 푌퐾 ∣퐴0, 퐿0, 푌0, 푎푔푒, 푠푒푥)
=
∫ ∫
푃 (퐴∗0, 푌
퐴¯∗0−,0
0 ∣퐴0, 퐿0, 푌0, 푎푔푒, 푠푒푥)
× 푃 (퐴1, ..., 퐴퐾 , 퐿1, ..., 퐿퐾 , 푌1, ..., 푌퐾 ∣퐴∗0, 푌
퐴¯∗0−,0
0 , 퐿0, 푌0, 푎푔푒, 푠푒푥)푑퐴
∗
0푑푌
퐴¯∗0−,0
0
푃 (퐴1, ..., 퐴퐾 , 퐿1, ..., 퐿퐾 , 푌1, ..., 푌퐾 ∣퐴∗0, 푌
퐴¯∗0−,0
0 , 퐿0, 푌0, 푎푔푒, 푠푒푥) can be determined by
푄(푡) and model (3.2.1), even though a direct computation is almost infeasible. We
will discuss our approach in Section 3.3.
To summarize, our model assumes that (퐴∗푡 , 푌
퐴¯∗푡−,0
푡 , 퐿푡, 푌푡) follows a continuous
time non-stationary Markov process deﬁned by the transition rate matrix 푄(푡), and
that 퐴푡 is determined deterministically by 퐴
∗
푡 . We only observe the (퐴푡, 푌푡, 퐿푡) at
time 0, 1, ⋅ ⋅ ⋅ , 퐾. Diﬀerent subjects are assumed to be independent realizations of
the process conditional on their baseline covariates and initial conditions.
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3.3 Estimation: MCMC with Data Augmentation
To estimate the model deﬁned in Section 3.2, we parametrize 훿푖 =
exp(훿˜푖)
1+exp(훿˜푖)
, 훼 = 훼(훼˜),
훽 = 훽(훽˜) and 훾 = 훾(훾˜). Denote Θ = (훿˜1, 훿˜2, 훿˜3, 훼˜, 훽˜, 훾˜). Θ is the collection of
parameters that needs to be estimated.
Even if we know the true value of Θ, it is quite diﬃcult to evaluate the likelihood
of the observed data in our model. The diﬃculty lies in the fact that the Markov
process is non-stationary and that it depends on baseline covariates. For a stationary
continuous time Markov process with ﬁnite number of states and without covariates,
transition matrix from time 푡 to time 푡 + 1 is simply 푒푄, where 푄 is the transition
rate matrix. With 푒푄 calculated once, the problem becomes a standard discrete time
hidden Markov model, where the transition matrix between states is 푒푄 and the
emission matrix easily deﬁned since 퐴푡, 푌푡, 퐿푡 are deterministic observations from the
states of the Markov model. With a non-stationary Markov process, the transition
matrix does not usually have a simple form (for two-state process, there is one, see
Singer (1981); for a more general process, see discussions in Wei and Norman (1963,
1964)). One practical approach may be discretizing the process and approximate the
transition matrix from time 푡 to time 푡 + 1 by
∏푛
푖=1[
1
푛
푄(푡 + 푖−1
푛
) + 퐼], which will be
quite time consuming, and considering that fact that we have covariates and we need
to do this computation for every subject in every time interval, it quickly becomes
computationally infeasible.
In this section, we propose a Monte Carlo Markov Chain approach with data
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augmentation for estimation (see more about data augmentation in van Dyk and
Meng (2001)). In our algorithm, we also need to discretize the continuous time
Markov process and approximate the process by an embedded Markov chain.
3.3.1 Discretization Scheme
Denote 푍푡 = (퐴
∗
푡 , 푌
퐴¯∗푡−,0
푡 , 퐿푡, 퐴푡, 푌푡) (notice that 푍푡 is also a Markov process under
the model deﬁned in Section 3.2). We discretize the continuous time Markov process
at the time grid of 1
푛
, i.e., we consider the embedded discrete time Markov chain 푍0,
푍 1
푛
, 푍 2
푛
, ⋅ ⋅ ⋅ , 푍푛−1
푛
, 푍1, 푍푛+1
푛
, ⋅ ⋅ ⋅ , 푍퐾 . We approximate the transition probability of
the discretized chain by (to simplify notation, we deﬁne 푌 0푡 = 푌
퐴¯∗푡−,0
푡 )
푃푟(푍푚+1
푛
∣푍푚
푛
)
≈[ 1
푛
훼(퐴∗푚+1
푛
;퐴∗푚
푛
, 퐿푚
푛
, 푎푔푒, 푠푒푥, 푌푚
푛
,
푚
푛
)]
퐼퐴∗푚+1
푛
∕=퐴∗푚
푛
× [1− 1
푛
(1 + 퐼퐴∗푚
푛
∕∈{0,푑−1})훼(퐴∗푚+1
푛
;퐴∗푚
푛
, 퐿푚
푛
, 푎푔푒, 푠푒푥, 푌푚
푛
,
푚
푛
)]
퐼퐴∗푚+1
푛
=퐴∗푚
푛
× [ 1
푛
훽(푌 0푚+1
푛
;푋푚
푛
, 푎푔푒, 푠푒푥, 푌푚
푛
,
푚
푛
)]
퐼
푌 0푚+1
푛
∕=푌 0푚
푛
× [1− 1
푛
훽(푌 0푚+1
푛
;푋푚
푛
, 푎푔푒, 푠푒푥, 푌푚
푛
,
푚
푛
)]
퐼
푌 0푚+1
푛
=푌 0푚
푛
× [ 1
푛
훾(퐿푚+1
푛
;푋푚
푛
, 푎푔푒, 푠푒푥, 푌푚
푛
, 퐴∗푚+1
푛
, 푌 0푚+1
푛
,
푚
푛
)]
퐼퐿푚+1
푛
∕=퐿푚
푛
× [1− 1
푛
훾(퐿푚+1
푛
;푋푚
푛
, 푎푔푒, 푠푒푥, 푌푚
푛
, 퐴∗푚+1
푛
, 푌 0푚+1
푛
,
푚
푛
)]
퐼퐿푚+1
푛
=퐿푚
푛
× 푃푟(퐴푚+1
푛
∣퐴∗푚+1
푛
)× 푃푟(푌푚+1
푛
∣푌 0푚+1
푛
, 퐴∗푚+1
푛
)
where 푃푟(퐴푚+1
푛
∣퐴∗푚+1
푛
) = 퐼퐴푚+1
푛
=퐼퐴∗푚+1
푛
≥푐 , and 푃푟(푌푚+1푛
∣푌 0푚+1
푛
, 퐴∗푚+1
푛
) is decided by
equation (3.2.1).
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3.3.2 The MCMC Algorithm
Notice that after discretizing the process, if we do observe full 푍푡 process, the evalua-
tion of the full likelihood is relatively easy, as we would avoid matrix multiplications.
Motivated by this fact, we consider an MCMC algorithm with data augmentation.
Denote the observed data by 푂, where 푂 = (퐴0, 푌0, 퐿0, 퐴1, 푌1, 퐿1, ⋅ ⋅ ⋅ , 퐴퐾 , 푌퐾 , 퐿퐾),
the full data by 푍, where 푍 = (푍0, 푍 1
푛
, 푍 2
푛
, ⋅ ⋅ ⋅ , 푍퐾), and the missing data by 푈 ,
where 푈 = 푍 −푂.
To ﬁt into the Bayesian framework, we assume a proper prior distribution for
Θ. In our implementation, the prior distribution 휋 is assumed to be a multi-normal
distribution, with mean (0, 0, ⋅ ⋅ ⋅ , 0) and covariance matrix 휎퐼, where 퐼 is the iden-
tity matrix. We view the proper prior distribution as a regularization in estimating
the parameters. It has been recognized for a long time that maximum likelihood
estimates for discretely observed continuous time Markov process could be very un-
stable (see Kalbﬂeisch and Lawless, 1985). For example, in the case of stationary
Markov process, if the transition rate matrix has large elements and the time interval
between two observations is too long, the transition probability between two observa-
tional time points could be close to the stationary distribution. Then the transition
rate matrix multiplied by any large positive number would explain the data very well.
MLE could have huge variance or not even exist. See Bladt and Sørensen (2005) for
a concrete example when MLE does not exist. In their example, the Markov model
is saturated, i.e., there is no constraint on the transition rate matrix. Although we
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have assumed structures for our transition rate matrix, we suspect that our likelihood
function is not well behaved either, as our experiments on MCMC with a ﬂat prior
distribution fails to converge even after a huge number of iterations.
With the setup, a sketch of a general MCMC algorithm with data augmentation
is in Figure 3.2.
Figure 3.2: MCMC with Data Augmentation
1. Initialize Θ and 푈 .
2. Given 푈 , we update Θ by simulating from 푃 (Θ∣푈,푂).
3. Given Θ, we update 푈 by simulating from 푃 (푈 ∣Θ, 푂).
4. Repeat 2-3.
Here 푃 (Θ∣푈,푂) ∝ 휋(Θ)푃 (푈,푂∣Θ) and 푃 (푈 ∣Θ, 푂) ∝ 푃 (푈,푂∣Θ). 푃 (푈,푂∣Θ) can
be easily calculated using the formula in Section 3.3.1. Under certain regularity
conditions, the limiting marginal distribution of Θ will be the posterior distribution
푃 (Θ∣푂).
With our model, it is quite diﬃcult to simulate directly from 푃 (Θ∣푈,푂) and
푃 (푈 ∣Θ, 푂). We therefore substitute step 2 and 3 by Metropolis-Hasting steps.
∙ Step 2 Given 푈 and Θ표푙푑, we simulate Θ푛푒푤 from a proposal distribution
푞(Θ∣Θ표푙푑), and calculate
푟1 = min(1,
푃 (Θ푛푒푤∣푈,푂)푞(Θ표푙푑∣Θ푛푒푤)
푃 (Θ표푙푑∣푈,푂)푞(Θ푛푒푤∣Θ표푙푑) ).
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We update Θ by Θ푛푒푤 with probability 푟1, and by Θ표푙푑 with probability 1− 푟1.
∙ Step 3 Given Θ, and 푈표푙푑, we simulate 푈푛푒푤 from a proposal distribution
푞(푈 ∣푈표푙푑), and calculate
푟2 = min(1,
푃 (푈푛푒푤∣Θ, 푂)푞(푈표푙푑∣푈푛푒푤)
푃 (푈표푙푑∣Θ, 푂)푞(푈푛푒푤∣푈표푙푑) ).
We update 푈 by 푈푛푒푤 with probability 푟2, and by 푈표푙푑 with probability 1− 푟2.
In our implementation, the proposal distribution 푞(Θ∣Θ표푙푑) is taken to be the multi-
normal distribution with mean Θ표푙푑 and covariance matrix being a diagonal matrix.
In this case, the calculation of 푟1 simpliﬁes to
푟1 = min(1,
푃 (Θ푛푒푤∣푈,푂)
푃 (Θ표푙푑∣푈,푂) ).
The proposal distribution 푞(푈 ∣푈표푙푑) is more complicated, which we describe in
the following section.
3.3.3 Proposal Distributions for the Augmented Data
To ﬁnd a good proposal distribution for 푈 , we ﬁrst need to be able to simulate a
whole path of the discretized Markov chain, such that the values of the path match
the observed values at the observational times, namely 0, 1, ⋅ ⋅ ⋅ , 퐾. Secondly, the
path we simulate has to have a signiﬁcant probability to occur under the Markov
model. There are available methods for simulating paths that match the end points in
continuous time stationary Markov process (see Blackwell, 2003; Bladt and Sørensen,
2005; Nielsen, 2002; Hobolth, 2008). In this chapter, we have designed a proposal
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distribution that works well for our model, which is a continuous time non-stationary
Markov process.
Rather than simulating the paths of states for the whole chain, our proposal
distribution simulates the 퐴∗푡 , 퐿푡, 푌
0
푡 , 푌푡 and 퐴푡 separately. Also, we do not simulate
the whole path altogether, but rather we update the path piece by piece, i.e., for one
subject, we update (퐴∗푖 , 푌
0
푖 , 푍푖+ 1
푛
, ⋅ ⋅ ⋅ , 푍푖+푛−1
푛
) once at a time, with the sequence of
푖 = 0, 1, 2, ⋅ ⋅ ⋅ , 퐾 − 1, and then update (퐴∗퐾 , 푌 0퐾).
Speciﬁcally, for any 푖 = 0, 1, 2, ⋅ ⋅ ⋅ , 퐾−1, we simulate the missing data as follows:
∙ If 퐴푖 = 1, simulate 퐴∗푖 = 2 + 퐵푒푟푛표푢푙푙푖(0.5); if 퐴푖 = 0, simulate 퐴∗푖 =
퐵푒푟푛표푢푙푙푖(0.5). Let 푞1 = 0.5.
∙ If 푌푖 = 0, simulate 푌 0푖 = 0, and let 푞2 = 1; if 푌푖 = 1, simulate 푌 0푖 =
퐵푒푟푛표푢푙푙푖(0.5). Let 푞2 = 0.5.
∙ To simulate the path for 퐿, we consider 푥푗 = 퐿푖+ 푗
푛
−퐿푖+ 푗−1
푛
, i.e., {푥푗}푛푗=1 is the
ﬁrst order diﬀerence of {퐿푖+ 푗
푛
}푛푗=0. Each 푥푗 must be +1, 0 or −1, 퐿푖 +
∑푚
푗=1 푥푗
must be either 1 or 0, and
∑푛
푗=1 푥푗 = 퐿푖+1−퐿푖. We would like to simulate the
푥푗’s satisfying these constraints with certain control over the number of non-
zeros in them (or equivalently, the number of jumps in 퐿), as we are expecting
the number of jumps to be small for our particular problem.
If 퐿푖 = 퐿푖+1, the number of jumps for the 퐿 process must be 0, 2, 4, ⋅ ⋅ ⋅ , 2× [푛2 ].
Deﬁne 푞∗퐿(푥) to be a probability distribution on 0, 2, 4, ⋅ ⋅ ⋅ , 2× [푛2 ], where [푥]
is the largest integer smaller than 푥. Simulate 푀 from 푞∗퐿. Randomly pick 푀
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positions from 푛 positions. Those 푀 positions will be the non-zero 푥푗’s. With
푀 and those 푀 positions, a 푥 sequence and the 퐿 sequence are determined.
We denote the proposal probability by
푞3 = 푞
∗
퐿(푀)
1⎛⎜⎜⎝푛
푀
⎞⎟⎟⎠
.
If 퐿푖 ∕= 퐿푖+1, the number of jumps for the 퐿 process must be 1, 3, 5, ⋅ ⋅ ⋅ ,
2× [푛
2
]− 1. A similar procedure can be adopted.
∙ Simulating 푌 0푡 uses exactly the same procedure as for simulating 퐿푡. Let 푞4 be
the probability from the proposal distribution.
∙ To simulate the path for 퐴∗, let 푥푗 = 퐴∗푖+ 푗
푛
− 퐴∗
푖+ 푗−1
푛
. Each 푥푗 must be +1, 0
or −1 (퐴∗ are only allowed to switch to adjacent levels), 퐴∗푖 +
∑푚
푗=1 푥푗 must
be between 0 and 3 inclusively, and
∑푛
푗=1 푥푗 = 퐴
∗
푖+1 − 퐴∗푖 . We ﬁrst simulate
the number of switches in the 퐴∗ process. If ∣퐴∗푖 − 퐴∗푖+1∣ = 푘, the number of
non-zeros in 푥푗 must be one of (푘, 푘 + 2, ..., 2 × [푛−푘2 ] + 푘). Deﬁne 푞∗퐴 to be
a probability distribution on them. We simulate 푀 from 푞∗퐴, and randomly
sample 푀 positions from 푛 for the non-zero 푥푗’s. However, since 퐴
∗ is not
binary, there could be many paths that has 푀 jumps and jump at the sampled
positions. We randomly sample one from the qualiﬁed paths. We denote the
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number of qualiﬁed paths by 푛푞, and let
푞5 = 푞
∗
퐴(푀)
1⎛⎜⎜⎝푛
푀
⎞⎟⎟⎠
1
푛푞
.
Conditional on 푀 and the 푀 positions, randomly sampling one path from
all qualiﬁed paths is not so straightforward. We describe our solution to this
problem Section 5.7.
∙ The simulation of 푌 follows the causal model (3.2.1). Let
푞6 =
푛−1∏
푗=1
푝푦(푌푖+ 푗
푛
;푌 0
푖+ 푗
푛
, 퐴∗
푖+ 푗
푛
).
∙ The simulation of 퐴 is deterministic: 퐴푖+ 푗
푛
= 퐼퐴∗
푖+
푗
푛
>푐. Let 푞7 = 1.
Let 푞푛푒푤 =
∏7
푗=1 푞푗. We have simulated a set of 푈푖 = (퐴
∗
푖 , 푌
0
푖 , 푍푖+ 1
푛
, ⋅ ⋅ ⋅ , 푍푖+푛−1
푛
)
from our proposal distribution and calculated the proposal probability as 푞푛푒푤. With
the proposal distribution, it is also easy to calculate the probability of the old paths
under the proposal distribution. We denote it as 푞표푙푑.
We then calculate, for 푖 > 0,
푟2,푖 = min(1,
푃 (퐴푖, 푌푖, 푈
푛푒푤
푖 , 푍푖+1∣Θ, 푍푖− 1
푛
)푞표푙푑
푃 (퐴푖, 푌푖, 푈 표푙푑푖 , 푍푖+1∣Θ, 푍푖− 1
푛
)푞푛푒푤
)
for 푖 = 0
푟2,푖 = min(1,
푃 (푌 00,푛푒푤, 퐴
∗
0,푛푒푤∣퐴0, 퐿0, 푌0)푃 (푈푛푒푤푖 , 푍푖+1∣Θ, 푍푖,푛푒푤)푞표푙푑
푃 (푌 00,표푙푑, 퐴
∗
0,표푙푑∣퐴0, 퐿0, 푌0)푃 (푈 표푙푑푖 , 푍푖+1∣Θ, 푍푖,표푙푑)푞푛푒푤
)
and keep 푈푛푒푤푖 with probability 푟2,푖.
To update (퐴∗퐾 , 푌
0
퐾), we simulate them as follows,
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∙ If 퐴퐾 = 1, simulate 퐴∗퐾 = 2 + 퐵푒푟푛표푢푙푙푖(0.5); if 퐴퐾 = 0, simulate 퐴∗퐾 =
퐵푒푟푛표푢푙푙푖(0.5). Let 푞1 = 0.5.
∙ If 푌퐾 = 0, simulate 푌 0퐾 = 0, and let 푞2 = 1; if 푌퐾 = 1, simulate 푌 0퐾 =
퐵푒푟푛표푢푙푙푖(0.5). Let 푞2 = 0.5.
푞푛푒푤 = 푞1푞2, and 푞표푙푑 is calculated accordingly. Deﬁne
푟2,퐾 = min(1,
푃 (푍퐾,푛푒푤∣푍퐾− 1
푛
,Θ)푞표푙푑
푃 (푍퐾,표푙푑∣푍퐾− 1
푛
,Θ)푞푛푒푤
)
we keep (퐴∗퐾,푛푒푤, 푌
0
퐾,푛푒푤) with probability 푟2,퐾 .
In this proposal distribution, we separate the simulation of the number of jumps
and the positions of the jumps, which gives us a better control over the proposal
distribution. We can incorporate our intuition of how frequent of the process jumps
into the proposal distribution and eﬃciently walk through the space of all possible
푈 . There are also shortcomings of this approach. As each component is simulated
separately, it is possible that several components jump together, which is a rare event
in the original model and makes our algorithm less eﬃcient. For the particular study
in this chapter, our proposal distribution seems to be working ﬁne.
As a summary, our full MCMC algorithm with data augmentation is in Figure 3.3.
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Figure 3.3: Full MCMC Algorithm with Data Augmentation
1. Initialize Θ and 푈 .
2. Given 푈 and Θ표푙푑, we simulate Θ푛푒푤 from a proposal distribution 푞(Θ∣Θ표푙푑),
and calculate
푟1 = 푚푖푛(1,
푃 (Θ푛푒푤∣푈,푂)푞(Θ표푙푑∣Θ푛푒푤)
푃 (Θ표푙푑∣푈,푂)푞(Θ푛푒푤∣Θ표푙푑) ).
We update Θ by Θ푛푒푤 with probability 푟1, and by Θ표푙푑 with probability 1− 푟1.
3. Given Θ, for every subject, we update 푈 by the algorithm described in Sec-
tion 3.3.3.
4. Repeat 2-3.
3.4 Simulation
In this section, we present one particular parametrization for the 훼, 훽 and 훾 functions.
The same parametrization will be used in our application to the vitamin A deﬁciency
data in the next section. We simulate a similar data set as the vitamin A deﬁciency
data from our Markov model, i.e., by setting the parameter values to be the estimates
from the real data, and the number of subjects to be the number of subjects in the
real data. We then estimate the parameters from the simulated data to see if our
MCMC algorithm can correctly reconstruct the true values.
The models for 훼, 훽 and 훾 are:
훼(퐴∗푡+ℎ;퐴
∗
푡 , 퐿푡, 푌푡, 푎푔푒, 푠푒푥, 푡; 훼˜)
78
= exp(훼˜0 + 훼˜1퐴
∗
푡 + 훼˜2퐿푡 + 훼˜3푌푡 + 훼˜4(푎푔푒) + 훼˜5(푠푒푥) + 훼˜6 cos(푡) + 훼˜7 sin(푡))
/{2[1 + exp(훼˜0 + 훼˜1퐴∗푡 + 훼˜2퐿푡 + 훼˜3푌푡 + 훼˜4(푎푔푒) + 훼˜5(푠푒푥) + 훼˜6 cos(푡)
+ 훼˜7 sin(푡))]}
훽(푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ;푋푡, 푎푔푒, 푠푒푥, 푡; 훽˜)
= exp(훽˜0 + 훽˜1퐴
∗
푡 + 훽˜2퐿푡 + 훽˜3푌푡 + 훽˜4푌
퐴¯∗푡−,0
푡 + 훽˜5(푎푔푒) + 훽˜6(푠푒푥)
+ 훽˜7 cos(푡) + 훽˜8 sin(푡))
/{1 + exp(훽˜0 + 훽˜1퐴∗푡 + 훽˜2퐿푡 + 훽˜3푌푡 + 훽˜4푌 퐴¯
∗
푡−,0
푡 + 훽˜5(푎푔푒) + 훽˜6(푠푒푥)
+ 훽˜7 cos(푡) + 훽˜8 sin(푡))}
훾(퐿푡+ℎ;푋푡, 푎푔푒, 푠푒푥,퐴
∗
푡+ℎ, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ , 푡; 훾˜)
= exp(훾˜0 + 훾˜1퐴
∗
푡 + 훾˜2퐿푡 + 훾˜3푌푡 + 훾˜4푌
퐴¯∗푡−,0
푡 + 훾˜5퐴
∗
푡+ℎ + 훾˜6푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ
+ 훾˜7(푎푔푒) + 훾˜8(푠푒푥) + 훾˜9 cos(푡) + 훾˜10 sin(푡))
/{2[1 + exp(훾˜0 + 훾˜1퐴∗푡 + 훾˜2퐿푡 + 훾˜3푌푡 + 훾˜4푌 퐴¯
∗
푡−,0
푡 + 훾˜5퐴
∗
푡+ℎ + 훾˜6푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ
+ 훾˜7(푎푔푒) + 훾˜8(푠푒푥) + 훾˜9 cos(푡) + 훾˜10 sin(푡))]}
In this formulation, We assume that all of 퐴∗푡 , 푌
0
푡 and 퐿푡 could depend on age,
sex, and seasonal factor cos(푡) and sin(푡). Also note that the values of function 훼 and
훾 are always between 0 and 0.5, and that the value of function 훽 is always between 0
and 1. The general model we proposed in Section 3.2 only requires these functions to
be positive. The validity of the more stringent models here relies on our belief that
vitamin A deﬁciency, counterfactual respiratory infection and stunting switch states
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infrequently. The models also prevents problems in discretization, as it guarantees
that, for example, 1
푛
훼 is always a probability.
Using the set of parameters we estimated from the vitamin A deﬁciency data, we
simulate from the above model for 250 subject from time 1 to time 6, with baseline
covariates and baseline variables generated randomly, and record 퐴푡, 푌푡 and 퐿푡 at the
integer times. We then estimate the model using our MCMC algorithm with a prior
distribution 푁(0, 퐼), i.e., we assume the prior distribution for every parameter is
independent standard normal. We repeat 10 independent simulations, and estimate
parameters by posterior mean from the 10 simulated data sets.
The estimation results from our simulated data sets are reported in Table 3.1. The
second and the third columns of Table 3.1 show the true parameter values and the
mean estimates. While the prior distribution obviously causes bias on some param-
eter estimates, the fourth column shows that most of the biases are non-signiﬁcant.
Considering the fact that we used a proper prior distribution as regularization and
the size of our data set, we believe that our MCMC algorithm is doing a decent job
in estimating the parameters.
3.5 Application
This section reports the result of our vitamin A deﬁciency analysis.
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Table 3.1: Simulation Result for the MCMC Algorithm
Parameter True Value Average Estimates⋄ t-statistic†
훿˜1 -3.3 -3.19 1.25
훿˜2 -2.01 -1.69 2.13
훿˜3 -0.77 -1.03 -1.94
훼˜0 -3.07 -2.18 4.64
∗
훼˜1 2.00 1.59 -3.62
∗
훼˜2 -0.13 -0.02 0.53
훼˜3 0.34 0.12 -1.29
훼˜4 0.05 0.04 -1.71
훼˜5 -1.11 -1.11 -0.04
훼˜6 0.04 0.01 -0.4
훼˜7 -0.35 -0.42 -0.73
훽˜0 -2.54 -2.08 7.11
∗
훽˜1 -0.7 -0.61 1.43
훽˜2 -0.17 -0.19 -0.24
훽˜3 0.91 0.32 -1.49
훽˜4 4.17 3.89 -1.11
훽˜5 -0.04 -0.04 1.24
훽˜6 -0.62 -0.75 -1.21
훽˜7 1.07 0.67 -4.59
∗
훽˜8 0.82 0.53 -4.17
∗
훾˜0 -2.79 -2.62 2.24
훾˜1 -0.32 -0.42 -0.73
훾˜2 2.5 2.27 -1.71
훾˜3 0.09 -0.25 -5.49
∗
훾˜4 -0.02 0.12 1.25
훾˜5 -0.29 -0.18 0.96
훾˜6 0.15 0.02 -1.15
훾˜7 -0.01 -0.01 -1.3
훾˜8 -0.02 -0.22 -1.56
훾˜9 0.18 0.06 -1.27
훾˜10 -0.52 -0.49 0.21
⋄ Average estimates for 10 simulations.
† Average bias / SD of the 10 estimated biases ×√10, compared with 푡0.975,9 = 2.26.
∗ denotes signiﬁcance at 5% level.
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3.5.1 Estimation Result
We estimate the model described in Section 3.2 and Section 3.4, using the real vita-
min A deﬁciency data. The independent standard normal distribution is also used
as the prior distribution for parameters. Note that the original data may have miss-
ing visits for particular subjects. We assume that the missing visits are missing at
random, i.e., for any subject, which visits are missing is independent of all the co-
variates, treatment, potential outcomes and outcomes. With such an assumption,
the application of our model and estimation algorithm is straightforward, as missing
visits simply means that the observational times are at a coarser time grid.
We have run multiple MCMC paths up to two million steps for each path, and
calculated the Gelman-Rubin statistics for each parameter as a criteria for judging
convergence. The Gelman-Rubin statistics for all parameters are smaller than 1.04.
The estimates are in Table 3.2.
In Table 3.2, the ﬁrst panel are estimates for the 훿˜’s, which are the logit of the 훿’s.
Recalling equation (3.2.1), the 훿’s represent the eﬀect of current vitamin A deﬁciency
on current respiratory infection status. Our estimates show that for 푌 0푡 = 0, if 퐴
∗
푡 = 1,
i.e., the subject is suﬀering from mild vitamin A deﬁciency, the probability of 푌푡 = 1,
i.e., the subject suﬀers from respiratory infection, is exp(−3.28)
1+exp(−3.28) = 3.6%. If 퐴
∗
푡 = 2,
the probability of 푌푡 = 1 is 11.8%. If 퐴
∗
푡 = 3, the probability of 푌푡 = 1 is 31.6%.
As expected, the higher level of vitamin A deﬁciency is causes higher probability of
respiratory infection. This shows a strong causal eﬀect of vitamin A deﬁciency on
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Table 3.2: Estimation Result from the Vitamin A Deﬁciency Data
Parameter Posterior Mean 95% Credible Set
훿˜1 -3.30 ( -4.27 , -2.57 )
훿˜2 -2.01 ( -3.39 , -1.00 )
훿˜3 -0.77 ( -2.34 , 0.85 )
훼˜0 -3.07 ( -4.10 , -2.16 )
훼˜1 2.00 ( 1.20 , 2.93 )
훼˜2 -0.13 ( -1.42 , 1.45 )
훼˜3 0.34 ( -1.34 , 1.88 )
훼˜4 0.05 ( 0.02 , 0.08 )
훼˜5 -1.11 ( -2.16 , -0.11 )
훼˜6 0.04 ( -0.68 , 0.78 )
훼˜7 -0.35 ( -1.09 , 0.35 )
훽˜0 -2.54 ( -3.23 , -1.90 )
훽˜1 -0.70 ( -1.84 , 0.27 )
훽˜2 -0.17 ( -1.46 , 0.95 )
훽˜3 0.91 ( -0.64 , 2.59 )
훽˜4 4.17 ( 2.53 , 5.64 )
훽˜5 -0.04 ( -0.06 , -0.01 )
훽˜6 -0.62 ( -1.46 , 0.14 )
훽˜7 1.07 ( 0.38 , 1.78 )
훽˜8 0.82 ( 0.19 , 1.55 )
훾˜0 -2.79 ( -3.57 , -2.12 )
훾˜1 -0.32 ( -2.03 , 1.1 )
훾˜2 2.50 ( 1.61 , 3.45 )
훾˜3 0.09 ( -1.39 , 1.47 )
훾˜4 -0.02 ( -1.45 , 1.53 )
훾˜5 -0.29 ( -1.70 , 1.24 )
훾˜6 0.15 ( -1.81 , 1.93 )
훾˜7 -0.01 ( -0.03 , 0.02 )
훾˜8 -0.02 ( -0.88 , 0.77 )
훾˜9 0.18 ( -0.54 , 0.87 )
훾˜10 -0.52 ( -1.26 , 0.18 )
83
the respiratory infection.
We also notice that 훼˜0, 훽˜0 and 훾˜0 are large negative numbers, which means that
all of 퐴∗푡 , 푌
0
푡 and 퐿푡 switch states infrequently. This in turn reassures us for our
particular choice of the 훼, 훽 and 훾 models in Section 3.4.
The credible set of 훼˜1 does not include zero, which indicates that the eﬀect of
current 퐴∗푡 level on the jump probability in the next instant is signiﬁcant. The
positive coeﬃcient shows that subject is less stable in higher vitamin A deﬁciency
levels. 훼˜4 is signiﬁcantly positive and 훼˜5 is signiﬁcantly negative, which shows that
the older and the female children are less stable in the levels of vitamin A deﬁciency.
In the model for counterfactual respiratory infection, a signiﬁcantly positive 훽˜4
shows that respiratory infection usually do not last long. A signiﬁcantly negative 훽˜5
shows that younger children are prone to be on and oﬀ with respiratory infections.
The signiﬁcance of 훽˜7 and 훽˜8 shows that the respiratory infection is highly seasonal.
In the model for stunting, 훾˜2 is signiﬁcantly positive, which indicates that stunting
usually does not last long either.
3.5.2 Simulation Based Causal Interpretation
With the estimated model, we get an estimate of the eﬀect of 퐴∗푡 on 푌푡 from the
훿’s. Moreover, equipped with the full parametric model, we can answer many other
causal questions by simulation.
Example Assume that Ben is 48-month old at time 1. He is not stunting, not
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suﬀering from respiratory infection, but has mild vitamin A deﬁciency (퐴∗ = 1).
What is the probability that Ben will be suﬀering from respiratory infection at time
4, if he starts taking vitamin A supplements and eﬀectively controls his deﬁciency
level at minimum (퐴∗ = 0)? What if he grows naturally without taking any vitamin
A supplements? What if his deﬁciency level is kept constantly at 2?
The answer to the example question can be easily given provided that our model is
true and we have the parameter values. We can use the information in the example as
the initial condition and simulate what would happen at time 4 based on our model.
For this particular example, we can use posterior mean as our parameter value.
The simulation results that answer the example questions are in Table 3.3. The
numbers show that if Ben is able to control his vitamin A deﬁciency at either level
0 or 1, it would beneﬁt him in terms of the probability of suﬀering from respiratory
infection. Note the probabilities of 푌4 = 1 for diﬀerent levels of 퐴
∗ are close to
but diﬀerent from the 훿’s. The numbers in Table 3.3 fully incorporate the dynamic
evolvement of all variables.
The 95% credible set is obtained by simulation with parameters values being
samples from the posterior distribution of the parameters, which are available from
our MCMC algorithm. This takes the uncertainty of estimated parameters into
account.
For a standard causal comparison, the improvement in 푃 (푌4 = 1) for controlling
퐴∗ at 0 over growing naturally is around 4.8%, with a 95% credible set (1.8%, 7.8%).
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Table 3.3: Simulation Based Causal Interpretation for the Example
퐴∗ level 푃 (푌4 = 1) 95% Credible Set
grow naturally 7.0% (4.6%, 10.3%)
0 2.2% (0.9%, 6.3%)
1 5.4% (3.4%, 9.6%)
2 13.2% (3.5%, 23.9%)
3 32.2% (9.9%, 75.5%)
The improvement in 푃 (푌4 = 1) for controlling 퐴
∗ at 1 over growing naturally is
around 1.6%, with a 95% credible set (−0.1%, 4.6%). The credible set is also obtained
by simulations from the posterior distribution of the parameters.
3.5.3 Model Assumptions Revisited
We have made many assumptions in our model and our causal interpretation relies
heavily on the soundness of these assumptions. In this section, we experiment with
a few variations of our model. These results largely conﬁrm that the model we used
in Section 3.2 is a reasonable and consistent description of the data.
Number of Levels for Vitamin A Deﬁciency
We estimated our model by assuming that vitamin A deﬁciency has four levels. The
lower two levels do no exhibit xerophthalmia, while the upper two levels do. It is
natural to ask if such a discretization is suﬃcient or necessary. We could consider
two alternatives of our model:
∙ 2-level 퐴∗ We assume that 퐴∗푡 only has two levels, 0 and 1. 퐴푡 = 1 if 퐴∗푡 = 1,
and 퐴푡 = 0 if 퐴
∗
푡 = 0. Assuming other model speciﬁcations are the same as
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before, we do not have any hidden levels of treatment.
∙ 6-level 퐴∗ We assume that 퐴∗푡 has six levels, 0, 1, 2, 3, 4, and 5. 퐴푡 = 1 if
퐴∗푡 > 2, and 퐴푡 = 0 if 퐴
∗
푡 < 3, and that other model speciﬁcations are the same
as before.
Under the 2-level 퐴∗ model, we assume that if 퐴푡 = 0, 푌푡 is solely decided by 푌 0푡 ,
and that we only need to estimate parameter 훿1 that is associated with 퐴
∗
푡 = 1.
Under the 6-level 퐴∗ model, we need to estimate parameters 훿푗, 푗 = 1, ..., 5, which
are associated with 퐴∗푡 = 1, ..., 5 respectively.
We estimate the both models using our MCMC algorithm and summarize the
estimates for 훿˜’s in Table 3.4. In the table we denote our original model as the 4-level
퐴∗ model. The 95% credible interval for each parameter is below its estimate. From
the estimates in the table, we believe that the 4-level 퐴∗ is a reasonable choice. In
the middle column, 훿˜2 and 훿˜3 are distinct enough from each other, and grouping them
together as in the 2-level 퐴∗ model is over-simpliﬁcation. One evidence is that in the
4-level 퐴∗ model estimates, 훿˜3 does not fall into the CI for 훿˜2. However, using the
6-level 퐴∗ model is un-necessary. For example, in the 6-level 퐴∗ model, 훿˜4 and 훿˜5 are
very close to each other, and their CI’s cover each other; 훿˜2 and 훿˜3 are also so close
to each that their CI’s cover each other. This shows that the 4-level 퐴∗ model has
captured more structures than the 2-level 퐴∗ model and that the 6-level 퐴∗ model is
not capturing more structures.
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Table 3.4: Estimates of 훿˜ from Diﬀerent Models
2-level 퐴∗ 4-level 퐴∗ 6-level 퐴∗
훿˜1 -3.30 훿˜1 -3.39
( -4.27 , -2.57 ) ( -4.29 , -2.59 )
훿˜2 -2.87
( -3.81 , -2.11 )
훿˜1 -2.08 훿˜2 -2.01 훿˜3 -1.79
( -3.27 , -1.12 ) ( -3.39 , -1.00 ) ( -2.98 , -0.83 )
훿˜3 -0.77 훿˜4 -0.88
( -2.34 , 0.85 ) ( -2.86 , 0.99 )
훿˜5 -0.35
( -2.15 , 1.58 )
The same phenomenon can be observed in terms of estimated causal eﬀect. It is
diﬃcult to directly compare the diﬀerence in counterfactual outcomes under diﬀerent
models, as the treatment levels mean diﬀerent things in these models. We consider
the following causal comparison as a fair comparison:
Example Consider all the boys who are 48-month old at time 1, not stunting, not
suﬀering from respiratory infection, but has symptoms of xerophthalmia (퐴1 = 1).
We randomly pick any one of them and randomly pick an 퐴∗ level that corresponds to
퐴 = 0, and treat him with vitamin A supplement such that his vitamin A deﬁciency
level is kept at that 퐴∗ level. At time 4, what is the expected diﬀerence between
the probability of getting respiratory infection if the child grows naturally and the
probability of getting respiratory infection if the child’s vitamin A deﬁciency is kept
at the randomly picked 퐴∗ level?
Note that the expectation is taken over the population of all such boys and the 퐴∗
levels that corresponds to 퐴 = 0. We recall that in Section 3.2.2, we have assumed
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Table 3.5: Estimates of the Average Causal Diﬀerence for Diﬀerent Models
2-level 퐴∗ 4-level 퐴∗ 6-level 퐴∗
Causal Diﬀerence 3.2% 12.9% 20.4%
CI (1.0%, 9.5%) (4.6%, 24.8%) (10.4%, 38.8%)
that the initial distribution of 퐴∗ given 퐴 is uniform over the corresponding levels.
The expected causal eﬀect is the simple average of causal diﬀerence for all possible
combinations of 퐴∗ levels corresponding to 퐴 = 1 and 퐴∗ levels corresponding to
퐴 = 0.
We summarize our simulation-based estimate of the average causal diﬀerence in
Table 3.5. The estimated causal diﬀerences for the 4-level 퐴∗ model and the 6-level
퐴∗ model are close to each other, as their credible intervals cover each other. The
estimated causal diﬀerence for the 2-level 퐴∗ model is signiﬁcantly diﬀerent from the
other two estimates. As a result, we believe that discretizing vitamin A deﬁciency
into four levels in our analysis is appropriate.
Continuous Time Ignorability
We assumed continuous time ignorability in our model (see Remark 3.2.1). With
a fully parametric model, we do not need the assumption for identiﬁcation. For
example, we can assume that the 훼 and 훽 functions as the follows:
훼(퐴∗푡+ℎ;퐴
∗
푡 , 퐿푡, 푌푡, 푌
0
푡 , 푎푔푒, 푠푒푥, 푡; 훼˜)
= exp(훼˜0 + 훼˜1퐴
∗
푡 + 훼˜2퐿푡 + 훼˜3푌푡 + 훼˜4(푎푔푒) + 훼˜5(푠푒푥) + 훼˜6 cos(푡)
+ 훼˜7 sin(푡) + 훼˜8푌
0
푡 )
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/{2[1 + exp(훼˜0 + 훼˜1퐴∗푡 + 훼˜2퐿푡 + 훼˜3푌푡 + 훼˜4(푎푔푒) + 훼˜5(푠푒푥) + 훼˜6 cos(푡)
+ 훼˜7 sin(푡) + 훼˜8푌
0
푡 )]}
훽(푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ;퐴
∗
푡+ℎ, 푋푡, 푎푔푒, 푠푒푥, 푡; 훽˜)
= exp(훽˜0 + 훽˜1퐴
∗
푡 + 훽˜2퐿푡 + 훽˜3푌푡 + 훽˜4푌
퐴¯∗푡−,0
푡 + 훽˜5(푎푔푒) + 훽˜6(푠푒푥)
+ 훽˜7 cos(푡) + 훽˜8 sin(푡) + 훽˜9퐴
∗
푡+ℎ)
/{1 + exp(훽˜0 + 훽˜1퐴∗푡 + 훽˜2퐿푡 + 훽˜3푌푡 + 훽˜4푌 퐴¯
∗
푡−,0
푡 + 훽˜5(푎푔푒) + 훽˜6(푠푒푥)
+ 훽˜7 cos(푡) + 훽˜8 sin(푡) + 훽˜9퐴
∗
푡+ℎ)}
By allowing 훼 depending on 푌 0푡 and 훽 depending on 퐴
∗
푡+ℎ, we are no longer assuming
the continuous time ignorability assumption (see Remark 3.2.1).
With this model, we summarize our estimates in Table 3.6. For comparison,
we include the estimates from the original model. The results show that the new
parameters 훼˜8 and 훽˜9 are not signiﬁcant at all. The new estimates of other parameters
are close to the original estimates. This indicates that continuous time ignorability
might be a reasonable assumption.
Functional Form of 푄
With the similar idea, diﬀerent functional forms of 푄 can be experimented to see
if we have missed out any relationship in our estimated model. For example, one
concern is that our models for 훼 and 훽 should contain interaction terms. One might
expect that if the child is having respiratory infection, the inﬂuence of vitamin A
90
Table 3.6: Estimation Result from the Vitamin A Deﬁciency Data without Contin-
uous Time Ignorability
Parameter Original Estimate New Posterior Mean 95% Credible Set
훿˜1 -3.30 -3.27 ( -4.06 , -2.58 )
훿˜2 -2.01 -1.85 ( -3.11 , -0.85 )
훿˜3 -0.77 -0.87 ( -2.85 , 0.86 )
훼˜0 -3.07 -3.02 ( -4.02 , -1.93 )
훼˜1 2.00 1.95 ( 1.11 , 2.85 )
훼˜2 -0.13 -0.20 ( -1.52 , 1.29 )
훼˜3 0.34 0.49 ( -1.01 , 1.98 )
훼˜4 0.05 0.05 ( 0.02 , 0.08 )
훼˜5 -1.11 -1.15 ( -2.20 , -0.18 )
훼˜6 0.04 0.05 ( -0.65 , 0.79 )
훼˜7 -0.35 -0.35 ( -1.03 , 0.32 )
훼˜8 0.04 ( -2.1 , 1.74 )
훽˜0 -2.54 -2.59 ( -3.35 , -1.93 )
훽˜1 -0.70 -0.3 ( -1.88 , 1.18 )
훽˜2 -0.17 -0.06 ( -1.33 , 1.24 )
훽˜3 0.91 2.59 ( 1.25 , 4.00 )
훽˜4 4.17 3.19 ( 1.81 , 4.63 )
훽˜5 -0.04 -0.04 ( -0.07 , -0.02 )
훽˜6 -0.62 -0.65 ( -1.63 , 0.23 )
훽˜7 1.07 1.18 ( 0.50 , 1.96 )
훽˜8 0.82 0.93 ( 0.18 , 1.69 )
훽˜9 -0.86 ( -2.26 , 0.66 )
훾˜0 -2.79 -2.79 ( -3.53 , -2.07 )
훾˜1 -0.32 -0.21 ( -1.64 , 1.24 )
훾˜2 2.50 2.51 ( 1.67 , 3.45 )
훾˜3 0.09 -0.04 ( -1.6 , 1.57 )
훾˜4 -0.02 0.13 ( -1.41 , 1.72 )
훾˜5 -0.29 -0.37 ( -1.85 , 0.97 )
훾˜6 0.15 0.02 ( -1.54 , 1.78 )
훾˜7 -0.01 -0.01 ( -0.03 , 0.01 )
훾˜8 -0.02 -0.01 ( -0.83 , 0.81 )
훾˜9 0.18 0.18 ( -0.51 , 0.85 )
훾˜10 -0.52 -0.53 ( -1.19 , 0.1 )
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deﬁciency on the child’s transition probability may be diﬀerent from that if the child
is not having respiratory infection. To see if this is the case, we parametrize 훼 and
훽 as
훼(퐴∗푡+ℎ;퐴
∗
푡 , 퐿푡, 푌푡, 푌
0
푡 , 푎푔푒, 푠푒푥, 푡; 훼˜)
= exp(훼˜0 + 훼˜1퐴
∗
푡 + 훼˜2퐿푡 + 훼˜3푌푡 + 훼˜4(푎푔푒) + 훼˜5(푠푒푥) + 훼˜6 cos(푡)
+ 훼˜7 sin(푡) + 훼˜8퐴
∗
푡푌푡)
/{2[1 + exp(훼˜0 + 훼˜1퐴∗푡 + 훼˜2퐿푡 + 훼˜3푌푡 + 훼˜4(푎푔푒) + 훼˜5(푠푒푥) + 훼˜6 cos(푡)
+ 훼˜7 sin(푡) + 훼˜8퐴
∗
푡푌푡)]}
훽(푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ;퐴
∗
푡+ℎ, 푋푡, 푎푔푒, 푠푒푥, 푡; 훽˜)
= exp(훽˜0 + 훽˜1퐴
∗
푡 + 훽˜2퐿푡 + 훽˜3푌푡 + 훽˜4푌
퐴¯∗푡−,0
푡 + 훽˜5(푎푔푒) + 훽˜6(푠푒푥)
+ 훽˜7 cos(푡) + 훽˜8 sin(푡) + 훽˜9퐴
∗
푡푌푡)
/{1 + exp(훽˜0 + 훽˜1퐴∗푡 + 훽˜2퐿푡 + 훽˜3푌푡 + 훽˜4푌 퐴¯
∗
푡−,0
푡 + 훽˜5(푎푔푒) + 훽˜6(푠푒푥)
+ 훽˜7 cos(푡) + 훽˜8 sin(푡) + 훽˜9퐴
∗
푡푌푡)}
The estimating results from this model is in Table 3.7. The results suggest that
the interaction term, 퐴∗푡푌푡, is not signiﬁcant in either the 훼 model or the 훽 model.
Estimates of other parameters are close to the original estimates. We do not ﬁnd
signiﬁcant evidence against our original plain vanilla model.
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Table 3.7: Estimation Result from the Vitamin A Deﬁciency Data with a Diﬀerent
푄
Parameter Original Estimate New Posterior Mean 95% Credible Set
훿˜1 -3.30 -3.39 ( -4.33 , -2.66 )
훿˜2 -2.01 -1.73 ( -2.72 , -0.86 )
훿˜3 -0.77 -1.04 ( -3.06 , 0.70 )
훼˜0 -3.07 -2.97 ( -4.09 , -1.94 )
훼˜1 2.00 1.78 ( 0.93 , 2.66 )
훼˜2 -0.13 -0.27 ( -1.59 , 1.29 )
훼˜3 0.34 0.14 ( -1.33 , 1.6 )
훼˜4 0.05 0.05 ( 0.02 , 0.08 )
훼˜5 -1.11 -1.01 ( -2.01 , 0.01 )
훼˜6 0.04 0.03 ( -0.69 , 0.72 )
훼˜7 -0.35 -0.40 ( -1.11 , 0.29 )
훼˜8 0.89 ( -0.31 , 2.29 )
훽˜0 -2.54 -2.56 ( -3.37 , -1.85 )
훽˜1 -0.70 -1.16 ( -2.38 , -0.05 )
훽˜2 -0.17 -0.18 ( -1.67 , 1.14 )
훽˜3 0.91 2.49 ( 1.05 , 3.86 )
훽˜4 4.17 3.05 ( 1.62 , 4.42 )
훽˜5 -0.04 -0.04 ( -0.07 , -0.02 )
훽˜6 -0.62 -0.70 ( -1.63 , 0.21 )
훽˜7 1.07 1.26 ( 0.59 , 1.99 )
훽˜8 0.82 0.90 ( 0.21 , 1.66 )
훽˜9 0.69 ( -0.49 , 1.97 )
훾˜0 -2.79 -2.86 ( -3.67 , -2.18 )
훾˜1 -0.32 -0.20 ( -2.02 , 1.32 )
훾˜2 2.50 2.50 ( 1.64 , 3.39 )
훾˜3 0.09 -0.08 ( -1.49 , 1.31 )
훾˜4 -0.02 0.24 ( -1.33 , 1.90 )
훾˜5 -0.29 -0.26 ( -1.89 , 1.37 )
훾˜6 0.15 0.08 ( -1.56 , 1.70 )
훾˜7 -0.01 -0.01 ( -0.03 , 0.02 )
훾˜8 -0.02 -0.02 ( -0.81 , 0.80 )
훾˜9 0.18 0.17 ( -0.49 , 0.89 )
훾˜10 -0.52 -0.54 ( -1.17 , 0.13 )
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3.6 Conclusion
In this chapter, we have considered a data set where it is reasonable to assume that
the treatment process, covariates, counterfactual outcome and the outcome follow
a continuous time process. However, only a coarsened indicator of the treatment
level, the covariates and the outcome are observed and they are only observed at the
discrete observational time points. We are facing problems with
1) Unmeasured confounders caused by the missing data in between two consecu-
tive observational time points, and
2) Measurement error in treatment levels, as the amount of treatment is not di-
rectly observable and the treatment levels in between two observational time
points are not observable.
In Chapter 2, we have shown that 1) would cause problems in standard longitudinal
estimations that are based on ignorability assumption in the observational data. Even
if the continuous time ignorability holds, the observational time ignorability may not
hold. 2) usually causes a even more severe problem in standard semi-parametric
methods, as one does not even know exactly how much treatment the subject has
received.
With both 1) and 2) in our data set, it requires more modeling assumption than
standard causal methods. We have chosen to fully model the process by a continu-
ous time non-stationary Markov process and assume that the data are discrete time
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observations of the process. We have also designed a MCMC algorithm with data
augmentation to estimate the parameters by constructing a reasonable proposal dis-
tribution for the augmented data. The Markov model and the MCMC algorithm
work well for our vitamin A deﬁciency data, as we have shown that in Section 3.4
the MCMC algorithm does produce estimates that are close to the true values and
that in Section 3.5 our estimates make sense in the context of vitamin A deﬁciency
and respiratory infection.
In the vitamin A deﬁciency study, we ﬁnd that the levels of vitamin A deﬁciency
has a strong causal eﬀect on the respiratory infection, as is evidenced by the values of
훿1, 훿2 and 훿3. By simulation, we are also able to estimate the causal eﬀect for certain
treatment regime through time. For example, we can estimate the diﬀerence in the
probabilities of having respiratory disease between keeping vitamin A deﬁciency at
the lowest level and keeping vitamin A deﬁciency at the highest level. The luxury
comes with the cost of more extensive modeling assumptions.
This chapter serves as an example for causal inference in longitudinal data with a
full model, when standard semi-parametric methods are not applicable. In particu-
lar, we have dealt with binary outcomes, binary covariates (it could be generalized to
discrete covariates), discrete treatment levels and that the treatment does not aﬀect
the outcome in a cumulative way. Many other examples have yet to be worked out,
e.g., examples with continuous covariates, examples with continuous outcomes, etc..
When working on a full causal model, domain knowledge, e.g., the biological relation-
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ships among diﬀerent variables, plays the most important role. Still, some modeling
considerations and computational techniques in this chapter could be borrowed and
generalized to other real world problems.
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Chapter 4
Controlling-the-future Revisited: the Optimal
Estimating Equation
The relaxed sequential randomization assumption (2.4.1) and the controlling-the-
future estimating equation (2.4.3) are powerful generalization of the standard g-
estimation. As we have shown in Chapter 2, they are especially useful in correcting
the bias caused by the unmeasured confounders in our setting of inferring causal
eﬀect from discretely observed continuous time processes. In this chapter, we re-
visit the controlling-the-future method from a theoretical point of view. We would
develop a semi-parametric theory that is parallel to the standard g-estimation, in-
cluding the derivation of the eﬃcient score function and the locally eﬃcient doubly
robust estimator. This chapter justiﬁes that the estimating equation (2.4.3) we used
in Chapter 2 would produce
√
푛 consistent and asymptotically normal and regular
estimators.
The organization of this chapter is as follows: in Section 4.1, we consider a single
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period model with relaxed ignorability assumption and derive its nuisance tangent
space and the eﬃcient score; Section 4.2 proposes a useful estimator that is motivated
by the eﬃcient score function and proves that the estimator is locally eﬃcient and
doubly robust; in Section 4.3, we consider two special cases of the general theory;
Section 4.4 extends the model to multi-period case; Section 4.5 concludes the chapter.
4.1 A Single Period Semi-parametric Model Under Relaxed
Ignorability Assumption
4.1.1 The Single Period Model
We consider a one-period deterministic model, with two outcomes 푌1 and 푌2. Let
(푌 01 , 푌
0
2 ) denote the potential outcomes if the subject does not receive any treatment,
and (푌1, 푌2) denote the observed outcome. Let 퐴 be the treatment assignment and
푋 be the collection of pre-treatment covariates.
We assume that ℎ1 and ℎ2 are the blip-down functions, such that 푌
0
1 = ℎ1 (푌1, 퐴,
푋; Ψ0), and that 푌
0
2 = ℎ2(푌2, 푌1, 퐴,푋; Ψ0). Here ℎ1 and ℎ2 are parametrized by Ψ.
When Ψ takes its true value Ψ0, the functions correctly blip 푌1 and 푌2 down to 푌
0
1 and
푌 02 respectively. We denote 푌
0
1 (Ψ) = ℎ1(푌1, 퐴,푋; Ψ) and 푌
0
2 (Ψ) = ℎ2(푌2, 푌1, 퐴,푋; Ψ)
as functions of Ψ. In what follows, we use lower case to denote the realization of
these random variables.
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We assume the following version of ignorability
푌 02 ∐ 퐴∣푋, 푌 01 (4.1.1)
With this model, the likelihood function of the observed variables for one subject
can be written as
푓푌1,푌2,퐴,푋(푦1, 푦2, 푎, 푥) =
∂ℎ1
∂푦1
∂ℎ2
∂푦2
푓푌 01 ,푌 02 ,퐴,푋(푦
0
1, 푦
0
2, 푎, 푥) (4.1.2)
=
∂ℎ1
∂푦1
∂ℎ2
∂푦2
푓푋,푌 01 (푥, 푦
0
1(Ψ0); 휂10)
× 푓푌 02 ∣푋,푌 01 (푦02(Ψ0)∣푥, 푦01(Ψ0); 휂20)푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0); 휂30)
Here, the parameters of our model are Ψ, 휂1, 휂2, 휂3. Their true values are Ψ0, 휂10,
휂20, and 휂30. The parameter of interest is Ψ. We assume that Ψ is a 푞 dimensional
vector. 휂1, 휂2, 휂3 are nuisance parameters, possibly inﬁnite dimensional. (4.1.2) here
describes the semi-parametric model under the sole condition that (4.1.1) is true.
4.1.2 Characterization of the Nuisance Tangent Space
Consider any parametric submodel:
푓푌1,푌2,퐴,푋(푦1, 푦2, 푎, 푥; Ψ, 훾1, 훾2, 훾3)
=
∂ℎ1
∂푦1
∂ℎ2
∂푦2
푓푋,푌 01 (푥, 푦
0
1(Ψ); 훾1)
× 푓푌 02 ∣푋,푌 01 (푦02(Ψ)∣푥, 푦01(Ψ); 훾2)푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ); 훾3)
where 훾1, 훾2, 훾3 are of dimension 푛1, 푛2 and 푛3 respectively.
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The nuisance score of this parametric submodel is
푆훾0 = {푆푇훾10 , 푆푇훾20 , 푆푇훾30}푇
where
푆훾10 =
∂ log 푓푋,푌 01 (푥, 푦
0
1(Ψ0); 훾10)
∂훾1
,
푆훾20 =
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0); 훾20)
∂훾2
,
and
푆훾30 =
∂ log 푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0); 훾30)
∂훾3
.
Deﬁne the following sub-spaces:
Λ훾0 = {퐵푞×(푛1+푛2+푛3)푆훾0}
Λ훾10 = {퐵푞×푛1푆훾10}
Λ훾20 = {퐵푞×푛2푆훾20}
Λ훾30 = {퐵푞×푛3푆훾30}
It is easy to see that Λ훾0 = Λ훾10 ⊕ Λ훾20 ⊕ Λ훾30 . We deﬁne Λ,Λ1,Λ2,Λ3 to be the
mean-square closure of all Λ훾0 ,Λ훾10 ,Λ훾20 ,Λ훾30 , respectively. It can also be shown that
Λ = Λ1 ⊕ Λ2 ⊕ Λ3 (see the argument on page 77 of Tsiatis (2006)). Here Λ is the
nuisance tangent space.
Λ1, Λ2 and Λ3 can be characterized as follows:
Lemma 4.1.1.
Λ1 = {푎1(푋, 푌 01 (Ψ0)) : 퐸[푎1(푋, 푌 01 (Ψ0))] = 01×푞}
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Λ2 = {푎2(푌 01 (Ψ0), 푌 02 (Ψ), 푋) : 퐸[푎2(푌 01 (Ψ0), 푌 02 (Ψ0), 푋)∣푋, 푌 01 (Ψ0)] = 01×푞}
Λ3 = {푎3(퐴,푋, 푌 01 (Ψ0)) : 퐸[푎3(퐴,푋, 푌 01 (Ψ0))∣푋, 푌 01 (Ψ0)] = 01×푞}
where 푎1, 푎2, 푎3 all have ﬁnite variance.
The proof of this lemma is routine and is omitted. See Tsiatis (2006).
We also notice that Λ1, Λ2 and Λ3 are orthogonal to each other, which can be
proved as follows.
∙ For Λ1 ∐ Λ2, pick any 푎1 ∈ Λ1 and 푎2 ∈ Λ2.
퐸[푎1푎
푇
2 ] = 퐸[푎1퐸[푎
푇
2 ∣푋, 푌 01 (Ψ0)]] = 0
∙ For Λ1 ∐ Λ3, pick any 푎1 ∈ Λ1 and 푎3 ∈ Λ3.
퐸[푎1푎
푇
3 ] = 퐸[푎1퐸[푎
푇
3 ∣푋, 푌 01 (Ψ0)]] = 0
∙ For Λ2 ∐ Λ3, pick any 푎2 ∈ Λ2 and 푎3 ∈ Λ3.
퐸[푎2푎
푇
3 ] = 퐸[푎2퐸[푎
푇
3 ∣푌 01 (Ψ0), 푌 02 (Ψ0), 푋]] = 퐸[푎2퐸[푎푇3 ∣푌 01 (Ψ0), 푋]] = 0
The second equality is because of the ignorability assumption.
4.1.3 The Space that is Orthogonal to the Nuisance Tangent Space
The Hilbert space ℋ = Λ ⊕ Λ⊥. Consider any function 푔(퐴,푋, 푌 01 , 푌 02 ) ∈ ℋ. Its
projection on to Λ is
∏
(푔∣Λ) =
∏
(푔∣Λ1) +
∏
(푔∣Λ2) +
∏
(푔∣Λ3)
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We then show the following facts.
Lemma 4.1.2.
∏
(푔∣Λ1) = 퐸[푔∣푋, 푌 01 (Ψ0)]∏
(푔∣Λ2) = 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]− 퐸[푔∣푋, 푌 01 (Ψ0)]∏
(푔∣Λ3) = 퐸[푔∣퐴,푋, 푌 01 (Ψ0)]− 퐸[푔∣푋, 푌 01 (Ψ0)]
Proof. For
∏
(푔∣Λ1) = 퐸[푔∣푋, 푌 01 (Ψ0)], we can show that for any 푎1 ∈ Λ1
퐸[{푔 − 퐸[푔∣푋, 푌 01 (Ψ0)]}푎푇1 ]
=퐸{퐸[(푔 − 퐸[푔∣푋, 푌 01 (Ψ0)])푎푇1 ∣푋, 푌 01 (Ψ0)]}
=퐸{퐸[(푔 − 퐸[푔∣푋, 푌 01 (Ψ0)])∣푋, 푌 01 (Ψ0)]푎푇1 }
=0
For
∏
(푔∣Λ2) = 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] − 퐸[푔∣푋, 푌 01 (Ψ0)], we can show that for
any 푎2 ∈ Λ2,
퐸[{푔 − 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)]}푎푇2 ]
=퐸{퐸[(푔 − 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)])푎푇2 ∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]}
=퐸{푎2(퐸[(푔 − 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)])∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)])푇}
=퐸{푎2(퐸[푔∣푋, 푌 01 (Ψ0)])푇}
=0
The last equality is because Λ1 and Λ2 are orthogonal to each other and 퐸[푔∣ 푋,
푌 01 (Ψ0)] ∈ Λ1.
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For
∏
(푔∣Λ3) = 퐸[푔∣퐴,푋, 푌 01 (Ψ0)]− 퐸[푔∣푋, 푌 01 (Ψ0)], given any 푎3 ∈ Λ3,
퐸[{푔 − 퐸[푔∣퐴,푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)]}푎푇3 ]
=퐸{퐸[{푔 − 퐸[푔∣퐴,푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)]}푎푇3 ∣퐴,푋, 푌 01 (Ψ0)]}
=퐸{푎3(퐸[{푔 − 퐸[푔∣퐴,푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)]}∣퐴,푋, 푌 01 (Ψ0)])푇}
=퐸{푎3(퐸[푔∣푋, 푌 01 (Ψ0)])푇}
=0
The last equality is because Λ1 and Λ3 are orthogonal to each other.
Therefore,
∏
(푔∣Λ) = 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푔∣퐴,푋, 푌 01 (Ψ0)]− 퐸[푔∣푋, 푌 01 (Ψ0)],
and
∏
(푔∣Λ⊥) = 푔 − 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]− 퐸[푔∣퐴,푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)].
It can be concluded that
Λ⊥ = {푔 − 퐸[푔∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]− 퐸[푔∣퐴,푋, 푌 01 (Ψ0)] + 퐸[푔∣푋, 푌 01 (Ψ0)], 푔 ∈ ℋ}.
(4.1.3)
4.1.4 The Eﬃcient Score
Consider the score function of our interest
푆Ψ0 =
∂ log(푓푌1,푌2,퐴,푋)
∂Ψ
(4.1.4)
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=
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log ∂ℎ2(Ψ0)
∂푦2
∂Ψ
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂Ψ
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂Ψ
+
∂ log 푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0))
∂Ψ
.
Note that 푆Ψ0 is a 푞 dimensional vector.
The eﬃcient score is then
푆푒푓푓 = 푆Ψ0 − 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푆Ψ0 ∣푋, 푌 01 (Ψ0)]− 퐸[푆Ψ0∣퐴,푋, 푌 01 (Ψ0)].
We do a few more steps of calculation to see what the eﬃcient score looks like.
First, re-write 푆Ψ0 as
푆Ψ0 =
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log ∂ℎ2(Ψ0)
∂푦2
∂Ψ
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
∂ℎ2(Ψ0)
∂Ψ
+
∂ log 푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
Then, if we factorize the likelihood as
푓푌1,푌2,퐴,푋(푦1, 푦2, 푎, 푥)
=
∂ℎ1
∂푦1
∂ℎ2
∂푦2
푓푋,푌 01 (푥, 푦
0
1(Ψ0))
× 푓푌 02 ∣푋,푌 01 (푦02(Ψ0)∣푥, 푦01(Ψ0))푓퐴∣푋,푌 01 ,푌 02 (푎∣푥, 푦01(Ψ0), 푦02(Ψ0)),
obviously,
퐸[
∂ log 푓퐴∣푋,푌 01 ,푌 02 (푎∣푥, 푦01(Ψ0), 푦02(Ψ0); 휂30)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] = 0푞×1.
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It is easy to see that
퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
=퐸[
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log ∂ℎ2(Ψ0)
∂푦2
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
퐸[
∂ℎ1(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
퐸[
∂ℎ1(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
퐸[
∂ℎ2(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)].
If we factorize the likelihood as
푓푌1,푌2,퐴,푋(푦1, 푦2, 푎, 푥)
=
∂ℎ1
∂푦1
푓푋,푌 01 (푥, 푦
0
1(Ψ0))푓퐴,푌2∣푋,푌 01 (푎, 푦2∣푥, 푦01(Ψ0)),
obviously
퐸[
∂ log 푓퐴,푌2∣푋,푌 01 (푎, 푦2∣푥, 푦01(Ψ0))
∂Ψ
∣푋, 푌 01 (Ψ0)] = 0푞×1
It is easy to verify that
퐸[푆Ψ0 ∣푋, 푌 01 (Ψ0)]
=퐸[
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
∣푋, 푌 01 (Ψ0)] +
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
퐸[
∂ℎ1(Ψ0)
∂Ψ
∣푋, 푌 01 (Ψ0)].
Similarly, if we factorize the likelihood as
푓푌1,푌2,퐴,푋(푦1, 푦2, 푎, 푥)
=
∂ℎ1
∂푦1
푓푋,푌 01 (푥, 푦
0
1(Ψ0))푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0))푓푌2∣퐴,푋,푌 01 (푦2∣푎, 푥, 푦01(Ψ0)),
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obviously
퐸[
∂ log 푓푌2∣퐴,푋,푌 01 (푦2∣푎, 푥, 푦01(Ψ0))
∂Ψ
∣퐴,푋, 푌 01 (Ψ0)] = 0푞×1
It is easy to see that
퐸[푆Ψ0∣퐴,푋, 푌 01 (Ψ0)]
=
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
+
∂ log 푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
.
Then we consider
푆푒푓푓
=푆Ψ0 − 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푆Ψ0∣푋, 푌 01 (Ψ0)]− 퐸[푆Ψ0∣퐴,푋, 푌 01 (Ψ0)]
=
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log ∂ℎ2(Ψ0)
∂푦2
∂Ψ
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
∂ℎ2(Ψ0)
∂Ψ
+
∂ log 푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
−
{
퐸[
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log ∂ℎ2(Ψ0)
∂푦2
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
퐸[
∂ℎ1(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
퐸[
∂ℎ1(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
퐸[
∂ℎ2(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
}
+
{
퐸[
∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
∣푋, 푌 01 (Ψ0)]
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+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
퐸[
∂ℎ1(Ψ0)
∂Ψ
∣푋, 푌 01 (Ψ0)]
}
−
{∂ log ∂ℎ1(Ψ0)
∂푦1
∂Ψ
+
∂ log 푓푌 01 ,푋(푦
0
1(Ψ0), 푥)
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
+
∂ log 푓퐴∣푋,푌 01 (푎∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
∂ℎ1(Ψ0)
∂Ψ
}
After a lot of cancelations among the terms, the ﬁnal expression for 푆푒푓푓 is that
푆푒푓푓 (4.1.5)
=
{∂ log ∂ℎ2(Ψ0)∂푦2
∂Ψ
− 퐸[∂ log
∂ℎ2(Ψ0)
∂푦2
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
}
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
(∂ℎ1(Ψ0)
∂Ψ
− 퐸[∂ℎ1(Ψ0)
∂Ψ
∣푋, 푌 01 (Ψ0)]
)
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
(∂ℎ2(Ψ0)
∂Ψ
− 퐸[∂ℎ2(Ψ0)
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)]
)
For the convenience of later discussion, we also consider writing 푆푒푓푓 as
푆푒푓푓 (4.1.6)
=
∂ log 푓푌2∣푋,푌 01 (푦2∣푥, 푦01(Ψ0))
∂Ψ
− 퐸(∂ log 푓푌2∣푋,푌 01 (푦2∣푥, 푦01(Ψ0))
∂Ψ
∣∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0))
4.2 Locally Eﬃcient Doubly Robust RAL Estimator
4.2.1 The Estimator that Achieves Semi-parametric Eﬃciency Bound
Given the eﬃcient score function (4.1.5) we derived in the previous section, we can
deﬁne
푆푒푓푓,푖(Ψ)
=
{∂ log ∂ℎ2(Ψ)∂푦2
∂Ψ
− 퐸[∂ log
∂ℎ2(Ψ)
∂푦2
∂Ψ
∣푌 02 (Ψ), 푋, 푌 01 (Ψ)]
}
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+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ)∣푥, 푦01(Ψ))
∂푦01(Ψ)
(∂ℎ1(Ψ)
∂Ψ
− 퐸[∂ℎ1(Ψ)
∂Ψ
∣푋, 푌 01 (Ψ)]
)
+
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ)∣푥, 푦01(Ψ))
∂푦02(Ψ)
(∂ℎ2(Ψ)
∂Ψ
− 퐸[∂ℎ2(Ψ)
∂Ψ
∣푌 02 (Ψ), 푋, 푌 01 (Ψ)]
)
where 푖 indicates each subject.
We solve for Ψˆ such that
∑
푖 푆푒푓푓,푖(Ψˆ) = 0 and . Ψˆ will be the RAL estimator that
achieves the semi-parametric eﬃciency bound, under the sole condition that (4.1.1)
is true. The semi-parametric eﬃciency bound is given by 퐸[푆푒푓푓 (푆푒푓푓 )
푇 ]−1. However,
this estimating equation requires that we know the true density function 푓푌 02 ∣푋,푌 01 and
that we can evaluate the conditional expectation involved in the estimating equation
under the true distribution, which are usually unpractical.
4.2.2 Construction of a Locally Eﬃcient Doubly Robust RAL Estimator
A more practical approach would be that we posit certain parametric model for
푓푌 02 ∣푋,푌 01 and 푓퐴∣푋,푌 01 . Let 푝1(푦
0
2∣푥, 푦01;훼1) be the working model for 푓푌 02 ∣푋,푌 01 , and let
푝2(푎∣푥, 푦01;훼2) be the working model for 푓퐴∣푋,푌 01 . We assume that 훼1 if of dimension
푚1 and 훼2 is of dimension 푚2. We can estimate 훼1 and 훼2 by maximizing the working
conditional likelihood functions:
훼ˆ1 = argmin
∏
푖
푝1(푦
0
2(Ψ
퐼)∣푥, 푦01(Ψ퐼);훼1)
훼ˆ2 = argmin
∏
푖
푝2(푎∣푥, 푦01(Ψ퐼);훼2)
where 푖 indicates diﬀerent individuals and Ψ퐼 is some initial estimate of Ψ퐼 that is
root-푛 consistent.
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We then deﬁne
푈(Ψ) =
{∂ log ∂ℎ2(Ψ)∂푦2
∂Ψ
−
∫ ∂ log ∂ℎ2(Ψ)
∂푦2
∂Ψ
푝2(푎∣푥, 푦01(Ψ); 훼ˆ2)푑푎
}
(4.2.1)
+
∂ log 푝1(푦
0
2(Ψ)∣푥, 푦01(Ψ); 훼ˆ1)
∂푦01(Ψ)
(∂ℎ1(Ψ)
∂Ψ
−
∫
∂ℎ1(Ψ)
∂Ψ
푝2(푎∣푥, 푦01(Ψ); 훼ˆ2)푑푎
)
+
∂ log 푝1(푦
0
2(Ψ)∣푥, 푦01(Ψ); 훼ˆ1)
∂푦02(Ψ)
(∂ℎ2(Ψ)
∂Ψ
−
∫
∂ℎ2(Ψ)
∂Ψ
푝2(푎∣푥, 푦01(Ψ); 훼ˆ2)푑푎
)
We then consider estimator for Ψ obtained by solving
∑
푖
푈푖(Ψ) = 0 (4.2.2)
where 푖 indicates diﬀerent subjects. We will show that this estimator is locally
eﬃcient and doubly robust.
4.2.3 Locally Eﬃciency
The estimator obtained from (4.2.2) is locally eﬃcient in the sense that if the working
models 푝1(푦
0
2∣푥, 푦01;훼1) and 푝2(푎∣푥, 푦01;훼2) are the correct models for 푓푌 02 ∣푋,푌 01 and
푓퐴∣푋,푌 01 , the estimator will be an RAL estimator that has the inﬂuence function
proportional to the eﬃcient score (4.1.5). No other estimators will have a smaller
asymptotic variance under the sole restriction that (4.1.1) is true.
Before proving the result, we show the following useful lemma.
Lemma 4.2.1. Assume that 푍1, 푍2, ..., 푍푛 are i.i.d. with ﬁnite mean and variance
and that 푔(푧, 휃) is smooth with respect to 휃 and that ∂푔(푧,휃)
∂휃
is bounded. If 퐸[푔(푍푖, 휃)] =
0 for 휃 in a neighborhood of 휃0 and 휃푛 converges to 휃0 with
√
푛 rate in probability,
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where 휃푛 could be a function of 푍1, ..., 푍푛, then
푛∑
푖=1
[푔(푍푖, 휃푛)− 푔(푍푖, 휃0)] = 푂푝(1).
Proof. By the assumption, with high probability, ∣휃푛 − 휃0∣ ≤ 퐶√푛 . Then with high
probability,
∣
푛∑
푖=1
[푔(푍푖, 휃푛)− 푔(푍푖, 휃0)]∣ ≤ sup
∣휃′−휃0∣≤ 퐶√푛
∣
푛∑
푖=1
[푔(푍푖, 휃
′)− 푔(푍푖, 휃0)]∣
Consider the variance of
∑푛
푖=1[푔(푍푖, 휃
′)− 푔(푍푖, 휃0)]. Since 퐸[푔(푍푖, 휃′)] = 0 and 퐸[ 푔(
푍푖, 휃0)] = 0,
푉 푎푟{
푛∑
푖=1
[푔(푍푖, 휃
′)− 푔(푍푖, 휃0)]}
=
푛∑
푖=1
퐸{[푔(푍푖, 휃′)− 푔(푍푖, 휃0)]2}
=푛(휃′ − 휃0)2퐸[푔′(푍푖, 휃∗)]
≤퐶∗
for ∣휃′ − 휃0∣ ≤ 퐶√푛 , where 퐶∗ is some positive constant.
This shows that with high probability the variance of
∑푛
푖=1[푔(푍푖, 휃푛)− 푔(푍푖, 휃0)]
is also ﬁnite. Therefore
푛∑
푖=1
[푔(푍푖, 휃푛)− 푔(푍푖, 휃0)] = 푂푝(1).
Lemma 4.2.2. If 푝1(푦
0
2∣푥, 푦01;훼10) and 푝2(푎∣푥, 푦01;훼20) are the correct models for
푓푌 02 ∣푋,푌 01 and 푓퐴∣푋,푌 01 , where 훼10 and 훼20 are the true parameter values, under cer-
tain regularity conditions on the smoothness of 푝1 and 푝2 with respect to 훼1 and 훼2
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respectively, the estimator Ψˆ by solving (4.2.2) have the inﬂuence function that is
proportional to the eﬃcient score (4.1.5).
Proof. If 푝1 and 푝2 are the true models, under mild regularity conditions, our maxi-
mum likelihood estimates 훼ˆ1 and 훼ˆ2 are
√
푛 consistent estimates for 훼10 and 훼20.
Denote
푝(푦2∣푥, 푦01(Ψ);훼1) =
∂ℎ2(Ψ)
∂푦2
푝1(푦
0
2(Ψ)∣푥, 푦01(Ψ);훼1).
Each individual 푈(Ψ0) in (4.2.2) can be written as
푈(Ψ0) =
∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
푝2(푎∣푥, 푦01; 훼ˆ2)푑푎
(4.2.3)
We add and subtract a few terms
푈(Ψ0)
=
{∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
푝2(푎∣푥, 푦01;훼20)푑푎
}
(4.2.4)
+
{∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
(4.2.5)
−
∫ (∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
)
푝2(푎∣푥, 푦01;훼20)푑푎
}
−
{∫ ∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
[
푝2(푎∣푥, 푦01(Ψ0); 훼ˆ2)− 푝2(푎∣푥, 푦01(Ψ0);훼20)
]
푑푎
}
(4.2.6)
−
{∫ (∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
)
(4.2.7)
× [푝2(푎∣푥, 푦01(Ψ0); 훼ˆ2)− 푝2(푎∣푥, 푦01(Ψ0);훼20)]푑푎}
111
If 푝1 and 푝2 are the true models, The ﬁrst term (4.2.4) is the eﬃcient score function.
Consider the second term (4.2.5).
∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
−
∫ (∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
)
푝2(푎∣푥, 푦01;훼20)푑푎
=
{∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
푝2(푎∣푥, 푦01(Ψ0);훼20)푑푎
}
− {∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
푝2(푎∣푥, 푦01(Ψ0);훼20)푑푎
}
Deﬁne the following 푔1 function
푔1(푍, 훼1)
=
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼1)
∂Ψ
−
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼1)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼20)푑푎
where 푍 = (퐴,푋, 푌 01 , 푌
0
2 ). If 푝1 and 푝2 are smooth enough, 푔 will satisfy the smooth-
ness condition in Lemma 4.2.1. We calculate
퐸[푔1(푍, 훼1)] =퐸{∂ log 푝(푌2∣푋, 푌
0
1 (Ψ0);훼1)
∂Ψ
− 퐸[∂ log 푝(푌2∣푋, 푌
0
1 (Ψ0);훼1)
∂Ψ
∣푋, 푌 01 (Ψ0), 푌 02 (Ψ0)]}
=0
Note that the expectations are calculated under the true distribution. Referring to
Lemma 4.2.1, we can show that
푂푝(1) =
∑
푖
{∂ log 푝(푌2∣푋, 푌 01 (Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푌2∣푋, 푌
0
1 (Ψ0);훼10)
∂Ψ
−
∫ (∂ log 푝(푌2∣푋, 푌 01 (Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푌2∣푋, 푌
0
1 (Ψ0);훼10)
∂Ψ
)
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× 푝2(푎∣푋, 푌 01 ;훼20)푑푎
}
Similarly, for (4.2.6), we deﬁne
푔2(푍, 훼2) =
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼2)푑푎.
Under regularity conditions, 푔2 is smooth enough in 훼2. We compute
퐸[푔2(푍, 훼2)] =퐸[
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼2)푑푎]
=퐸{퐸[
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼2)푑푎∣푋, 푌 01 (Ψ0)]}
=퐸{
∫
퐸[
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
∣푋, 푌 01 (Ψ0), 퐴 = 푎]
× 푝2(푎∣푋, 푌 01 (Ψ0);훼2)푑푎}
=0
By Lemma 4.2.1,
푂푝(1)
=
∑
푖
{∫ ∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
[
푝2(푎∣푥, 푦01(Ψ0); 훼ˆ2)− 푝2(푎∣푥, 푦01(Ψ0);훼20)
]
푑푎
}
For (4.2.7),
∣∣ ∫ (∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
)
× [푝2(푎∣푥, 푦01(Ψ0); 훼ˆ2)− 푝2(푎∣푥, 푦01(Ψ0);훼20)]푑푎∣∣
=
∣∣(훼ˆ1 − 훼10)(훼ˆ2 − 훼20) ∂
∂훼2
∫
∂2 log 푝(푦2∣푥, 푦01(Ψ0);훼∗1)
∂Ψ∂훼1
푝2(푎∣푥, 푦01(Ψ0);훼∗2)푑푎
∣∣
Under certain smoothness regularity condition,
∣∣ ∂
∂훼2
∫
∂2 log 푝(푦2∣푥, 푦01(Ψ0);훼∗1)
∂Ψ∂훼1
푝2(푎∣푥, 푦01(Ψ0);훼∗2)푑푎
∣∣
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could be bounded by a constant 퐶 ′. Then (4.2.7) could be bounded by 퐶 ′
∣∣(훼ˆ1 −
훼10)(훼ˆ2 − 훼20)
∣∣. Considering that ∣∣(훼ˆ1 − 훼10)∣∣ is 푂푝( 1√푛) and ∣∣(훼ˆ2 − 훼20)∣∣ is also
푂푝(
1√
푛
), we get,
∑
푖
{∫ (∂ log 푝(푌2∣푋, 푌 01 (Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푌2∣푋, 푌
0
1 (Ψ0);훼10)
∂Ψ
)
× [푝2(푎∣푋, 푌 01 (Ψ0); 훼ˆ2)− 푝2(푎∣푋, 푌 01 (Ψ0);훼20)]푑푎}
=푛[푂푝(
1√
푛
)]2
=푂푝(1)
Combining all the results above, we have
∑
푖
푈푖(Ψ0) =
∑
푖
푆푒푓푓,푖(Ψ0) +푂푝(1)
Notice that
∑
푖 푆푒푓푓,푖 is of order 푂푝(
√
푛). Therefore, Ψˆ that solve
∑
푖 푈푖(Ψ) = 0 will
have the same inﬂuence function as the estimator that solves
∑
푖 푆푒푓푓,푖(Ψ) = 0. Ψˆ
achieves the semi-parametric bound under the sole condition of (4.1.1).
Hence, Lemma 4.2.2 proves that the estimator from (4.2.2) is locally eﬃcient, in
the sense that if both 푝1 and 푝2 are the correct model, the estimator achieves the
semi-parametric eﬃciency bound. However, if 푝1 and 푝2 are both wrong the estimator
may not be consistent. In the following section, we will show that the second best
thing for the estimator is true, i.e., as long as one of 푝1 and 푝2 is the correct model,
the estimator will be consistent.
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4.2.4 Double Robustness
In this section, 푝1 and 푝2 may not be the true distribution, but we still assume that
our estimated 훼ˆ1 and 훼ˆ2 converge to some 훼10 and 훼20 respectively with
√
푛 rate.
We do Taylor expansion for Ψ around Ψ0 with
∑
푖 푈푖(Ψ) = 0.
0 =
1
푛
∑
푖
{∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
푝2(푎∣푥, 푦01; 훼ˆ2)푑푎
}
(4.2.8)
+
{ 1
푛
∑
푖
∂
∂Ψ
(∂ log 푝(푦2∣푥, 푦01(Ψ∗); 훼ˆ1)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ∗); 훼ˆ1)
∂Ψ
푝2(푎∣푥, 푦01; 훼ˆ2)푑푎
)푇}
(4.2.9)
× (Ψˆ−Ψ0)
where Ψ∗ is between Ψˆ and Ψ0. Denote (4.2.9) to be 퐵푛. Under certain regularity
conditions, 퐵푛 will be nonsingular and ∣퐵푛∣−1 will be bounded.
Then,
Ψˆ−Ψ0
=퐵−1푛
1
푛
∑
푖
{∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
푝2(푎∣푥, 푦01; 훼ˆ2)푑푎
}
(4.2.10)
=퐵−1푛 ×{
1
푛
∑
푖
{∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
푝2(푎∣푥, 푦01;훼20)푑푎
}
(4.2.11)
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+
1
푛
∑
푖
{∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
−
∫ (∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
)
푝2(푎∣푥, 푦01;훼20)푑푎
}
(4.2.12)
− 1
푛
∑
푖
{∫ ∂ log 푝(푦2∣푥, 푦01(Ψ0);훼10)
∂Ψ
× [푝2(푎∣푥, 푦01(Ψ0); 훼ˆ2)− 푝2(푎∣푥, 푦01(Ψ0);훼20)]푑푎} (4.2.13)
− 1
푛
∑
푖
{∫ (∂ log 푝(푦2∣푥, 푦01(Ψ0); 훼ˆ1)
∂Ψ
− ∂ log 푝(푦2∣푥, 푦
0
1(Ψ0);훼10)
∂Ψ
)
× [푝2(푎∣푥, 푦01(Ψ0); 훼ˆ2)− 푝2(푎∣푥, 푦01(Ψ0);훼20)]푑푎}
}
(4.2.14)
Since 훼ˆ1 → 훼10 with
√
푛 rate, each term in (4.2.12) will be of order 1√
푛
. The
summation will be of order
√
푛, and (4.2.12) itself is of order 1√
푛
. Similarly, we can
argue that (4.2.13) and (4.2.14) are of order 1√
푛
. It is worth noting that if both 푝1
and 푝2 are true models, by the proof of Lemma 4.2.2, (4.2.12), (4.2.13) and (4.2.14)
are of order 1
푛
. When 푝1 and 푝2 are not the true models, this is not true. However,
we only need them to be of order 1√
푛
for the purpose of this section.
(4.2.11) is the average of 푛 i.i.d. random variables. By the law of large numbers,
it will converge to its expectation with
√
푛 rate,
퐸
[∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼20)푑푎
]
.
(4.2.15)
If this expectation is 0, the right hand side of (4.2.10) is converging to 0 with
√
푛
rate. Thus, Ψˆ will be
√
푛 consistent.
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It is easy to show that (4.2.15) is 0 if either 푝1 or 푝2 is the true model.
If 푝1 is the correct model,
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
=
∂ log 푝(푌2∣퐴,푋, 푌 01 (Ψ0);훼10)
∂Ψ
because of ignorability (4.1.1). It is the true conditional score function conditional
on 퐴,푋, 푌 01 (Ψ0). Thus,
퐸
[∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼20)푑푎
]
=퐸
{
퐸
[∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼20)푑푎
∣∣푋, 푌 01 (Ψ0)]}
=퐸
{
퐸
[∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
∣∣푋, 푌 01 (Ψ0)]
−
∫
퐸
[∂ log 푝(푌2∣퐴 = 푎,푋, 푌 01 (Ψ0);훼10)
∂Ψ
∣∣퐴 = 푎,푋, 푌 01 (Ψ0)]
× 푝2(푎∣푋, 푌 01 (Ψ0);훼20)푑푎
}
=0
If 푝2 is the correct model
퐸
[∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
−
∫
∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
푝2(푎∣푋, 푌 01 (Ψ0);훼20)푑푎
]
=퐸
[∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
− 퐸(∂ log 푝(푌2∣푋, 푌 01 (Ψ0);훼10)
∂Ψ
∣푋, 푌 01 (Ψ0)
)]
=0
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Therefore, as long as one of 푝1 and 푝2 is the correct model, Ψˆ from solving (4.2.2)
will be
√
푛 consistent. Ψˆ is doubly robust.
To summarize, we have constructed an RAL estimator that is locally eﬃcient and
doubly robust. It is worth noting that our locally eﬃciency is “weaker” than the lo-
cally eﬃciency in standard g-estimation. Our estimator achieves the semi-parametric
eﬃciency bound under the sole condition that ignorability (4.1.1) is true. In stan-
dard g-estimation, the semi-parametric eﬃciency bound under the sole restriction of
standard ignorability is the same as the semi-parametric eﬃciency bound under the
restriction that both standard ignorability and the propensity score model are true
(see Robins et al., 1992). However, this is not the case with our relaxed ignorability
(4.1.1), as the propensity score model in our setting also involves Ψ.
4.3 Important Special Cases
4.3.1 When the Treatment is Binary
If the treatment is binary, the eﬃcient score can be simpliﬁed.
푆푒푓푓
=푆Ψ0 − 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0)] + 퐸[푆Ψ0 ∣푋, 푌 01 (Ψ0)]− 퐸[푆Ψ0∣퐴,푋, 푌 01 (Ψ0)]
=퐴× 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 1]
+ (1− 퐴)× 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 0]
− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0))× 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 1]
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− (1− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0)))× 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 0]
+ 푃 (퐴 = 1∣푋, 푌 01 (Ψ0))× 퐸[푆Ψ0∣푋, 푌 01 (Ψ0), 퐴 = 1]
+ (1− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0)))× 퐸[푆Ψ0 ∣푋, 푌 01 (Ψ0), 퐴 = 0]
− 퐴× 퐸[푆Ψ0∣푋, 푌 01 (Ψ0), 퐴 = 1]− (1− 퐴)× 퐸[푆Ψ0 ∣푋, 푌 01 (Ψ0), 퐴 = 0]
=
[
퐴− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0))
]
× {퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 1]− 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 0]}
− [퐴− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0))]
× {퐸[푆Ψ0∣푋, 푌 01 (Ψ0), 퐴 = 1]− 퐸[푆Ψ0∣푋, 푌 01 (Ψ0), 퐴 = 0]}
=
[
퐴− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0))
]
× {퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 1]− 퐸[푆Ψ0∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 0]
− 퐸[푆Ψ0∣푋, 푌 01 (Ψ0), 퐴 = 1] + 퐸[푆Ψ0∣푋, 푌 01 (Ψ0), 퐴 = 0]
}
If we plug in the functional form of 푆Ψ0 , the eﬃcient score can be further simpliﬁed
to
푆푒푓푓 =
[
퐴− 푃 (퐴 = 1∣푋, 푌 01 (Ψ0))
]
× {퐸[∂ log 푓푌2∣푋,푌 01 (푦2∣푥, 푦01(Ψ0))
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 1]
− 퐸[∂ log 푓푌2∣푋,푌 01 (푦2∣푥, 푦
0
1(Ψ0))
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 0]
}
Using the general theory in Section 4.2, we can consider the following estimating
equation ∑
푖
(퐴− 푃 (퐴 = 1∣푋, 푌 01 (Ψ); 훼ˆ))푔(푌 02 (Ψ), 푌 01 (Ψ), 푋) = 0
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where 훼ˆ can be estimated by maximizing conditional likelihood as in Section 4.2.2,
and 푔 is any function. The estimator will be consistent, as long as our propensity
score model is correct. It is also locally eﬃcient in the sense that if function 푔 happens
to be
퐸[
∂ log 푓푌2∣푋,푌 01 (푦2∣푥, 푦01(Ψ0))
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 1]
− 퐸[∂ log 푓푌2∣푋,푌 01 (푦2∣푥, 푦
0
1(Ψ0))
∂Ψ
∣푌 02 (Ψ0), 푋, 푌 01 (Ψ0), 퐴 = 0],
the inﬂuence function for the estimator will be proportional to the eﬃcient score
function.
4.3.2 Special Blip-down Functions
We now assume that ∂ℎ2(Ψ0)
∂푦2
= 1, ∂ℎ1(Ψ0)
∂Ψ
= −퐴, and ∂ℎ2(Ψ0)
∂Ψ
= −푐퐴, where 푐 is a
constant. Note that this implicitly assumes that Ψ is of one dimension. The eﬃcient
score becomes
푆푒푓푓 =− (퐴− 퐸[퐴∣푋, 푌 01 (Ψ0)])
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
− 푐(퐴− 퐸[퐴∣푋, 푌 01 (Ψ0)])
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
=− (퐴− 퐸[퐴∣푋, 푌 01 (Ψ0)])
× [∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
+ 푐
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
]
Assuming we can correctly model 퐸[퐴∣푋, 푌 01 (Ψ0)] as 퐸[퐴∣푋, 푌 01 (Ψ0);훼0], the fol-
lowing estimating equation can also be used for any 푔 function,
∑
푖
(퐴− 퐸[퐴∣푋, 푌 01 (Ψ); 훼ˆ])푔(푌 02 (Ψ), 푌 01 (Ψ), 푋) = 0.
120
where 훼ˆ can be estimated using least square principle. Under mild regularity condi-
tions, 훼ˆ is
√
푛 consistent. The estimator for Ψ by solving the estimating equation will
be
√
푛 consistent. It is also locally eﬃcient in the sense that if function 푔 happens
to be
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
+ 푐
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
,
the inﬂuence function for the estimator is the eﬃcient score.
4.3.3 Identiﬁcation Issue
The semi-parametric eﬃciency bound is 퐸[푆푒푓푓 (푆푒푓푓 )
푇 ]−1. Therefore, for Ψ to be
identiﬁable, 푆푒푓푓 must not be a constant, i.e., 0.
This implies that
퐴− 퐸[퐴∣푋, 푌 01 (Ψ0)] ∕= 0
and that
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
+ 푐
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
∕= 0.
The former equation is a usual assumption. The latter equation might be violated
if e.g.,
log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0)) = 퐶 −
(푦02(Ψ0)− 푐푦01(Ψ0)− 훽푥)2
2휎
i.e., assuming a normal regression model for 푌 02 ∣푋, 푌 01 and the regression coeﬃcient
for 푌 01 is exactly 푐. This will induce
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦01(Ψ0)
+ 푐
∂ log 푓푌 02 ∣푋,푌 01 (푦
0
2(Ψ0)∣푥, 푦01(Ψ0))
∂푦02(Ψ0)
= 0.
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And hence Ψ will not be identiﬁable.
One example when the above case is true is that, assuming 퐴 is binary, 푌 02 =
푐푌 01 + 훽푋 + 휖, where 휖 is normal with zero mean, 푌
1
2 = 푌
0
2 + 푐Ψ, and 푌
1
1 = 푌
0
1 + Ψ.
It is easy to see that 푌 12 = 푐푌
1
1 + 훽푋 + 휖. Therefore, knowing (푌
0
1 , 푌
1
1 ) is equivalent
to knowing (푌 02 , 푌
1
2 ). 푌2 does not contain more information about the causal eﬀect
Ψ, which makes Ψ un-identiﬁable.
However, if 푌 02 = 푐푌
0
1 + 훽푋 + 휖, 푌
1
2 = 푌
0
2 + 푑Ψ, 푑 ∕= 푐, and 푌 11 = 푌 01 + Ψ, Ψ will
be identiﬁable. Now 푌 12 = 푐푌
1
1 + (푑− 푐)Ψ + 훽푋 + 휖, and (푌 02 , 푌 12 ) contain additional
information about the causal eﬀect Ψ.
4.4 Extension to Multi-period Case
We consider a 퐾-period study, assuming that
∙ 퐴0, 퐴1, ..., 퐴퐾−1 are the treatment levels at time 0, 1, ..., 퐾 − 1.
∙ 푌0, 푌1, ..., 푌퐾 are the actual outcomes at time 0, 1, ..., 퐾.
∙ 퐿0, 퐿1, ..., 퐿퐾−1 are the covariates at time 0, 1, ..., 퐾 − 1. 퐿푡 does not include
푌푡.
∙ 푌 푎¯푘 is the counterfactual outcome at time 푘 under treatment regime 푎¯ = (푎0,
푎1, ..., 푎퐾−1).
∙ 푌 푘,0푡 is the counterfactual outcome at time 푡 ≥ 푘 + 1, under treatment regime
푎¯ = (퐴0, 퐴1, ..., 퐴푘, 0, ..., 0).
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Note that consistency assumption requires that 푌 푘,0푘+1 = 푌푘+1.
We assume a rank preserving model:
푌 푘,0푘+2 = ℎ푘,푘+2(푌
푘+1,0
푘+2 , 푌
푘,0
푘+1, 퐿¯푘, 푌¯푘, 퐴¯푘; Ψ0)
⋅ ⋅ ⋅
푌 푘,0푚 = ℎ푘,푚(푌
푘+1,0
푚 , 푌¯
푘,0
(푘+1):(푚−1), 퐿¯푘, 푌¯푘, 퐴¯푘; Ψ0),푚 > 푘 + 1
where 퐿¯푘 = (퐿0, ..., 퐿푘), 퐴¯푘 = (퐴0, ..., 퐴푘), 푌¯
푘,0
(푘+1):(푚−1) = (푌
푘,0
푘+1, 푌
푘,0
푘+2, ⋅ ⋅ ⋅ , 푌 푘,0푚−1), and
ℎ푘,푚’s are known rank preserving functions. We assume Ψ is the parameter of our
interest and is a 푞 dimensional vector. Ψ achieves its true value at Ψ0.
We next show that with this model, given 푌푚, 퐿¯푚−1, 푌¯푚−1, 퐴¯푚−1 and ℎ푘,푚’s, we
are able to blip 푌푚 down to 푌
0¯
푚.
∙ With function ℎ푘−2,푘, 2 ≤ 푘 ≤ 푚 and 푌푘, 1 ≤ 푘 ≤ 푚, we can get 푌 푘−2,0푘 , 2 ≤
푘 ≤ 푚.
∙ With function ℎ푘−3,푘, 3 ≤ 푘 ≤ 푚 and 푌 푘−2,0푘 , 2 ≤ 푘 ≤ 푚, we can get 푌 푘−3,0푘 , 3 ≤
푘 ≤ 푚.
∙ ...
∙ With function ℎ0,푚−1 and ℎ1,푚 and the counterfactuals above, we can get 푌 0¯푚−1
and 푌 1,0푚 .
∙ With function ℎ0,푚 and the counterfactuals we obtained above, we can get 푌 0¯푚.
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We denote
푌 0¯푚 = ℎ푚(푌푚, 퐿¯푚−1, 푌¯푚−1, 퐴¯푚−1; Ψ)
We also assume the following ignorability assumption
푌 푘,0푚 ∐ 퐴푘∣퐿¯푘, 푌¯푘, 퐴¯푘−1, 푌 푘−1,0푘+1 ,푚 > 푘 + 1 (4.4.1)
With the rank preserving model described above, the ignorability assumption is
equivalent to
푌 0¯푚 ∐ 퐴푘∣퐿¯푘, 푌¯푘, 퐴¯푘−1, 푌 0¯푘+1,푚 > 푘 + 1 (4.4.2)
4.4.1 Likelihood Function
We consider the likelihood function of 퐴¯퐾−1, 퐿¯퐾−1 and 푌¯퐾 , for one subject. We note
the convention that 퐴¯−1 = 휙 and 퐿¯−1 = 휙.
푓퐴¯퐾−1,퐿¯퐾−1,푌¯퐾 (푎¯퐾−1, 푙¯퐾−1, 푦¯퐾)
=푓퐴¯퐾−1,퐿¯퐾−1,푌¯ 0¯퐾
(푎¯퐾−1, 푙¯퐾−1, 푦¯0¯퐾(Ψ))
∏
1≤푚≤퐾
∂ℎ푚
∂푦푚
=(
∏
1≤푚≤퐾
∂ℎ푚
∂푦푚
)× 푓푌¯ 0¯퐾 (푦¯
0¯
퐾(Ψ))
×
퐾−1∏
푘=0
푓퐿푘∣퐿¯푘−1,퐴¯푘−1,푌¯ 0¯퐾 (푙푘∣푙¯푘−1, 푎¯푘−1, 푦¯
0¯
퐾(Ψ))푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯ 0¯퐾 (푎푘∣푙¯푘, 푎¯푘−1, 푦¯
0¯
퐾(Ψ))
=(
∏
1≤푚≤퐾
∂ℎ푚
∂푦푚
)× 푓푌¯ 0¯퐾 (푦¯
0¯
퐾(Ψ))
×
퐾−1∏
푘=0
푓퐿푘∣퐿¯푘−1,퐴¯푘−1,푌¯ 0¯퐾 (푙푘∣푙¯푘−1, 푎¯푘−1, 푦¯
0¯
퐾(Ψ))푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1(푎푘∣푙¯푘, 푎¯푘−1, 푦¯
0¯
푘+1(Ψ))
=(
∏
1≤푚≤퐾
∂ℎ푚
∂푦푚
(Ψ))× 푓푌¯ 0¯퐾 (푦¯
0¯
퐾(Ψ); 휂푦)
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×
퐾−1∏
푘=0
푓퐿푘∣퐿¯푘−1,퐴¯푘−1,푌¯ 0¯퐾 (푙푘∣푙¯푘−1, 푎¯푘−1, 푦¯
0¯
퐾(Ψ); 휂푙푘)
× 푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1(푎푘∣푙¯푘, 푎¯푘−1, 푦¯
0¯
푘+1(Ψ); 휂푎푘)
The third equality is because of ignorability assumption and the rank preserving
model. Note that in practice, under rank preserving model, we usually do the fol-
lowing parametrization
푓퐴0∣퐿0,푌¯ 0¯1 (푎0∣푙0, 푦¯
0¯
1(Ψ); 휂푎0) = 푓퐴0∣퐿0,푌0,푌 0¯1 (푎0∣푙0, 푦0, 푦
0¯
1(Ψ0); 휂
∗
푎0)
and
푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1(푎푘∣푙¯푘, 푎¯푘−1, 푦¯
0¯
푘+1(Ψ); 휂푎푘) = 푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯푘,푌 0¯푘+1(푎푘∣푙¯푘, 푎¯푘−1, 푦¯푘, 푦
0¯
푘+1; 휂
∗
푎푘).
Denote the true values of the parameters as Ψ0, 휂푦0, 휂푙푘0 and 휂푎푘0.
4.4.2 Nuisance Tangent Space
Consider any parametric sub-model
푓퐴¯퐾−1,퐿¯퐾−1,푌¯퐾 (푎¯퐾−1, 푙¯퐾−1, 푦¯퐾)
=(
∏
1≤푚≤퐾
∂ℎ푚
∂푦푚
(Ψ))× 푓푌¯ 0¯퐾 (푦¯
0¯
퐾(Ψ); 훾푦)
×
퐾−1∏
푘=1
푓퐿푘∣퐿¯푘−1,퐴¯푘−1,푌¯ 0¯퐾 (푙푘∣푙¯푘−1, 푎¯푘−1, 푦¯
0¯
퐾(Ψ); 훾푙푘)
× 푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1(푎푘∣푙¯푘, 푎¯푘−1, 푦¯
0¯
푘+1(Ψ); 훾푎푘)
where 훾푦 is of dimension 푛푦, 훾푙푘 is of dimension 푛푙푘, and 훾푎푘 is of dimension 푛푎푘.
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The nuisance score of this parametric submodel is
푆훾 = 푆(푎¯퐾−1, 푙¯퐾−1, 푦¯퐾 ; Ψ0, 훾0) =
∂ log 푓퐴¯퐾−1,퐿¯퐾−1,푌¯퐾 (푎¯퐾−1, 푙¯퐾−1, 푦¯퐾 ; Ψ0, 훾0)
∂훾
∣훾=훾0
Denote
푆훾푦 =
∂ log 푓푌¯ 0¯퐾
(푦¯0¯퐾(Ψ); 훾푦)
∂훾푦
푆훾푙푘 =
∂ log 푓퐿푘∣퐿¯푘−1,퐴¯푘−1,푌¯ 0¯퐾 (푙푘∣푙¯푘−1, 푎¯푘−1, 푦¯
0¯
퐾(Ψ); 훾푙푘)
∂훾푙푘
푆훾푎푘 =
∂ log 푓퐴푘∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1(푎푘∣푙¯푘, 푎¯푘−1, 푦¯
0¯
푘+1(Ψ); 훾푎푘)
∂훾푎푘
Deﬁne
Λ훾 = {퐵푞×(푛푦+∑푛푎푘+∑푛푙푘)푆훾}
Λ훾푦 = {퐵푞×푛푦푆훾푦}
Λ훾푙푘 = {퐵푞×푛푙푘푆훾푙푘}
Λ훾푎푘 = {퐵푞×푛푎푘푆훾푎푘}
By deﬁnition, it is easy to see that
Λ훾 = Λ훾푦 ⊕ {⊕퐾−1푘=0 Λ훾푙푘 ⊕ Λ훾푎푘}.
We deﬁne Λ,Λ푦,Λ푙푘,Λ푎푘 to be the mean-square closure of all Λ훾,Λ훾푦 ,Λ훾푙푘 ,Λ훾푎푘 , re-
spectively. It can also be proved that
Λ = Λ푦 ⊕ {⊕퐾−1푘=0 Λ푙푘 ⊕ Λ푎푘}.
Here Λ is the nuisance tangent space.
We also notice that Λ푦, Λ푙푘, Λ푎푘 can be characterized as follows:
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Lemma 4.4.1.
Λ푦 = {푎푦(푌¯ 0¯퐾(Ψ)) : 퐸[푎푦(푌¯ 0¯퐾(Ψ))] = 0}
Λ푙푘 = {푎푙푘(퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ)) : 퐸[푎푙푘(퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ)∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ)] = 0}
Λ푎푘 = {푎푎푘(퐴¯푘, 퐿¯푘, 푌¯ 0¯푘+1(Ψ)) : 퐸[푎푎푘(퐴¯푘, 퐿¯푘, 푌¯ 0¯푘+1(Ψ))∣퐴¯푘−1, 퐿¯푘, 푌¯ 0¯푘+1(Ψ)] = 0}
The proof of this lemma is exactly the same as the proofs from Tsiatis (2006). It
can also be proved that these subspaces are orthogonal to each other, using properties
of conditional expectation and the ignorability assumption.
For example, to prove that Λ푙푘1∐Λ푎푘2 , 푘1 ≤ 푘2, pick any ℎ1 ∈ Λ푙푘1 and ℎ2 ∈ Λ푎푘2 .
퐸[ℎ1ℎ
푇
2 ] = 퐸{퐸[ℎ1ℎ푇2 ∣퐿¯푘1 , 퐴¯푘1−1, 푌¯ 0¯퐾(Ψ)]}
= 퐸{ℎ1퐸[ℎ푇2 ∣퐿¯푘1 , 퐴¯푘1−1, 푌¯ 0¯퐾(Ψ)]}
= 퐸{ℎ1퐸[퐸{ℎ푇2 ∣퐿¯푘2 , 퐴¯푘2−1, 푌¯ 0¯퐾(Ψ)}∣퐿¯푘1 , 퐴¯푘1−1, 푌¯ 0¯퐾(Ψ)]}
= 퐸{ℎ1퐸[퐸{ℎ푇2 ∣퐿¯푘2 , 퐴¯푘2−1, 푌¯ 0¯푘2+1(Ψ)}∣퐿¯푘1 , 퐴¯푘1−1, 푌¯ 0¯퐾(Ψ)]}
= 퐸{ℎ1퐸[01×푞∣퐿¯푘1 , 퐴¯푘1−1, 푌¯ 0¯퐾(Ψ)]}
= 0
The third equality is because 푘1 ≤ 푘2. The fourth equality uses the ignorability
assumption. Proofs for the orthogonality of other pairs follow the same fashion.
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4.4.3 The Eﬃcient Score
Consider the score function of interest
푆Ψ0 =
∂ log(푓퐴¯퐾−1,퐿¯퐾−1,푌¯퐾 )
∂Ψ
The eﬃcient score is
푆푒푓푓 = 푆Ψ0 −
∏
(푆Ψ0 ∣Λ푦)−
퐾−1∑
푘=0
[
∏
(푆Ψ0∣Λ푙푘) +
∏
(푆Ψ0∣Λ푎푘)].
We then show the following facts.
Lemma 4.4.2.
∏
(푆Ψ0∣Λ푦) = 퐸[푆Ψ0∣푌¯ 0¯퐾 ]∏
(푆Ψ0∣Λ푙푘) = 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]− 퐸[푆Ψ0∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ]∏
(푆Ψ0∣Λ푎푘) = 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1]− 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1]
Proof. For
∏
(푆Ψ0∣Λ푦) = 퐸[푆Ψ0∣푌¯ 0¯퐾 ], we can show that for any ℎ ∈ Λ푦
퐸[{푆Ψ0 − 퐸[푆Ψ0∣푌¯ 0¯퐾 ]}ℎ푇 ]
=퐸{퐸[(푆Ψ0 − 퐸[푆Ψ0∣푌¯ 0¯퐾 ])ℎ푇 ∣푌¯ 0¯퐾 ]}
=퐸{퐸[(푆Ψ0 − 퐸[푆Ψ0∣푌¯ 0¯퐾 ])∣푌¯ 0¯퐾 ]ℎ푇}
=0
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For
∏
(푆Ψ0∣Λ푙푘) = 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]−퐸[푆Ψ0∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ], we can show that
for any ℎ ∈ Λ푙푘,
퐸[{푆Ψ0 − 퐸[푆Ψ0 ∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ] + 퐸[푆Ψ0∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ]}ℎ푇 ]
=퐸{퐸[(푆Ψ0 − 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ] + 퐸[푆Ψ0 ∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ])ℎ푇 ∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]}
=퐸{퐸[(푆Ψ0 − 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ] + 퐸[푆Ψ0 ∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ])∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]ℎ푇}
=퐸{퐸[퐸[푆Ψ0∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ]∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]ℎ푇}
=퐸{퐸[푆Ψ0∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ]ℎ푇}
=0
For
∏
(푆Ψ0∣Λ푎푘) = 퐸[푆Ψ0 ∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1]−퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1], we can show that
for any ℎ ∈ Λ푎푘
퐸[{푆Ψ0 − 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1] + 퐸[푆Ψ0 ∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1]}ℎ푇 ]
=퐸{퐸[(푆Ψ0 − 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1] + 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1])ℎ푇 ∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1]}
=퐸{퐸[(푆Ψ0 − 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1] + 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1])∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1]ℎ푇}
=퐸{퐸[퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1]∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1ℎ푇}
=퐸{퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1]ℎ푇}
=0
By the previous lemma, we get
푆푒푓푓 =푆Ψ0 − 퐸[푆Ψ0 ∣푌¯ 0¯퐾 ]
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−
퐾−1∑
푘=1
{퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]− 퐸[푆Ψ0∣퐿¯푘−1, 퐴¯푘−1, 푌¯ 0¯퐾 ]}
−
퐾−1∑
푘=1
{퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1]− 퐸[푆Ψ0 ∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1]}
=
퐾−1∑
푘=0
{퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾 ]− 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾 ]
− 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1] + 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1]}.
Let
푆푒푓푓 (Ψ) =
퐾−1∑
푘=0
{퐸[푆Ψ∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ)]− 퐸[푆Ψ∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ)]
− 퐸[푆Ψ∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1(Ψ)] + 퐸[푆Ψ∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ)]}
The eﬃcient estimate of Ψ is thus given by the solution from
∑
푖 푆푒푓푓 (Ψ) = 0, where
푖 indicates diﬀerent individuals. This is the optimal estimating equation for the
controlling-the-future method.
We would like to simplify the formula for 푆푒푓푓 . The following formulas are ob-
tained using the similar trick of factorization of the likelihood as before.
퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
=퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
+ 퐸[
∂ log[푓퐿¯푘,퐴¯푘,푌¯ 0¯퐾
(푙¯푘, 푎¯푘, 푦¯
0¯
퐾(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
=퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)] +
∂ log[푓퐿¯푘,퐴¯푘,푌¯ 0¯푘+1
(푙¯푘, 푎¯푘, 푦¯
0¯
푘+1(Ψ0))]
∂Ψ
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+ 퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
Similarly
퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
=퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
+ 퐸[
∂ log[푓퐿¯푘,퐴¯푘−1,푌¯ 0¯퐾
(푙¯푘−1, 푎¯푘−1, 푦¯0¯퐾(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
=퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
+ 퐸[
∂ log[푓퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1
(푙¯푘−1, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
+ 퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘−1, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
=퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
+ 퐸[
∂ log[푓퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1
(푙¯푘−1, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ0)]
+ 퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘−1, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1(Ψ0)]
=
∑
1≤푚≤푘+1
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
+
∂ log[푓퐿¯푘,퐴¯푘,푌¯ 0¯푘+1
(푙¯푘, 푎¯푘, 푦¯
0¯
푘+1(Ψ0))]
∂Ψ
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and that
퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ0)]
=
∑
1≤푚≤푘+1
퐸[
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ0)]
+ 퐸[
∂ log[푓퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1
(푙¯푘, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ0)]
Given the above and with a lot of cancelation, we get
퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]− 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
− 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘, 푌¯ 0¯푘+1(Ψ0)] + 퐸[푆Ψ0∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ0)]
=퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
− 퐸[
∑
1≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
−
∑
1≤푚≤푘+1
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
+
∑
1≤푚≤푘+1
퐸[
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯푘+1(Ψ0)]
+
{
퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
− 퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘−1, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
}
=퐸[
∑
푘+2≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
− 퐸[
∑
푘+2≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
132
+
{
퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
− 퐸[
∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐿¯푘,퐴¯푘−1,푌¯ 0¯푘+1({푦
0¯
푡 (Ψ0)}퐾푡=푘+2∣푙¯푘−1, 푎¯푘−1, 푦¯0¯푘+1(Ψ0))]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
}
≡푆푒푓푓,푘
Thus
푆푒푓푓,푘
=퐸[
∑
푘+2≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]
− 퐸[
∑
푘+2≤푚≤퐾
∂ log[∂ℎ푚
∂푦푚
(Ψ0)]
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]
+
퐾∑
푡=푘+2
(∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐴¯푘−1,퐿¯푘,푌¯푘+1({푦0¯푡 (Ψ0)}퐾푡=푘+2∣푎¯푘−1, 푙¯푘, 푦¯푘+1)]
∂푌 0¯푡
× {퐸[∂푌
0¯
푡 (Ψ0)
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]− 퐸[
∂푌 0¯푡 (Ψ0)
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]}
)
+
(∂ log[푓{푌 0¯푡 }퐾푡=푘+2∣퐴¯푘−1,퐿¯푘,푌¯푘+1({푦0¯푡 (Ψ0)}퐾푡=푘+2∣푎¯푘−1, 푙¯푘, 푦¯푘+1)]
∂푌 0¯푘+1
× {퐸[∂푌
0¯
푘+1(Ψ0)
∂Ψ
∣퐿¯푘, 퐴¯푘, 푌¯ 0¯퐾(Ψ0)]− 퐸[
∂푌 0¯푘+1(Ψ0)
∂Ψ
∣퐿¯푘, 퐴¯푘−1, 푌¯ 0¯퐾(Ψ0)]}
)
We get an eﬃcient score that is a natural extension of the eﬃcient score in the
single period case. Locally eﬃcient estimators that are doubly robust can be con-
structed in a similar way as in Section 4.2, which we omit here.
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4.5 Conclusion
In this chapter, we have developed the semi-parametric theory for the relaxed ignor-
ability assumption and the controlling-the-future method we used in Chapter 2. In
particular, we have characterized the nuisance tangent space under the sole restric-
tion that the relaxed ignorability (4.1.1) is true, and calculated the eﬃcient score and
the semi-parametric eﬃciency bound. Motivated by the form of the eﬃcient score
function, we propose a locally eﬃcient and doubly robust estimator.
The multi-period generalization of the theory is straightforward. It is worth
noting that even though we have only considered ignorability assumption that only
allows treatment assignment depend on the next period potential outcome given the
historical treatment and covariates, the formulas and the derivation are almost the
same for extended assumptions that allows treatment assignment to depend on more
than one period of future potential outcomes (see extended formulations in Joﬀe
and Robins (2009)). Similar locally eﬃcient and doubly robust estimator can be
constructed in the same fashion as in the single period model.
We admit that the discussion in this chapter is incomplete. In this chapter, we
have required that there are more than one outcomes associated with the treatment,
and our discussion of the multi-period case has focused on studies with repeated
measurements of the outcomes. In the extended formulation of Joﬀe and Robins
(2009), it is possible to extend the ideas of the basic controlling-the-future method to
cases when we only have a single measurement of outcome and the treatment could
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depend on the potential outcome in known functional form, possibly parametrized by
a ﬁnite dimensional parameter. This extension does not always lead to identiﬁcation.
Work is in progress studying when identiﬁcation can be achieved and how to construct
useful estimator with good properties.
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Chapter 5
Appendices
5.1 Estimating Covariance Matrix of Estimated Parameters
The formulas in this section can be used to estimate the covariance matrix of the
estimated parameters from naive g-estimation of Section 2.2.1, modiﬁed g-estimation
of Section 2.2.3, and the controlling-the-future estimation of Section 2.4.1.
We denote 휃 = (Ψ, 훽). In Section 2.2.1 and Section 2.2.3, 훽 is the parameter in
the propensity score model. In Section 2.4.1, 훽 = (훽푋 , 훽ℎ) is the parameter in the
propensity score model. Let 푈(휃) be the vector of the left hand side of the estimating
equations (Equation (2.2.5) in Section 2.2.1, Equation (2.2.7) in Section 2.2.3, and
Equation (2.4.4) in Section 2.4.1, respectively). We also denote
푈푖,푘,푚(휃) ≡ (퐴∗푖,푘 − 푝푖,푘(훽))[푔(푌 0∗푖,푚(Ψ), 푋∗푖,푘), 푋∗푖,푘]푇 ,
for the naive g-estimation and the modiﬁed g-estimation, and denote
푈푖,푘,푚(Ψ; 훽푋 , 훽ℎ) ≡ (퐴∗푖,푘 − 푝푖,푘(Ψ; 훽푋 , 훽ℎ))[푔(푌 0∗푖,푚(Ψ), 푋∗푖 , ℎ푖), 푋∗푖,푘, ℎ푖,푘]푇 ,
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for the controlling-the-future estimation. Then 푈(휃) =
∑
푈푖,푘,푚.
Let 퐵(휃) = 퐸[∂푈(휃)
∂휃
], which can be estimated as
퐵ˆ(휃) = −
∑
푖,푘,푚
{∂푈푖,푘,푚
∂휃
}∣휃=휃ˆ
where 휃ˆ is the solution from the corresponding estimating equations, and 푘 < 푚 in
both g-estimations and 푘 < 푚 − 1 in controlling-the-future estimation. Then the
covariance matrix of the estimator 휃ˆ can be estimated as
퐶표푣(휃ˆ) = 퐵ˆ−1(휃) ˆ퐶표푣[푈(휃)]퐵ˆ−1(휃)′
by the Delta-method, where 퐶표푣[푈(휃)] is estimated by
ˆ퐶표푣[푈(휃)] =
∑
푖
푈푖(휃ˆ)푈푖(휃ˆ)
′
where 푈푖 =
∑
푘,푚 푈푖,푘,푚(휃ˆ), 푘 < 푚 in both g-estimations and 푘 < 푚−1 in controlling-
the-future estimation.
5.2 Deﬁnition of 푁푡 and Explicit Formula of 휆푡
This section gives the deﬁnition of 푁푡, the counting process that counts the number of
changes in the treatment process, and an explicit formula of 휆푡, the intensity process
of 푁푡 with respect to the ﬁltration of 휎(푍¯푡). The deﬁnitions will be used in the proof
of Theorem 2.3.3.
Following the standard deﬁnition of a counting process deﬁned from a ca`dla`g
process, we ﬁrst deﬁne a sequence of stopping times:
휏1 = inf
푡>0
{푡 : 퐴푡 ∕= 퐴0}
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휏2 = inf
푡>휏1
{푡 : 퐴푡 ∕= 퐴휏1}
휏3 = inf
푡>휏2
{푡 : 퐴푡 ∕= 퐴휏2}
⋅ ⋅ ⋅
Then, 푁푡 can be deﬁned as
{푁푡 = 푘} = {휏푘 ≤ 푡 < 휏푘+1} (5.2.1)
Assume 퐴푡 is a binary ca`dla`g process such that 푁푡 deﬁned in (5.2.1) is a counting
process on [0, 퐾], satisfying
∙ 푁푡 is a non-negative integer.
∙ 푁푠 ≤ 푁푡 for 푠 ≤ 푡.
∙ 푑푁푡 = 푁푡 −푁푡− is either 0 or 1.
∙ 퐸[푁푡] <∞.
Given 푁푡, 휆푡 is the intensity process with respect to 휎(푍¯푡). We will give a formula
for 휆푡 in terms of 퐴푡, which can then be explicitly related to the propensity score of
퐴푡. First, we denote
푟푡(훿) = (1− 퐴푡−)퐴푡+훿 + 퐴푡−(1− 퐴푡+훿).
Then deﬁne
휆푡 ≡ lim
훿↓0
퐸[푟푡(훿)∣휎(푍¯푡−)]
훿
(5.2.2)
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As a regularity condition, we assume that the limit on the right hand side of (5.2.2)
always exists and is ﬁnite. The following lemma shows that the so-deﬁned 휆푡 is the
intensity process for 푁푡.
Lemma 5.2.1. 휆푡 deﬁned in Equation (5.2.2) is the intensity process for counting
process 푁푡, w.r.t. 휎(푍¯푡). In other words,
lim
훿↓0
푃푟(푁푡+훿 −푁푡− = 1∣휎(푍¯푡−))
훿
= 휆푡
Proof. The proof is simple.
푃푟(푁푡+훿 −푁푡− = 1∣휎(푍¯푡−))
=푃푟(휏푁푡−+1 ≤ 푡+ 훿 < 휏푁푡−+2∣휎(푍¯푡−))
=푃푟(퐴푡+훿 ∕= 퐴푡−∣휎(푍¯푡−))− 푃푟(퐴푡+훿 ∕= 퐴푡−, 푁푡+훿 −푁푡− ≥ 2∣휎(푍¯푡−))
=푃푟(퐴푡+훿 ∕= 퐴푡−∣휎(푍¯푡−))−푂(훿2)
=퐸[푟푡(훿)∣휎(푍¯푡−)]−푂(훿2)
Divide both sides by 훿 and take the limit with 훿 ↓ 0, we can get the desired
result.
5.3 Proof of FTSR Implying CTSR
We assume that 푍푡 is a ca`dla`g process, and everything we discuss is in an a.s. sense.
By the deﬁnition of continuous time sequential randomization in Deﬁnition 2.2.1,
we only need to prove that 휆푡 deﬁned in the Appendix B is also the intensity process
for 푁푡 with respect to the ﬁltration of 휎(푍¯푡, 푌
0
푡+).
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First, we denote
ℋ푡− ≡ 휎(푍¯푡−)
ℱ푡−,푡+ ≡ 휎(푍¯푡−, 푌 0푡+)
We also deﬁne
휂푡 ≡ lim
훿↓0
퐸[푟푡(훿)∣ℱ푡−,푡+]
훿
.
As a regularity condition, we assume that 휂푡 exists and is ﬁnite. By a similar proof as
in Lemma 5.2.1, 휂푡 is the intensity process of 푁푡 with respect to the ﬁltration ℱ푡−,푡+.
Therefore, proving Theorem 2.3.3 is equivalent to proving that 휆푡 = 휂푡.
To bridge our intuition in the discrete time case into the continuous time case,
we assume the following regularity conditions:
1. We assume that 휂푡 deﬁned above always exists and is positive random functions.
We also assume that 휂푡 is bounded by some constant that is independent of 푡.
(Note that by the Dominated Convergence Theorem of conditional expectation,
휆푡 also exists and is positive, and can be bounded by the same constant.)
2. We assume that for any ﬁnite sequence of time points, 푡1 ≤ 푡2 ≤ 푡3 ≤ ⋅ ⋅ ⋅ ≤ 푡푛,
the density 푝푟(푍푡1 = 푧1, 푍푡2 = 푧2, ⋅ ⋅ ⋅ , 푍푡푛 = 푧푛) is well-deﬁned, and is locally
uniformly bounded, i.e. there exists a constant 퐷 and a rectangle 퐵 ≡ [푡1 −
훿1, 푡1 + 훿1]× [푡2− 훿2, 푡2 + 훿2]×⋅ ⋅ ⋅× [푡푛− 훿푛, 푡푛+ 훿푛], for any (푡′1, 푡′2, ⋅ ⋅ ⋅ , 푡′푛)푇 ∈ 퐵
and for any possible value of (푧1, 푧2, ⋅ ⋅ ⋅ , 푧푛)푇 ,
푝푟(푍푡′1 = 푧1, 푍푡′2 = 푧2, ⋅ ⋅ ⋅ , 푍푡′푛 = 푧푛) ≤ 퐷
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For any conditional expectation involving ﬁnite sequence of time points, we
choose the version that is deﬁned by the joint density.
3. Given any ﬁnite sequence of time points, 푡1 ≤ 푡2 ≤ 푡3 ≤ ⋅ ⋅ ⋅ ≤ 푡푛 and any
possible value of (푧1, 푧2, ⋅ ⋅ ⋅ , 푧푛)푇 , we assume that the following convergence is
uniform in a closed neighborhood of 푡˜ ≡ (푡1, 푡2, 푡3, ⋅ ⋅ ⋅ , 푡푛)
푝푟(푍푡′1 = 푧1, 푍푡′2 = 푧2, ⋅ ⋅ ⋅ , 푍푡′푛 = 푧푛)
= lim
Δ↓0
푃푟(푍푡′1 ∈ [푧1, 푧1 + Δ1], 푍푡′2 ∈ [푧2, 푧2 + Δ2], ⋅ ⋅ ⋅ , 푍푡′푛 ∈ [푧푛, 푧푛 + Δ푛])
Δ1 ×Δ2 × ⋅ ⋅ ⋅ ×Δ푛
where (푡′1, 푡
′
2, ⋅ ⋅ ⋅ , 푡′푛)푇 is in a neighborhood of 푡˜.
4. Given any ﬁnite sequence of time points, 푡1 ≤ 푡2 ≤ 푡3 ≤ ⋅ ⋅ ⋅ ≤ 푡푖 ≤ ⋅ ⋅ ⋅ ≤ 푡푛 and
any possible value of (푧1, 푧2, ⋅ ⋅ ⋅ , 푧푛)푇 , we deﬁne
푓(훿) =
푝푟(퐴푡푖+훿 ∕= 퐴푡푖 ∣푍푡1 = 푧1, 푍푡2 = 푧2, ⋅ ⋅ ⋅ , 푍푡푛 = 푧푛)
훿
.
We assume that lim훿↓0 푓(훿) exists and is positive and ﬁnite. We also assume
that 푓(훿) is ﬁnite and is right-continuous in 훿, and the continuity is uniform
with respect (훿, 푡푖) in [0, 훿0]×퐵(푡푖), where 퐵(푡푖) is a closed neighborhood of 푡푖.
Further, we assume that the above assumption is true if any of the 푍 in 푓 is in
its left-limit value rather than the concurrent value.
Remark 5.3.1. The third regularity condition is needed when we want to prove con-
vergence in density. For example, consider that when 훿 ↓ 0, we have 푍푡2+훿 → 푍푡2 .
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Then, we can see that
lim
훿↓0
푝푟(푍푡1 = 푧1, 푍푡2+훿 = 푧2, 푍푡3 = 푧3)
= lim
훿↓0
lim
Δ1↓0
Δ2↓0
Δ3↓0
푃푟(푍푡1 ∈ [푧1, 푧1 + Δ1], 푍푡2+훿 ∈ [푧2, 푧2 + Δ2], 푍푡3 ∈ [푧3, 푧3 + Δ3])
Δ1Δ2Δ3
= lim
Δ1↓0
Δ2↓0
Δ3↓0
lim
훿↓0
푃푟(푍푡1 ∈ [푧1, 푧1 + Δ1], 푍푡2+훿 ∈ [푧2, 푧2 + Δ2], 푍푡3 ∈ [푧3, 푧3 + Δ3])
Δ1Δ2Δ3
= lim
Δ1↓0
Δ2↓0
Δ3↓0
푃푟(푍푡1 ∈ [푧1, 푧1 + Δ1], 푍푡2 ∈ [푧2, 푧2 + Δ2], 푍푡3 ∈ [푧3, 푧3 + Δ3])
Δ1Δ2Δ3
=푝푟(푍푡1 = 푧1, 푍푡2 = 푧2, 푍푡3 = 푧3)
The validity of interchanging the limits at second equality is because of the third
regularity condition. The third equality comes from the fact that probabilities are
expectations of indicator functions and that dominated convergence theorem applies.
Next, we notice the following lemma:
Lemma 5.3.2.
퐸[휂푡∣ℋ푡−] = 휆푡
Proof.
퐸[휂푡∣ℋ푡−] =퐸[lim
훿↓0
퐸[푟푡(훿)∣ℱ푡−,푡+]
훿
∣ℋ푡−]
= lim
훿↓0
퐸[푟푡(훿)∣ℋ푡−]
훿
=휆푡
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The second equality is because of Dominant Convergence Theorem and Tower
Property of conditional expectation (see Rogers and Williams 1994, p139-140), since
ℋ푡− ⊂ ℱ푡−,푡+.
Remark 5.3.3. If 휂푡 is also ℋ푡−-measurable, we will have
휆푡 = 퐸[휂푡∣ℋ푡−] = 휂푡
Therefore, the main step to prove Theorem 2.3.3 is to prove that 휂푡 isℋ푡−-measurable,
when ﬁnite time sequential randomization is true.
Before proving 휂푡 is ℋ푡−-measurable, we need two more lemmas.
Lemma 5.3.4. If the ca`dla`g process 푍푡 follows the ﬁnite time sequential ran-
domization as deﬁned in Deﬁnition 2.3.2, then the following version of FTSR is
also true,
푝푟(퐴푡푛∣퐿¯푡푛−1 , 퐿푡푛−, 퐴¯푡푛−1 , 푌¯ 0푡푛−1 , 푌 0푡푛−, 푌 0푡푛+) (5.3.1)
=푝푟(퐴푡푛∣퐿¯푡푛−1 , 퐿푡푛−, 퐴¯푡푛−1 , 푌¯ 0푡푛−1 , 푌 0푡푛−)
where 퐿¯푡푛−1 = (퐿푡1 , 퐿푡2 , ⋅ ⋅ ⋅ , 퐿푡푛−1), 퐴¯푡푛−1 = (퐴푡1 , 퐴푡2 , ⋅ ⋅ ⋅ , 퐴푡푛−1), 푌¯ 0푡푛−1 = (푌 0푡1, 푌 0푡2,
⋅ ⋅ ⋅ , 푌 0푡푛−1), and 푌 0푡푛+ = (푌 0푡푛+1 , 푌 0푡푛+2 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙).
Remark 5.3.5. The diﬀerence between (5.3.1) and the original deﬁnition of FTSR
is that in (5.3.1) most 퐿’s and 푌 0’s are stated in their concurrent values, while in
Deﬁnition 2.3.2, they are all stated in their left limits. Lemma 5.3.4 is only for
technical convenience.
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Proof. Without loss of generality, we only need to prove that if we have
푝푟(퐴푡2∣퐿푡1−, 퐿푡2−, 퐴푡1 , 푌 0푡1−, 푌 0푡2−, 푌 0푡3−) = 푝푟(퐴푡2 ∣퐿푡1−, 퐿푡2−, 퐴푡1 , 푌 0푡1−, 푌 0푡2−)
for any 푡1 < 푡2 < 푡3, we will have
푝푟(퐴푡2 ∣퐿푡1 , 퐿푡2−, 퐴푡1 , 푌 0푡1 , 푌 0푡2−, 푌 0푡3) = 푝푟(퐴푡2∣퐿푡1 , 퐿푡2−, 퐴푡1 , 푌 0푡1 , 푌 0푡2−).
Or equivalently, if we have
푝푟(퐴푡2 , 퐿푡1−, 퐿푡2−, 퐴푡1 , 푌
0
푡1−, 푌
0
푡2−, 푌
0
푡3−)푝푟(퐿푡1−, 퐿푡2−, 퐴푡1 , 푌
0
푡1−, 푌
0
푡2−) (5.3.2)
=푝푟(퐴푡2 , 퐿푡1−, 퐿푡2−, 퐴푡1 , 푌
0
푡1−, 푌
0
푡2−)푝푟(퐿푡1−, 퐿푡2−, 퐴푡1 , 푌
0
푡1−, 푌
0
푡2−, 푌
0
푡3−)
for any 푡1 < 푡2 < 푡3, we need to prove that
푝푟(퐴푡2 , 퐿푡1 , 퐿푡2−, 퐴푡1 , 푌
0
푡1
, 푌 0푡2−, 푌
0
푡3
)푝푟(퐿푡1 , 퐿푡2−, 퐴푡1 , 푌
0
푡1
, 푌 0푡2−) (5.3.3)
=푝푟(퐴푡2 , 퐿푡1 , 퐿푡2−, 퐴푡1 , 푌
0
푡1
, 푌 0푡2−)푝푟(퐿푡1 , 퐿푡2−, 퐴푡1 , 푌
0
푡1
, 푌 0푡2−, 푌
0
푡3
)
Since (5.3.2) is true for any triple of 푡1 < 푡2 < 푡3, we hope to ﬁnd a sequence of
푡1,푘 → 푡1 and 푡3,푘 → 푡3, such that 퐿푡1,푘− → 퐿푡1 , 푌 0푡1,푘− → 푌 0푡1 and 푌 0푡3,푘− → 푌 0푡3 .
Considering 퐿푡1 for example, since 퐿푡 is a ca`dla`g process, we choose any 푡1,푘 ↓ 푡1.
We then choose 푠1,푘 ∈ (푡1, 푡1,푘), such that ∣퐿푠1,푘 − 퐿푡1,푘−∣ < 1푘 . Notice that
∣퐿푡1 − 퐿푡1,푘−∣ ≤ ∣퐿푡1 − 퐿푠1,푘 ∣+ ∣퐿푠1,푘 − 퐿푡1,푘−∣
Let 푘 →∞, since 퐿 is right continuous, the ﬁrst term on the right hand side converges
to zero, and the second term is controlled by 1
푘
. Therefore, 퐿푡1,푘− converges to 퐿푡1 ,
a.s.. (Note that the proof is for a point-wise convergence. 푠1,푘 may be a random
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function of 휔, but 푡1,푘 is a deterministic sequence.) Similar proofs holds for 푌
0
푡1
and
푌 0푡3 .
By deﬁnition, (5.3.2) holds for every set of (푡1,푘, 푡2, 푡3,푘). Therefore, we can take
the limit to both sides of (5.3.2) when 푘 → ∞. Using a similar argument as in
Remark 5.3.1, we can take limit inside the density function and thus prove that
(5.3.3) is true.
Lemma 5.3.6. Suppose FTSR is true. If we deﬁne
ℱ = 휎(푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
ℋ = 휎(푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡−)
we have
lim
훿↓0
퐸[푟푡(훿)∣ℱ ]
훿
= lim
훿↓0
퐸[푟푡(훿)∣ℋ]
훿
(5.3.4)
Proof. First, we notice that the limits on both sides of equation (5.3.4) exist and
ﬁnite. This fact follows from the regularity condition 1 that 휂푡 exist and is ﬁnite.
Take lim훿↓0
퐸[푟푡(훿)∣ℱ ]
훿
for example.
lim
훿↓0
퐸[푟푡(훿)∣ℱ ]
훿
= lim
훿↓0
퐸[퐸[푟푡(훿)∣휎(푍¯푡−, 푌 0푡 )]∣ℱ ]
훿
=퐸[lim
훿↓0
퐸[푟푡(훿)∣휎(푍¯푡−, 푌 0푡 )]
훿
∣ℱ ]
=퐸[휂푡∣ℱ ]
The existence is guaranteed by the dominated convergence theorem, and 퐸[휂푡∣ℱ ] is
obviously ﬁnite.
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Given equation (2.3.3) and Lemma 5.3.4, we always have
퐸[퐼퐴푡 ∕=퐴푡푛 ∣퐿¯푡−, 퐴¯푡푛 , 푌¯ 0푡−, 푌 0푡+] = 퐸[퐼퐴푡 ∕=퐴푡푛 ∣퐿¯푡−, 퐴¯푡푛 , 푌¯ 0푡−] (5.3.5)
where 퐿¯푡− = (퐿푡1 , 퐿푡2 , ⋅ ⋅ ⋅ , 퐿푡푛−1 , 퐿푡푛 , 퐿푡−)푇 , 퐴¯푡푛 = (퐴푡1 , 퐴푡2 , ⋅ ⋅ ⋅ , 퐴푡푛)푇 ,
푌¯ 0푡− = (푌
0
푡1
, 푌 0푡2 , ⋅ ⋅ ⋅ , 푌 0푡푛 , 푌 0푡−)푇 , and 푌 0푡+ = (푌 0푡푛+1 , 푌 0푡푛+2 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)푇 .
In the regularity conditions, since we assumed existence of joint density, the usual
deﬁnition of conditional probability is a version of the conditional expectation deﬁned
using 휎-ﬁelds. In our case, we have
lim
훿↓0
퐸[푟푡(훿)∣ℱ ]
훿
= lim
훿↓0
푝푟(퐴푡+훿 ∕= 퐴푡−∣푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
훿
= lim
훿↓0
lim
푡푛↑푡−
푝푟(퐴푡+훿 ∕= 퐴푡푛∣푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡푛 , 퐿푡−, 푌 0푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
훿 + (푡− 푡푛)
= lim
푡푛↑푡−
lim
훿↓0
푝푟(퐴푡+훿 ∕= 퐴푡푛∣푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡푛 , 퐿푡−, 푌 0푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
훿 + (푡− 푡푛)
= lim
푡푛↑푡−
푝푟(퐴푡 ∕= 퐴푡푛∣푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡푛 , 퐿푡−, 푌 0푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
푡− 푡푛
= lim
푡푛↑푡−
퐸[퐼퐴푡 ∕=퐴푡푛 ∣퐿¯푡−, 퐴¯푡푛 , 푌¯ 0푡−, 푌 0푡+]
푡− 푡푛
The second equality is guaranteed by the third regularity condition. The interchange-
ability of limits are guaranteed by the fourth regularity condition, since we have
lim
훿↓0
푝푟(퐴푡+훿 ∕= 퐴푡푛∣푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡푛 , 퐿푡−, 푌 0푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
훿 + (푡− 푡푛)
=
푝푟(퐴푡 ∕= 퐴푡푛∣푍푡1 , ⋅ ⋅ ⋅ , 푍푡푛−1 , 푍푡푛 , 퐿푡−, 푌 0푡−, 푌 0푡푛+1 , ⋅ ⋅ ⋅ , 푌 0푡푛+푙)
푡− 푡푛
being uniform in 푡푛.
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Similarly, we can prove that
lim
훿↓0
퐸[푟푡(훿)∣ℋ]
훿
= lim
푡푛↑푡−
퐸[퐼퐴푡 ∕=퐴푡푛 ∣퐿¯푡−, 퐴¯푡푛 , 푌¯ 0푡−]
푡− 푡푛
Therefore, we have
lim
훿↓0
퐸[푟푡(훿)∣ℱ ]
훿
= lim
푡푛↑푡−
퐸[퐼퐴푡 ∕=퐴푡푛 ∣퐿¯푡−, 퐴¯푡푛 , 푌¯ 0푡−, 푌 0푡+]
푡− 푡푛
= lim
푡푛↑푡−
퐸[퐼퐴푡 ∕=퐴푡푛 ∣퐿¯푡−, 퐴¯푡푛 , 푌¯ 0푡−]
푡− 푡푛
= lim
훿↓0
퐸[푟푡(훿)∣ℋ]
훿
Now we prove the ﬁnal key lemma
Lemma 5.3.7. Given FTSR, 휂푡 is ℋ푡−-measurable.
Proof. We prove the result by the deﬁnition of a measurable function with respect
to a 휎-ﬁeld.
For any 푎 ∈ ℛ, consider the following set
퐵 ≡ {휔 : 휂푡 ≤ 푎}
Since 휂푡 is measurable w.r.t. ℱ푡−,푡+, 퐵 ∈ ℱ푡−,푡+.
By Lemma (25.9) (Rogers and Williams, 1994), 퐵 is a 휎-cylinder, and it can be
decided by variables from countably many time points. Suppose the collection of
these countably many time points is 푆. 푆 = 푆1
∪
푆2, where 푡1,푖 < 푡 for 푡1,푖 ∈ 푆1, and
푡2,푗 > 푡 for 푡2,푗 ∈ 푆2.
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Let ℱ푆 denote the 휎-ﬁeld generated by (푍푡1,푖 , 푖 ∈ 풩 ;푍푡−;푌 0푡2,푗 , 푗 ∈ 풩 ). We have
augmented the 휎-ﬁeld generated by variables from 푆 with 푍푡−.
Next deﬁne the following series of 휎-ﬁelds:
ℱ1 = 휎(푍푡1,1 , 푍푡−, 푌 0푡2,1)
ℱ2 = 휎(ℱ1, 푍푡1,2 , 푌 0푡2,1)
⋅ ⋅ ⋅
ℱ∞ = ℱ푆
Considering the following sets:
퐵1 = {휔 : 퐸[휂푡∣ℱ1] ≤ 푎}
퐵2 = {휔 : 퐸[휂푡∣ℱ2] ≤ 푎}
⋅ ⋅ ⋅
퐵푆 = 퐵∞ = {휔 : 퐸[휂푡∣ℱ푆] ≤ 푎}
We have 퐵푘 ∈ ℱ푘.
It’s easy to see that
퐵1 ⊃ 퐵2 ⊃ ⋅ ⋅ ⋅ ⊃ 퐵푆
because
퐸[퐸[휂푡∣ℱ푘]∣ℱ푘−1] = 퐸[휂푡∣ℱ푘−1]
and taking conditional expectation preserves the direction of inequality.
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Also, with the above deﬁnitions, ℱ푘 ↑ ℱ푆. Therefore, by Theorem (5.7) from
Durrett 2005, Chapter 4, we know that
퐸[휂푡∣ℱ푘]→ 퐸[휂푡∣ℱ푆] a.s.
Then, it is easy to see that 퐼퐵1 → 퐼퐵푆 a.s., and that
퐵푆 =
∞∩
푖=1
퐵푖
with diﬀerence up to a null set.
We now claim that
퐵푆 = 퐵 (5.3.6)
with diﬀerence up to a null set.
Obviously 퐵 ⊂ 퐵푆. Suppose 푃푟(퐵푆 −퐵) > 0. Since 퐵푆 −퐵 ∈ ℱ푆, we have∫
퐵푆−퐵
휂푡푃푟(푑휔) =
∫
퐵푆−퐵
퐸[휂푡∣ℱ푆]푃푟(푑휔)
Then
퐿퐻푆 > 푎푃푟(퐵푆 −퐵)
and
푅퐻푆 ≤ 푎푃푟(퐵푆 −퐵)
This is a contradiction.
Therefore, 퐵 =
∩∞
푖=1퐵푖 with diﬀerence up to a null set.
Next, we deﬁne
ℋ1 = 휎(푍푡1,1 , 푍푡−)
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ℋ2 = 휎(ℋ1, 푍푡1,2)
⋅ ⋅ ⋅
Given FTSR, by Lemma 5.3.6, we have
퐸[휂푡∣ℱ푘] = 퐸[휂푡∣ℋ푘]
Therefore, every 퐵푘 ∈ ℋ푘, and thus 퐵푘 ∈ ℋ푡−.
Since 퐵 =
∩∞
푖=1퐵푖, 퐵 ∈ ℋ푡− as well. By the deﬁnition of a measurable function,
휂푡 is measurable with respect to ℋ푡−.
Combining all the results in this Appendix, we have proved Theorem 2.3.3.
5.4 Proof of Theorem 2.3.4
Proof. Denote 풢푡 = 휎(푌 0푡−, 퐿푡−, 퐴푡−) and 풢푡0,푡 = 휎({푌 0푙− : 푡0 ≤ 푙 ≤ 푡}, {퐿푙− : 푡0 ≤ 푙 ≤
푡}, {퐴푙 : 푡0 ≤ 푙 < 푡}). Recall the deﬁnition of 푟푡(훿) = (1−퐴푡−)퐴푡+훿 +퐴푡−(1−퐴푡+훿),
and 푍푡 = (푌
0
푡 , 퐿푡, 퐴푡)
푇 . By the Markovian property, we have
퐸[푟푡(훿)∣휎(푍¯푡−)] = 퐸[푟푡(훿)∣풢푡0,푡],
for any 푡0 < 푡. Since 풢푡0,푡 ↓ 풢푡, by Durrett 2005 (Chapter 4, Theorem 6.3),
퐸[푟푡(훿)∣풢푡0,푡] → 퐸[푟푡(훿)∣풢푡]. Therefore,
퐸[푟푡(훿)∣휎(푍¯푡−)] = 퐸[푟푡(훿)∣풢푡],
Similarly, we can show that
퐸[푟푡(훿)∣휎(푍¯푡−, 푌 0푡+푠)] = 퐸[푟푡(훿)∣휎(풢푡, 푌 0푡+푠)].
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Therefore, we have a reduced form of continuous time sequential randomization
lim
훿↓0
퐸[푟푡(훿)∣휎(풢푡, 푌 0푡+푠)]
훿
= lim
훿↓0
퐸[푟푡(훿)∣휎(푍¯푡−, 푌 0푡+푠)]
훿
= lim
훿↓0
퐸[푟푡(훿)∣휎(푍¯푡−)]
훿
= lim
훿↓0
퐸[푟푡(훿)∣풢푡]
훿
First, we notice that if we can prove
푝푟(푌 0푡+푠, 퐴푡−∣푌 0푡−, 퐿푡−)푝푟(퐴푡∣푌 0푡−, 퐿푡−) = 푝푟(푌 0푡+푠, 퐴푡∣푌 0푡−, 퐿푡−)푝푟(퐴푡−∣푌 0푡−, 퐿푡−),
(5.4.1)
we can conclude (2.3.4). The reason is as follows: assuming that we have (5.4.1) to
be true, we integrate 퐴푡− out on both sides of the equation. We will get
푝푟(푌 0푡+푠∣푌 0푡−, 퐿푡−)푝푟(퐴푡∣푌 0푡−, 퐿푡−) = 푝푟(푌 0푡+푠, 퐴푡∣푌 0푡−, 퐿푡−).
Divide the above equation by 푝푟(푌 0푡+푠∣푌 0푡−, 퐿푡−), we obtain (5.4.1).
Consider
푔(훿1, 훿2) ≡ 푝푟(푌 0푡+푠∣퐴푡+훿1 = 푎1, 퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
where 훿1 > 0 and 훿2 > 0.
We observe that
lim
훿1↓0
lim
훿2↓0
푔(훿1, 훿2)
= lim
훿1↓0
푝푟(푌 0푡+푠∣퐴푡+훿1 = 푎1, 퐴푡− = 푎2, 푌 0푡−, 퐿푡−)
= lim
훿1↓0
푝푟(푌 0푡+푠, 퐴푡+훿1 = 푎1∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−)
푝푟(퐴푡+훿1∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−)
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=푝푟(푌 0푡+푠∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−) lim
훿1↓0
푝푟(퐴푡+훿1 = 푎1∣푌 0푡+푠, 퐴푡− = 푎2, 푌 0푡−, 퐿푡−)
푝푟(퐴푡+훿1 = 푎1∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−)
=
⎧⎨⎩
푝푟(푌 0푡+푠∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−)× lim훿1↓0 1−푝푟(퐴푡+훿1 ∕=퐴푡−∣푌
0
푡+푠,퐴푡−=푎2,푌
0
푡−,퐿푡−)
1−푝푟(퐴푡+훿1 ∕=퐴푡−∣퐴푡−=푎2,푌 0푡−,퐿푡−)
if 푎1 = 푎2
푝푟(푌 0푡+푠∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−)× lim훿1↓0
푝푟(퐴푡+훿1
∕=퐴푡−∣푌 0푡+푠,퐴푡−=푎2,푌 0푡−,퐿푡−)
훿
푝푟(퐴푡+훿1
∕=퐴푡−∣퐴푡−=푎2,푌 0푡−,퐿푡−)
훿
if 푎1 ∕= 푎2
=푝푟(푌 0푡+푠∣퐴푡− = 푎2, 푌 0푡−, 퐿푡−)
Here taking limit inside density is guaranteed by the third regularity condition, and
the last equality is because of continuous time sequential randomization assumption.
We also observe that
lim
훿2↓0
lim
훿1↓0
푔(훿1, 훿2)
= lim
훿2↓0
푝푟(푌 0푡+푠∣퐴푡−훿2 , 퐴푡, 푌 0푡−, 퐿푡−)
= lim
훿2↓0
푝푟(푌 0푡+푠∣퐴푡, 푌 0푡−, 퐿푡−)
=푝푟(푌 0푡+푠∣퐴푡, 푌 0푡−, 퐿푡−)
The second equality used the Markov property.
If we can interchange the limits, then
푝푟(푌 0푡+푠∣퐴푡−, 푌 0푡−, 퐿푡−) = 푝푟(푌 0푡+푠∣퐴푡, 푌 0푡−, 퐿푡−).
Equation (5.4.1) follows from the deﬁnition of conditional density.
152
We now establish the fact that
lim
훿2↓0
lim
훿1↓0
푔(훿1, 훿2) = lim
훿1↓0
lim
훿2↓0
푔(훿1, 훿2)
by showing that lim훿1↓0 푔(훿1, 훿2) is uniform in 훿2.
Deﬁne 푔1(훿2) = lim훿1↓0 푔(훿1, 훿2), then
∣푔(훿1, 훿2)− 푔1(훿2)∣
=
∣∣∣∣푝푟(푌 0푡+푠, 퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
−푝푟(푌
0
푡+푠, 퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
∣∣∣∣
=푝푟(푌 0푡+푠∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
×
∣∣∣∣푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−, 푌 0푡+푠)푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
−푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌
0
푡−, 퐿푡−, 푌
0
푡+푠)
푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
∣∣∣∣
Consider the ratio
푝푟(퐴푡+훿1=푎1∣퐴푡−훿2=푎2,푌 0푡−,퐿푡−,푌 0푡+푠)
푝푟(퐴푡+훿1=푎1∣퐴푡−훿2=푎2,푌 0푡−,퐿푡−)
. We claim that it converges to
푝푟(퐴푡=푎1∣퐴푡−훿2=푎2,푌 0푡−,퐿푡−,푌 0푡+푠)
푝푟(퐴푡=푎1∣퐴푡−훿2=푎2,푌 0푡−,퐿푡−)
uniformly in 훿2.
If 푎1 = 푎2, density 푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−) is bounded from below by
a positive number. By the third regularity condition,
푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−, 푌 0푡+푠)
→ 푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−, 푌 0푡+푠)
and
푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)→ 푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
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uniformly in 훿2, as 훿1 ↓ 0. When the denominators are bounded from below by a
positive number, the ratio also converges uniformly.
If 푎1 ∕= 푎2, by the fourth regularity condition,
푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−, 푌 0푡+푠)
훿1 + 훿2
→ 푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌
0
푡−, 퐿푡−, 푌
0
푡+푠)
훿2
and
푝푟(퐴푡+훿1 = 푎1∣퐴푡−훿2 = 푎2, 푌 0푡−, 퐿푡−)
훿1 + 훿2
→ 푝푟(퐴푡 = 푎1∣퐴푡−훿2 = 푎2, 푌
0
푡−, 퐿푡−)
훿2
uniformly in 훿2, as 훿1 ↓ 0. Also the denominator 푝푟(퐴푡+훿1=푎1∣퐴푡−훿2=푎2,푌
0
푡−,퐿푡−)
훿1+훿2
is bounded
from below by a positive number. Hence we establish the uniformly convergence of
the ratio.
Combining the two cases above, ∣푔(훿1, 훿2)− 푔1(훿2)∣ is bounded by 푂(훿1) that does
not depend on 훿2, so 푔(훿1, 훿2)→ 푔1(훿2) uniformly in 훿2. Therefore,
lim
훿2↓0
lim
훿1↓0
푔(훿1, 훿2) = lim
훿1↓0
lim
훿2↓0
푔(훿1, 훿2)
By the argument at the beginning of the proof, we have proved the ﬁrst part of the
theorem.
To show that (2.3.4) implies FTSR, without of loss of generality, we consider
푝푟(퐴푡∣퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−, 푌 0푡+푠)
=
푝푟(퐴푡, 퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌
0
(푡−푚)−, 푌
0
푡+푠)∑
푖=0,1 푝푟(퐴푡 = 푖, 퐿푡−, 푌
0
푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−, 푌
0
푡+푠)
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=
푝푟(푌 0푡+푠∣퐴푡, 퐿푡−, 푌 0푡−)푝푟(퐴푡, 퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−)∑
푖=0,1 푝푟(푌
0
푡+푠∣퐴푡 = 푖, 퐿푡−, 푌 0푡−)푝푟(퐴푡 = 푖, 퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−)
=
푝푟(푌 0푡+푠∣퐿푡−, 푌 0푡−)푝푟(퐴푡, 퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−)∑
푖=0,1 푝푟(푌
0
푡+푠∣퐿푡−, 푌 0푡−)푝푟(퐴푡 = 푖, 퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−)
=
푝푟(퐴푡, 퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌
0
(푡−푚)−)∑
푖=0,1 푝푟(퐴푡 = 푖, 퐿푡−, 푌
0
푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−)
=푝푟(퐴푡∣퐿푡−, 푌 0푡−, 퐴푡−푚, 퐿(푡−푚)−, 푌 0(푡−푚)−)
The second equality is because of Markov property. The third equality used equation
(2.3.4). We have proved the second half of the theorem.
5.5 Simulation Parameters
In all simulation models from M1 to M4, we specify parameters as follows:
∙ Let 푔(푉, 푡) = 퐶, a constant. Let 퐶 = 100.
∙ For M1 (also in M3 and M4), let 휃 = 0.2 and 휎 = 1.
∙ For M2, let 푚 = 2, 휃1 = 0.2, 휎1 = 1 and 휃2 = 1, 휎2 = 0.5. The transition
probability of 퐽푡 would be 푃 (푡) = 푒
퐴푡, where 퐴 =
⎛⎜⎜⎝−1 1
1 −1
⎞⎟⎟⎠.
∙ For initial value, 푒0 is generated from 푁(0, 휎√2휃 ).
∙ The causal parameter Ψ = 1.
∙ In M1, M2 and M3, 푠(퐴푡, 푌푡) = 푒훼0+훼1퐴푡+훼2푌푡+훼3퐴푡푌푡 . Let 훼1 = −0.3, 훼2 =
−0.005, 훼3 = 0.007 and 훼0 = −0.2.
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∙ In M4, 퐴푡 is generated as follows: if 푌푡−0.5 > 101 and 푌푡 > 101, 퐴푡 jumps
to 0 with probability 0.7, if 퐴푡 has not been 0; if 푌푡0.5 < 99 and 푌푡 < 99, 퐴푡
jumps to 1 with probability 0.7, if it has not been 1; otherwise, 퐴푡 is generated
following the same model as similar to that in M1, except that 푠(퐴푡, 퐿
∗
푡 ) =
푒훼0+훼1퐴푡+훼2퐿
∗
푡+훼3퐴푡퐿
∗
푡 . The values of the 훼’s are the same as before.
∙ In M4, 휂푡 follows an Ornstein-Uhlenbeck process with parameters 휃 = 0.2 and
휎 = 1.
∙ For initial value, 퐴0 is generated from 퐵푒푟푛표푢푙푙푖(푒푥푝푖푡(훼0 + 훼2푌0)).
∙ 퐾 = 5 is the number of periods.
∙ Number of subjects 푛 = 5000.
5.6 Continuous Time Ignorability
In this section, we give a technical deﬁnition of continuous time ignorability assump-
tion, and prove a suﬃcient condition for a Markov process to satisfy the continuous
time ignorability assumption.
This deﬁnition of continuous time ignorability follows and extends the formula-
tions by Lok (Lok, 2008), whose formulation is only for a single outcome. It also
generalizes the formulation in Chapter 2, whose deﬁnition is for a rank preserving
model.
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Deﬁnition 5.6.1 (Continuous Time Ignorability). Assume that 푋푡 = (퐴
∗
푡 , 퐿푡, 푌푡,
푌
퐴¯∗푡−0
푡 )
푇 is a continuous time ca`dla`g process and that 퐴∗푡 is a discrete jumping process.
Let
ℱ푡,ℎ = 휎(퐿¯푡−, 푌¯푡−, 퐴¯∗푡−, 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ),
and
ℱ푡 = 휎(퐿¯푡−, 푌¯푡−, 퐴¯∗푡−).
Assume that
퐸[퐼퐴∗푠 jumps more than once within [푡,푡+ℎ]∣ℱ푡,ℎ] = 표1(ℎ).
where 표1(ℎ)/ℎ→ 0 a.s. when ℎ→ 0.
We say that the process satisﬁes continuous time ignorability assumption,
if
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣ℱ푡,ℎ] = ℎ푠(퐿¯푡−, 푌¯푡−, 퐴¯∗푡−) + 표2(ℎ)
where 푠(.) is a nonnegative functional, bounded and measurable with respect to ℱ푡,
and 표2(ℎ)/ℎ→ 0 a.s. when ℎ→ 0.
The deﬁnition basically states that treatment at time 푡 only depends on observable
historical covariates, outcomes and treatments prior to time 푡, and does not depend
on the future potential outcome.
The following lemma can be used to prove that our model follows the continuous
time ignorability.
157
Lemma 5.6.2. Assume that 푋푡 = (퐴
∗
푡 , 퐿푡, 푌푡, 푌
퐴¯∗푡−0
푡 )
푇 is a continuous time Markov
process and that it satisﬁes the regularity conditions in Deﬁnition 5.6.1. Let
풢푡,ℎ = 휎(퐿푡−, 푌푡−, 퐴∗푡−, 푌 퐴¯
∗
푡−,0
푡− , 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ),
and
ℋ푡 = 휎(퐿푡−, 푌푡−, 퐴∗푡−).
If
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡− ∣풢푡,ℎ] = ℎ푠∗(퐿푡−, 푌푡−, 퐴∗푡−) + 표3(ℎ), (5.6.1)
where 푠∗(.) is a nonnegative functional, bounded and measurable with respect to ℋ푡,
and 표3(ℎ)/ℎ→ 0 a.s. when ℎ→ 0, then the Markov process satisﬁes the continuous
time ignorability.
Proof. Let 풢푡 = 휎(퐿푡−, 푌푡−, 퐴∗푡−, 푌 퐴¯
∗
푡−,0
푡− ), ℱ ′푡 = 휎(퐿¯푡−, 푌¯푡−, 퐴¯∗푡−, 푌¯ 퐴¯
∗
푡−,0
푡− ), and ℱ ′푡,ℎ =
휎(퐿¯푡−, 푌¯푡−, 퐴¯∗푡−, 푌¯
퐴¯∗푡−,0
푡− , 푌
퐴¯∗
(푡+ℎ)−,0
푡+ℎ ).
We claim that
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡− ∣ℱ ′푡,ℎ] = 퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣풢푡,ℎ]
For any ﬁnite set of 푡1 < 푡2 < ⋅ ⋅ ⋅ < 푡푛 < 푡, let
ℱ ′푛,푡,ℎ = 휎(퐿푡1 , ..., 퐿푡푛 , 퐿푡−, 푌푡1 , ..., 푌푡푛 , 푌푡−, 퐴∗푡1 , ..., 퐴∗푡푛 , 퐴∗푡−, 푌
퐴¯∗푡1−,0
푡1 , ...,
푌
퐴¯∗푡푛−,0
푡푛 , 푌
퐴¯∗푡−,0
푡− , 푌¯
퐴¯∗
(푡+ℎ)−,0
(푡+ℎ)− ).
It is easy to see that
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡− ∣ℱ ′푛,푡,ℎ] = 퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡− ∣풢푡,ℎ], 푎.푠.,
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because of the Markov property of 푋푡 and the equivalence of conditional expectation.
By the deﬁnition of conditional expectation,∫
퐵
퐼퐴∗푡+ℎ ∕=퐴∗푡−푑푃 =
∫
퐵
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣풢푡,ℎ]푑푃, 푎.푠.
for any 퐵 ∈ ℱ ′푛,푡,ℎ. Since ℱ ′푡,ℎ is generated by all such ℱ ′푛,푡,ℎ’s, by dominated con-
vergence theorem, the above equation is true for any 퐵 ∈ ℱ ′푡,ℎ. Therefore, we have
proved that
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡− ∣ℱ ′푡,ℎ] = 퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣풢푡,ℎ]
Therefore,
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣ℱ ′푡,ℎ] = ℎ푠∗(퐿푡−, 푌푡−, 퐴∗푡−) + 표3(ℎ)
and
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣ℱ푡,ℎ] = 퐸{퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡− ∣ℱ ′푡,ℎ]∣ℱ푡,ℎ}
= ℎ푠∗(퐿푡−, 푌푡−, 퐴∗푡−) + 퐸[표3(ℎ)∣ℱ푡,ℎ]
As we have assumed that 표3(ℎ)/ℎ → 0 a.s. as ℎ → 0, 퐸[표3(ℎ)/ℎ∣ℱ푡,ℎ] → 0 a.s. as
ℎ→ 0 by dominated convergence theorem. Denote 표4(ℎ) = 퐸[표3(ℎ)∣ℱ푡,ℎ]
We have proven that
퐸[퐼퐴∗푡+ℎ ∕=퐴∗푡−∣ℱ푡,ℎ] = ℎ푠∗(퐿푡−, 푌푡−, 퐴∗푡−) + 표4(ℎ)
which satisﬁes the deﬁnition of the continuous time ignorability.
Using Lemma 5.6.2 to prove that our model satisﬁes Deﬁnition 5.6.1 is straightfor-
ward. It is easy to see that the model we deﬁned in Section 3.2 guarantees equation
(5.6.1).
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5.7 Simulation of Endpoint-Conditioned Bounded Simple Ran-
dom Walk
This section describes how we simulate the path of 퐴∗ given the number of switches
in the path and that the path matches certain starting point and ending point. We
reformulate the problems as the follows. We need to simulate a series of binary
푥′1, 푥
′
2, ⋅ ⋅ ⋅ , 푥′푀 being either +1 or −1, such that 푠푘 =
∑푘
푗=1 푥
′
푗 is always between 퐿
and 푈 inclusively, 퐿 < 푈 , and that 푠푀 = 푁 , assuming all qualifying paths have the
same probability.
We start by considering all the paths that only matches the end points, and
assume all these paths have the same probability. We denote the proportion of these
paths that are bounded between 퐿 and 푈 to be 푝(푀,푁,퐿, 푈). It is then very easy
to get a recursive equation
푝(푀,푁,퐿, 푈) =
푀 −푁
2푀
푝(푀 − 1, 푁 + 1, 퐿+ 1, 푈 + 1) (5.7.1)
+
푀 +푁
2푀
푝(푀 − 1, 푁 − 1, 퐿− 1, 푈 − 1)
with boundary conditions properly deﬁned.
If the function 푞(푀,푁,퐿, 푈) can be calculated easily, we can calculate
푃 (푥′1 = 1∣{푥′푗}푀푗=1 is a qualiﬁed path.)
=
푃 (푥′1 = 1, {푥′푗}푀푗=1 is a qualiﬁed path.)
푃 ({푥′푗}푀푗=1 is a qualiﬁed path.)
=
푃 (푥′1 = 1)푝(푀 − 1, 푁 − 1, 퐿− 1, 푈 − 1)
푝(푀,푁,퐿, 푈)
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=
푀+푁
2푀
푝(푀 − 1, 푁 − 1, 퐿− 1, 푈 − 1)
푝(푀,푁,퐿, 푈)
,
and
푃 (푥′2 = 1∣푥′1 = 1, {푥′푗}푀푗=1 is a qualiﬁed path.)
=
푃 (푥′2 = 1∣푥′1 = 1)푃 ({푥′푗}푀푗=1 is a qualiﬁed path.∣푥′1 = 1, 푥′2 = 1)
푃 ({푥′푗}푀푗=1 is a qualiﬁed path.∣푥′1 = 1)
=
푀+푁−1
2푀−2 푝(푀 − 2, 푁 − 2, 퐿− 2, 푈 − 2)
푝(푀 − 1, 푁 − 1, 퐿− 1, 푈 − 1) .
Similarly, we can calculate any
푃 (푥′푘 = 1∣푥′1 = 푖1, ⋅ ⋅ ⋅ , 푥′푘−1 = 푖푘−1, {푥′푗}푀푗=1 is a qualiﬁed path.)
in a similar fashion, and thus simulate 푥′푗 sequentially.
The key to the computation is how to evaluate 푝(푀,푁,퐿, 푈) eﬃciently. The
recursive equation (5.7.1) with proper boundary conditions can be used to evaluate
the function, but it is very ineﬃcient. Instead, we give a closed form formula for
푝(푀,푁,퐿, 푈), which can be evaluated much faster. Deﬁne 푛푞 as the number of
qualifying paths. Using reﬂection principle repeatedly, it can be shown that
푛푞 =
푀∑
푘=0
[⎛⎜⎜⎝ 푀
푘(푈 + 1)− 푘(퐿− 1) + (푀 +푁)/2
⎞⎟⎟⎠
−
⎛⎜⎜⎝ 푀
(푘 + 1)(푈 + 1)− 푘(퐿− 1) + (푀 +푁)/2
⎞⎟⎟⎠
−
⎛⎜⎜⎝ 푀
푘(푈 + 1)− (푘 + 1)(퐿− 1) + (푀 −푁)/2
⎞⎟⎟⎠
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+⎛⎜⎜⎝ 푀
(푘 + 1)(푈 + 1)− (푘 + 1)(퐿− 1) + (푀 −푁)/2
⎞⎟⎟⎠
]
Then
푝(푀,푁,퐿, 푈) =
푛푞⎛⎜⎜⎝ 푀
(푀 +푁)/2
⎞⎟⎟⎠
Here 푛푞 can be used to calculate the proposal distribution in Section 3.3.3.
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